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Zusammenfassung 
Kleine GTPasen sind Guanosinnukleotidbindende und –hydrolysierende Enzyme die, in 
Abhängigkeit von dem gebundenen Nukleotid, Guanosintriphosphat (GTP) oder 
Guanosindiphosphat (GDP), in zwei Aktivitätszuständen existieren. Dadurch fungieren sie 
als binäre Schalter, die Signalprozesse ausschließlich in aktivem, GTP-gebundenem Zustand 
ermöglichen. Kleine GTPasen sind in zahlreichen intrazellulären Signalprozessen, wie der 
Organisation des Zytoskeletts, vesikulärem Transport, Zellkernimport und –export, sowie 
Zellwachstum und –überleben, involviert.  
Aufgrund ihrer spezifischen Lokalisierung zu zellulären Membrankompartimenten, 
sowie der Abhängigkeit ihrer Aktivität von der Lokalisierung und dem Nukleotidstatus, sind 
kleine GTPasen attraktive Ziele für die Entwicklung von Biosensoren. Traditionelle 
Aktivitätssensoren für kleine GTPasen basieren auf Förster-Resonanz-Energietransfer 
zwischen zwei Fluoreszenzproteinen, die an die Ziel-GTPase und eine spezifische 
Bindedomäne fusioniert sind. Die Bindedomäne, ein natürlicher Bestandteil von 
Effektorproteinen, fungiert hier als Affinitätstag, der nur mit der GTP-gebundenen GTPase 
interagiert und somit die Differenzierung des Aktivitätsstatus ermöglicht. Obwohl dieses 
Sensordesign weitverbreitet ist, weist es einige Nachteile auf. Zum einen wird nicht die 
direkte Aktivierung der kleinen GTPase, sondern das nachfolgende Bindeereignis der 
Effektordomäne detektiert. Diese Interaktion konkurriert mit endogenen 
Interaktionspartnern wie Effektoren oder GAP. Desweiteren besteht die Annahme, dass 
Effektorbindung kleine GTPasen auf Membranen stabilisieren kann, wodurch traditionelle 
Sensoren möglicherweise nicht den tatsächlichen Regulationszustand reflektieren. Zum 
anderen sind diese FRET-basierte Sensoren vergleichbar groß, da neben der kleinen GTPase 
und der Effektordomäne noch zwei Fluoreszenzproteine und mehrere 
Verbindungssequenzen enthalten sind. 
Kürzlich wurde eine neue Art von FRET-basierten Sensoren zur Visualisierung der 
Aktivität von kleinen GTPasen entwickelt. Diese Sensoren ermöglichen eine direkte 
Detektion von konformationellen Änderungen in der kleinen GTPase, oder der Interaktion 
mit Effektorproteinen, und bestehen lediglich aus einem Fluoreszenzprotein, der kleinen 
GTPase und einem synthetischen Fluorophor, welches durch Aminosäureseitenketten-
markierung in die GTPase eingebracht wird. Dadurch sind diese Sensoren einerseits deutlich 
kleiner als herkömmliche Sonden und verwenden das ursprüngliche C-terminale 
Lokalisierungssignal der kleinen GTPase. Andererseits enthalten diese konformationellen 
Sensoren keinen Affinitätstag. Diese Unabhängigkeit von einer spezifischen Bindedomäne 
ermöglicht zum einen eine native Regulation des Sensors durch endogene 
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Regulationssysteme, während das Sensordesign andererseits auch für GTPasen ohne 
bekannte Effektorproteine anwendbar ist. Zunächst wurden die konformationellen 
Sensoren zur Visualisierung von Rab1b Aktivität entwickelt und wurden später auf eine 
weitere kleine GTPase, KRas, übertragen. Dadurch konnte die Universalität des 
Sensordesigns demonstriert werden. Nichts desto trotz weißt diese erste Generation der 
konformationellen Sensoren durch den sehr aufwendigen Herstellungsprozess, der 
Expertise in zahlreichen biochemischen und chemisch biologischen Methodiken benötigt, 
einen großen Nachteil auf. Daher ist das Ziel dieser Arbeit die Entwicklung einer zweiten 
Generation konformationeller Sensoren, bei der der Herstellungsprozess und die 
Anwendung in Zellstudien durch genetische Kodierung des Sensors massiv erleichtert 
werden. Um den benötigten FRET-Akzeptor, ein synthetisches Fluorophor, in die kleine 
GTPase einfügen zu können, wurde Stopkodonsuppressionsmutagenese und intrazelluläre 
orthogonale Fluoreszenzmarkierung verwendet. Der erste Teil dieser Arbeit fokussiert auf 
die Etablierung dieser beiden Schritte und verwendet Rab1b als Zielprotein, um eine 
Vergleichbarkeit mit der ersten Sensorgeneration zu gewährleisten. Der neu entwickelte, 
genetisch kodierte konformationelle Rab1b Sensor ermöglicht die raumzeitliche 
Visualisierung von Rab1b Aktivität in lebenden Zellen. Im Weiteren wurde der genetisch 
kodierte Rab1b Sensor mit dem neu entwickelten reversiblen Kryo-Arrest von lebenden 
Zellen kombiniert, um Rab1b Aktivität während vesikulärem Transport zu detektieren. 
Der zweite Teil dieser Arbeit konzentriert sich auf die Übertragung des Sensordesigns 
auf eine weitere kleine GTPase, Rheb. Bislang ist kein spezifisches Effektorprotein für Rheb 
bekannt, wodurch die Entwicklung von traditionellen Aktivitätssensoren nicht möglich ist. 
Rheb ist ein außergewöhnlich interessantes Ziel für die Biosensorenentwicklung, da dieses 
Protein als Aktivator für mTOR-Komplex 1, einen Masterregulator von Zellmetabolismus 
und –wachstum, bekannt ist. Der in dieser Arbeit entwickelte genetisch kodierte 
Rhebsensor ermöglicht die raumzeitliche Visualisierung von Rhebaktivität in lebenden 
Zellen.  
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Abstract 
Small GTPases are guanosine nucleotide binding enzymes that exist in two states, being 
active in the guanosine-triphosphate- (GTP) and inactive in the guanosine-diphosphate- 
(GDP) bound state. Thus, these proteins act as binary molecular switches, allowing signaling 
exclusively in the GTP-bound state and function in a variety of cellular signaling processes, 
including cytoskeleton organization, membrane trafficking, nuclear transport, cell survival 
and proliferation.  
Due to their localization to different cellular compartments as well as their nucleotide- 
and localization-dependent activity, small GTPases are attractive targets for biosensor 
development. Traditional biosensors for small GTPase activity are FRET-based and utilize 
binding domains of effector proteins as affinity tags. Effector proteins interact specifically 
with the GTP-bound state of a small GTPase. Thus, the affinity tag allows for discrimination 
between the activity states. To generate a FRET-probe, both interaction partners are fused 
to a fluorescent protein, enabling sensor read-out by FRET.  
Although widely used, this approach suffers a number of disadvantages. On the one 
hand, they report the activity indirectly, by binding of the affinity tag to the activated 
protein, instead of reporting the activation event directly. In fact, the interaction of the 
affinity tag with the small GTPase competes with endogenous effector proteins. As effector 
binding can stabilize small GTPases on membranes, these probes may not report the native 
regulation of the respective protein. On the other hand, such probes are comparatively 
large, containing the small GTPase, the affinity tag, two fluorescent proteins and several 
linkers.  
Recently, a new type of FRET-based sensors for small GTPase activity was developed. 
These probes allow for direct detection of conformational changes within the target protein 
and hence report activation or binding of endogenous effector directly. Moreover, the 
conformational probes consist only of a fluorescent protein, the target small GTPase and a 
synthetic dye introduced to the protein fold. Thus, these probes are smaller than traditional 
sensors, do not utilize an affinity tag and contain the native C-terminal localization signal of 
the small GTPase. This design allows for native regulation by endogenous proteins and the 
sensor principle is also applicable to targets with unknown effector proteins. Initially, such 
conformational sensors were developed for Rab1b activity and were later on applied onto a 
second small GTPase, KRas, demonstrating the versatility of the sensor design. However, 
the first generation of conformational sensors for small GTPase activity suffers from a labor-
intensive preparation process, which requires a high number of methods and expertise. The 
work presented in this thesis focused on the development of a second generation of the 
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conformational probes for small GTPases. In the first part, the sensor approach was 
genetically encoded, facilitating the preparation process and the application to cellular 
studies. The stop codon suppression technique and subsequent intracellular fluorescence 
labeling were used to introduce the FRET acceptor into the protein fold. To establish the 
protocols for stop codon mutagenesis and intracellular fluorescence labeling of small 
GTPases, the previously well characterized Rab1b conformational sensor was used. The 
obtained genetically encoded conformational Rab1b sensor allowed for spatiotemporal 
monitoring of Rab1b effector binding in live cells. Moreover, the genetically encoded Rab1b 
sensor was combined with the novel reversible cryo-arrest of living cells to analyze Rab1b 
vesicular transport in living cells.  
The second part of this work focused on the application of the genetically encoded 
sensor design to another small GTPase, Rheb. At the present time, no effector protein has 
been reported for Rheb, hindering the development of conventional probes to monitor 
Rheb spatiotemporal activity. Rheb is a particularly interesting target due to its role as an 
activator of mTORC1, a master regulator for cell metabolism, growth and proliferation. This 
work demonstrates the establishment of a genetically encoded Rheb sensor using the 
previously described conformational sensor design. This Rheb sensor allows visualization of 
spatiotemporal Rheb activity in living cells.  
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1. Introduction 
1.1 Small GTPases 
Small GTPases are guanosine nucleotide binding and hydrolyzing enzymes. The bound 
nucleotide, either guanosine triphosphate (GTP) or guanosine diphosphate (GDP), defines 
the enzyme’s activity state, being active in the GTP-bound state and inactive in the GDP-
bound form. Thereby small GTPases act as binary molecular switches, allowing for signal 
transduction only in the active state 1. Members of the Ras superfamily of small GTPases 
function as monomeric G proteins and possess key roles in a variety of cellular signaling 
processes including cytoskeleton organization, cell movement, membrane trafficking, 
nuclear transport and proliferation 2. Based on sequence and functional similarities, the Ras 
superfamily is divided into five major branches: Ras, Rho, Rab, Ran and Arf 3. Nucleotide 
binding and hydrolysis are performed by a set of conserved sequence elements, the G 
domain, which is common to all G proteins 4. The G domain comprises five G boxes (G1-G5) 
that are located over a stretch of approximately 20 kDa, conserved in structure and 
biochemistry. Small GTPases share two additional elements, the switch I and switch II 
regions 1. These regions undergo conformational changes during nucleotide exchange and 
hydrolysis and report the nucleotide of a GTPase, enabling the interaction with effector 
proteins. Effector proteins bind specifically to the active, GTP-bound state and thereby 
mediate downstream signaling in dependency of the nucleotide state of the small GTPase.  
Another hallmark shared by the majority of small GTPases is their post-translational 
modification, which, in combination with the sequence context directly upstream, dictates 
the specific subcellular localizations 5,6. The majority of Ras and Rho GTPases contain a 
C-terminal CAAX motif, which serves as a recognition site for the farnesyltransferase and 
the geranylgeranyltransferase I 7,8. Both enzymes catalyze a covalent addition of isoprenoid 
moieties to the cysteine residue of the tetrapeptide motif. In contrast, members of the Rab 
family do not share a consensus prenylation motif and terminate in a distinct set of 
cysteine-containing C-terminal motifs (CC, CXC, CCX, CCXX, or CCXXX) 9. These motifs are 
recognized and modified by the geranylgeranyltransferase II, which covalently attaches 
(two) geranylgeranyl groups to the cysteine residues 9. Together with the sequence context 
directly upstream, the hypervariable domain, these lipid modifications facilitate membrane 
targeting of the small GTPases to their specific cellular compartments, which is essential for 
their respective biological function 10.  
The activity of small GTPases is regulated by a set of specific enzymes called Guanosine-
nucleotide exchange factors (GEFs) and GTPase activating proteins (GAPs). GEFs bind to the 
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inactive, GDP-bound state of a small GTPase and activate the protein by promoting 
exchange of the nucleotide from GDP to GTP. In contrast, GAPs catalyze the hydrolysis of 
GTP to GDP, resulting in inactivation of the small GTPase 11. Inactive Rho and Rab GTPases 
can further be regulated by guanine nucleotide dissociation inhibitors (GDIs) 12. The Rab-GDI 
interaction involves the switch regions and allows for masking of the prenyl modification, 
promoting cytosolic sequestration of the GTPase 13. As membrane localization is essential 
for the biological function, the GDI-mediated membrane extraction of small GTPases 
represents an additional regulatory mechanism.  
 
1.1.1 The family of Rab GTPases 
Ras-like proteins from rat brain (Rab) GTPases have been initially identified as key 
players for the secretory pathway in yeast 14,15. Until now, 11 Ypt/Rabs were found in 
budding yeast and more than 60 different Rabs in mammals.  At least 42 Rab proteins are 
expressed in all cells, while others are more tissue-specific 16,17.  
Rab GTPases share five conserved sequences motifs in addition to the conserved G 
domain, distinguishing them from other members of the Ras superfamily 18. These Rab 
family motifs (RabF1-F5) are located in or in close proximity to the switch and interswitch 
regions and were identified by sequence alignment. Moreover, based on four Rab subfamily 
conserved sequences (RabSF1-RabSF4) Rab GTPases can be divided into subfamilies. The 
RabSF motifs are believed to convey specificity towards the respective GEFs, GAPs and 
effector proteins, whereas the RabF motifs are thought to be responsible for the 
discrimination of the nucleotide state and/or involved in the interaction with universal 
regulators such as Rab escort protein (REP) and GDP dissociation inhibitor (GDI) 18. 
REP binds to newly synthesized, unmodified Rab proteins and presents the protein to 
the RabGGTase, which then covalently attaches (two) geranylgeranyl groups at the 
C-terminal cysteines of Rab 9,19. REP is believed to subsequently deliver the modified Rab to 
its specific target membrane 20,21. In contrast to REP, which interacts with both modified 
and unmodified Rab with high affinity, the structurally and functionally closely related GDI 
binds only to prenylated Rabs with high affinity 22-24. Two GDI were found in human, 
whereas only one GDI has been identified in yeast 25. These GDI proteins have the capacity 
to bind and solubilize all Rabs. The affinity of GDI towards Rab is reduced by three orders of 
magnitude upon exchange of GDP to GTP, raising the idea that Rab activation stabilizes its 
membrane association by impeding the GDI-mediated membrane extraction 22. In contrast, 
delivery of Rab proteins to membranes is believed to be mediated by a GDI-displacement 
factor (GDF). GDF can dissociate the Rab:GDI complex, facilitating the membrane 
attachment of Rab 26,27. However, whether all Rab proteins require a GDF, as well as the 
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exact mechanism of GDF-mediated GDI displacement, remain unclear. Interestingly, the 
Legionella protein DrrA, a GEF for Rab1, has been reported to displace Rab1 from GDI, 
bypassing any need for GDF activity 28,29. Moreover, ectopic mistargeting of GEFs has been 
shown to cause mistargeting of their respective Rab proteins, highlighting the importance of 
GEFs on the membrane delivery and stabilization of Rabs on membranes 28,30-32.  
Rab GEFs show a high diversity in primary and tertiary structure, hindering their 
identification by sequence homology analysis. Consequently, the number of known Rab 
GEFs is relatively small in comparison to the over 60 identified members of Rab GTPases 33. 
Despite their high variation in structure and size, Rab GEFs can be divided into several 
different families, the two largest being the Vps9 and the DENN domain families 34,35. Other 
GEFs do not relate or comprise two or more subunits, such as the multi-domain TRAPP 
complex which possesses GEF activity towards Ypt1/Rab1 36. The general mechanism of 
GEF-mediated nucleotide exchange of Rab proteins is similar to the one observed for other 
small GTPases and leads from the binary nucleotide-protein complex via a trimeric 
nucleotide-GTPase-GEF complex to a binary GTPase-GEF complex 1. The subsequent binding 
of the nucleotide, predominantly GTP due to its higher abundance in cells, reverses this 
series. Both, removal of the Mg2+ ion, which is important for nucleotide binding, and the 
GEF-induced conformational changes within the small GTPase account for the initial 
nucleotide release leading from the trimeric to the nucleotide-free binary complex 1,37. In 
contrast to Rab GEFs, Rab GAPs share a conserved catalytic Tre-2/Bub2/Cdc16 (TBC) 
homology domain consisting of approximately 200 amino acids 38-40. Rab GAPs have been 
shown to promote the hydrolysis of GTP to GDP via a conserved catalytic arginine-glutamine 
finger 39,41-43. Interestingly, approximately a quarter of the 42 TBC proteins identified in 
human and mouse lack the conserved catalytic arginine residue, which makes these 
proteins unlikely to possess GAP activity towards Rab GTPases 44.  
Intensive investigations revealed that the different Rab proteins localize to the cytosolic 
side of various cellular compartments and function in membrane trafficking throughout the 
whole secretory pathway (Figure 1.1) 45-47.  
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Figure 1.1: Rab GTPases localize to specific cellular compartments and are key players in membrane 
trafficking.  Schematic overview of the cellular localization and function of different Rab proteins in 
mammalian cells. Figure modified from Stenmark & Olkkonen 48. 
 
Rab GTPases are believed to act in Rab cascades to establish the polarity of the 
secretory and endocytic pathways (Figure 1.2) 49,50. This model suggests that a GEF recruits 
its specific Rab (here denoted RabA) to a specific membrane. The active RabA can then 
recruit the GEF of the subsequent Rab of the cascade, RabB, which in turn recruits a third 
GEF to activate RabC. One the one hand, this model is supported by the findings, that most 
characterized Rab GEFs are cytosolic proteins that can associate with other Rab effectors to 
activate locally specific Rab proteins 25,51. While on the other hand, many Rab effectors can 
simultaneously bind two adjacently acting Rab GTPases, linking their respective localization 
and function 52-55. Therefore, Rab effectors may organize the transitions between two Rab 
proteins within a cascade. Moreover, it was shown that a Rab protein, e.g. RabB, can also 
recruit the specific GAP of the previously acting Rab, e.g. RabA (Figure 1.2 B) 50. Thereby 
RabA would be removed from the respective membrane, sharpening the boundaries 
between the individual Rab proteins. One example of a Rab cascade is the Ypt1(Rab1)-
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Ypt31/31(Rab11)-Sec4(Rab8) cascade which coordinates the secretory pathway in budding 
yeast 56,57. 
 
Figure 1.2: Schematic model of Rab GTPase cascades. A) Rab GTPases are believed to act in Rab 
cascades. First, a GEF recruits its cognate Rab protein (RabA) to a membrane. The active RabA can 
subsequently recruit the GEF of RabB which in turn recruits GEF C after activation. In this model, all Rab 
proteins of a cascade can be active simultaneously. B) In this second model, a Rab protein recruits also the 
GAP of the antecedent Rab, resulting in its deactivation and removal from the membrane. Thereby, the 
boundaries between the different Rabs of a cascade are sharpened. Figure modified from Pfeffer et al. 25. 
 
The first Ypt/Rab protein identified in yeast was the Golgi-resident Ypt1 58. Both, Ypt1 
and its mammalian homologue Rab1, are essential for the homeostasis of the Golgi complex 
and function in vesicular transport at the endoplasmic reticulum (ER) - Golgi interface 59-61. 
Rab1 has been shown to localize to ER-derived COPII-coated vesicles and is believed to 
mediate tethering and fusion of these vesicles 62-65. In fact, numerous Rab1 effector proteins 
including p115, GM130, Giantin and Golgin84 are Golgi-resident tethering factors 62,66-68. 
Moreover, Rab1 has been found to regulate cargo sorting at ER exit sites (ERES) as well as 
autophagosome formation 69,70. Initially Rab1 was believed to mediate only the anterograde 
ER-to-Golgi transport, but was subsequently found to be also essential for retrograde 
transport 61,71. The two identified isoforms, Rab1a and Rab1b, share a high degree of 
sequence similarity (~ 92 %) and seem to have similar but distinct functions 72-75. 
The multi-subunit protein complex Transport Protein Particle (TRAPP) has been 
established as a GEF for Ypt1/Rab1 and potentially Ypt31/32 36. While the composition and 
function of the three distinct TRAPP complexes found in yeast are well understood, the two 
proposed mammalian TRAPP complexes (mTRAPP) are less characterized 76-78. Mutation 
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analysis has assigned the three yeast TRAPP complexes to distinct steps of the secretory 
pathway, where TRAPP I functions in the ER to cis-Golgi transport, TRAPP II in the 
trans-Golgi to plasmamembrane transport and TRAPP III mediates trafficking from the ER to 
the pre-autophagosomal structure (PAS) 79-82. In contrast, direct evidence was found for 
only one mammalian TRAPP complex, mTRAPP II, and a second mTRAPP complex 
(mTRAPP III) was proposed by proteomic studies 76,78,83. Similar to their yeast orthologs, 
different subunits of mTRAPP II were found to interact with COPI and COPII coat 
components 78,84. Thus, mTRAPP II is believed to associate to vesicles after budding from the 
ER and to subsequently activate Rab1, ensuring proper targeting of the vesicles to the Golgi 
complex 85,86. Whether the function of mTRAPP II in ER-to-Golgi transport is restricted to its 
function as a Rab1 GEF or if the complex itself could act as a tether for vesicle tethering and 
fusion, remains controversial 76,80,86-88. 
The ER-resident protein TBC1D20 was identified as a GAP for Rab1b and Rab2a 89-93. 
TBC1D20 shares 26 % homology with the yeast Ypt1 GAP Gyp8 and consists of 403 amino 
acids 90. As its name suggests, TBC1D20 contains the Tre-2/Bub2/Cdc16 (TBC) homology 
domain, which is common for all Rab GAPs and promotes hydrolysis of Rab GTPases by a 
dual arginine/glutamine finger mechanism 38-43. Unlike other Rab GAPs TBC1D20 contains a 
C-terminal transmembrane domain mediating its cellular localization 90. Due to its role as a 
negative regulator of Rab1b, TBC1D20 overexpression causes disruption of the ER-to-Golgi 
transport and loss of the Golgi complex 89,91. Interestingly, inactivation or depletion of 
TBC1D20 blocks ER exit sites, but did not alter the secretory pathway or the Golgi structure 
in mammalian cells, suggesting that another, yet unknown GAP may contribute to Rab1 
inactivation during ER-to-Golgi trafficking 69,91,94. Recently, a role of TBC1D20 in regulating 
autophagy has also emerged 89.  
 
1.1.2 The small GTPase Rheb 
Ras homolg enriched in brain (Rheb), a member of the Ras family of small GTPases, is 
evolutionary highly conserved from yeast to human 95-97. While no Rheb was found in plants 
and only one RHEB gene has been described in lower eukaryotes such as yeast or 
Drosophila, two RHEB genes, RHEB1 and RHEB2, were found in mammals 98-100. Although 
the two gene products share 54 % identity and 74 % similarity, their tissue expression 
profile differs. Despite its name, Rheb1 is ubiquitously expressed, while Rheb2 expression is 
more limited 97,98,100,101. Hereafter, Rheb refers to Rheb1.  
Rheb consists of 184 amino acids and shares the common architecture of Ras-like 
GTPases. The N-terminal 169 amino acids contain the GTPase domain, whereas the 
15 C-terminal amino acids form the hypervariable region (HVR), including a CAAX 
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prenylation motif. Similar to other small GTPases, the switch I region of Rheb undergoes 
conformational changes during the nucleotide cycle. In contrast, the switch II region of Rheb 
maintains a relatively stable structure, adopting a unique conformation that differs from the 
long helix observed in other Ras GTPases 98,102. Moreover, the catalytic mechanism of 
GTP hydrolysis of Rheb differs. On the one hand, the Gln64, which corresponds to Gln61 in 
Ras, is buried in a hydrophobic core and cannot interact with GTP or the catalytic site. On 
the other hand, Tyr35 was shown to inhibit the intrinsic GTPase activity, maintaining Rheb 
in its highly active state 103. In fact, mutation of Tyr35 to alanine increases the intrinsic 
GTPase activity by approximately 10-fold and renders this mutant insensitive to GAP 
activity 103. Although Rheb shares the C-terminal CAAX motif with other Ras family 
members, it lacks the polybasic domain in the HVR, which in combination with prenylation 
of the CAAX motif, targets Ras proteins to the cytoplasma membrane 104,105. Both Rheb1 and 
Rheb2 become farnesylated 106,107 and associate with various endomembranes, including 
lysosomes, mitochondria and peroxisomes 101,106,108-113. Farnesylation, followed by cleavage 
of the -AAX motif and subsequent carboxymethylation are essential for membrane targeting 
and biological function of Rheb 100.  
The best characterized function of Rheb is its role as an activator of the 
mechanistic/mammalian target of Rapamycin (mTOR) complex 1, which acts as a master 
regulator of cell metabolism, growth and proliferation 114. mTOR, a highly conserved 
serine/threonine kinase, can form two structurally and functionally distinct complexes, 
mTORC1 and mTORC2 115-117. Interestingly, Rheb activates only mTORC1 but not mTORC2 
118. mTORC1 is regulated by various extracellular stimuli and intracellular mechanisms 
including the energy status, growth factors and amino acids, and integrates these signals to 
cell metabolism (Figure 1.3). Intensive research of the last decades has identified two 
distinct mechanisms by which mTORC1 senses the availability of nutrients. The first well-
established mechanism is the growth factor signaling. Growth factor stimulation is a multi-
step process which leads to the activation of the PI3K-Akt signaling axis, resulting in Akt-
mediated phosphorylation of the tuberous sclerosis (TSC) complex. The TSC complex is an 
oligomeric complex comprising TSC1, TSC2 and TBC1D7. TSC2 possesses GAP function 
towards Rheb, positioning the TSC complex as a major negative regulator of mTORC1 113,119-
125. On the one hand, the phosphorylation of the TSC complex inhibits the GAP activity of 
TSC2 towards Rheb, allowing the small GTPase to become active by a yet unidentified 
mechanism. On the other hand, phosphorylated TSC dissociates from the lysosomal surface 
and thus away from its substrate. Rheb-GTP is believed to subsequently activate mTORC1 
but the exact mechanism remains elusive 126-129. In addition to growth factors, the TSC 
complex is also regulated by various other signals, including hypoxia, genotoxic stress and 
low energy (Figure 1.3) 122,130-132. These signals seem to be integrated equally to growth 
factor sensing onto Rheb via regulation of the TSC complex.  
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Figure 1.3: Integration of different stimuli on mTORC1 signaling. Growth factor stimulation activates a 
multi-step signaling pathway which causes AKT-mediated phosphorylation of the TSC complex. 
Phosphorylation is thought to inhibit the GAP activity of TSC2 towards Rheb and induces the dissociation 
of the TSC complex from the lysosomal surface and thus away from its substrate. Rheb adapts the GTP-
bound state by a yet unknown mechanism and Rheb-GTP subsequently activates mTORC1. Similar to 
growth factor sensing, mTORC1 is regulated by stress and energy status. In contrast, amino acids are 
sensed via the Rag GTPases which act on mTORC1 in a Rheb-independent fashion. Activation of 
mTORC1 promotes cell growth and proliferation, while mTORC1 inactivation initiates autophagy, a 
catabolic process enabling cells to adapt to starvation. Figure modified from Jewell et al. 133   
 
The second mechanism mediating mTORC1 activation is the availability of amino acid. 
The presence of amino acids is sensed by the v-ATPase (Figure 1.4). Under low amino acid 
conditions, the v-ATPase binds the Ragulator complex, inhibiting its GEF activity towards 
RagA. In parallel, the GATOR1 complex exerts its GAP activity towards RagA, maintaining the 
heteromeric RagGTPases in an inactive state which is does not allow for recruitment of 
mTORC1 to the lysosomal surface. Hence, mTORC1 is distributed diffusely in the cytosol. 
Upon amino acid stimulation, the v-ATPase and Ragulator undergo conformational changes, 
allowing Ragulator to activate RagA. In parallel, the Folliculin complex promotes the GTP 
hydrolysis of RagC, resulting in an active Rag GTPase heterodimer. The active RagGTPases, 
containing RagA-GTP and RagC-GDP, recruit mTORC1 to the lysosomal surface, allowing for 
Rheb-mediated activation.  
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Figure 1.4: Amino acid sensing on the lysosomal surface. In the absence of amino acids the v-ATPase 
inhibits the Ragulator complex, preventing its GEF activity towards RagA. In addition, the GATOR1 
complex exerts its GAP activity on RagA, maintaining the heterodimeric Rag GTPases in an inactive state 
which does not allow for mTORC1 recruitment to the lysosomal surface. Amino acid stimulation causes 
conformational changes in the v-ATPase and the Ragulator complex, enabling the Ragulator complex to 
function as a GEF for RagA. GATOR1 may be inhibited by GATOR2. The active RagGTPases recruit 
mTORC1 to the lysosomal surface, enabling its activation by Rheb-GTP in the presence of growth factors. 
Figure modified from Jewell et al. 133  
 
Whether this mechanism senses all 20 amino acids equally or only specific amino acids, 
such as leucine and arginine, remains controversial. Although leucine and arginine are 
crucial for mTORC1 activation, they are not sufficient for mTORC1 activation in cells 
deprived of the remaining 18 amino acids 134,135. However, some amino acid transporters in 
the plasma membrane cotransport different amino acids, hindering the precise 
differentiation between cellular transport and sensing event 136.  
 
The current model of mTORC1 activation is that the presence of amino acids regulates 
mTORC1 recruitment to the lysosome, whereas the growth factor signaling integrates on 
Rheb-mediated mTORC1 activation. Thus, both stimuli are required to activate mTORC1 and 
promote cell growth (Figure 1.5).  
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Figure 1.5: Nutrient signal integration at the lysosomal surface. Both, the amino acid availability and 
the growth factor signaling axes converge on the lysosomal surface to regulate mTORC1 activity. Amino 
acid signaling integrates on the v-ATPase/Ragulator pathway and enables mTORC1 recruitment to the 
lysosome, enabling subsequent mTORC1 activation by GTP-bound Rheb. The activity of Rheb is regulated 
by growth factor signaling, a multi-step signaling process resulting in phosphorylation of the TSC complex 
via the PI3K/Akt axis. The phosphorylated TSC dissociates from the lysosomal surface, allowing Rheb to 
become active. Hence, mTORC1 can only be activated by Rheb if both signaling pathways are triggered. 
Figure modified from Dibble et al. 132  
 
In addition to the TSC complex-dependent regulation of mTORC1 activity, other signals 
regulating Rheb activity in a TSC-independent fashion have been reported. On the one 
hand, Rheb seems to be regulated by PRAK-mediated phosphorylation, which was found to 
decrease the nucleotide binding of Rheb, which may weaken its ability to activate mTORC1 
137. Zheng et al. found that this process is induced by energy depletion and may represent 
an AMPK-independent mechanism of mTORC1 regulation in response to the energy status. 
On the other hand, two proteins were reported to bind Rheb and potentially sequester 
Rheb away from the lysosomal surface, which may lead to a decrease of mTORC1 signaling. 
Kim et al. found that PDE4D, which is responsible for the degradation of cAMP, binds Rheb 
under low cAMP conditions, whereas high cAMP levels disrupted this interaction 138. A 
similar interaction was found by Lee et al. for GAPDH and Rheb 139. Under low glucose 
conditions GAPDH was reported to bind Rheb independently of its nucleotide state, 
whereas high levels of Gly-3P, the GAPDH substrate, inhibited the interaction. In fact, this 
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interaction has been found to decrease mTORC1 activity. Hence, this study identified a 
mechanism of Rheb/mTORC1 regulation that seems to be independent of AMPK/TSC 
signaling 139,140.  
Thus, Rheb and thereby mTORC1 activity, is regulated by a variety of signaling 
pathways. Some of these pathways seem to act on the nucleotide state of Rheb, e.g. by 
recruitment of its GAP, the TSC complex, while other stimuli may utilize binding to Rheb to 
eliminate Rheb-mediated mTORC1 activation.  
 
1.2 FRET-based biosensors 
Due to their role in a plethora of intracellular signaling processes, small GTPases are 
popular targets for biosensor development. A majority of biosensors are based on Foerster 
Resonance Energy Transfer (FRET), a non-radiative energy transfer between two 
fluorophores that have overlapping emission and excitation spectra 141. In addition to the 
spectral overlap, this energy transfer depends on the distance and the relative orientation 
of the two fluorophores. FRET has been widely used in cellular studies to assess protein-
protein interactions or protein activity using biosensors.  
Several imaging methods can be utilized to monitor FRET. The practically most feasible 
strategy is ratiometric imaging which utilizes separate fluorescence intensity images of the 
donor and the acceptor to calculate the ratio of the fluorescence intensities of the two 
images 141. When FRET occurs, this ratio is increased. Although this method can be used at 
any fluorescence microscope, due to photo-bleaching, spectral bleed-through it is prone to 
artifacts and requires appropriate subtraction of the background. Moreover, proper signal 
detection may be impaired by probe relocation, especially when monitoring bimolecular 
probes. The most commonly used fluorescent proteins for ratiometric imaging are CFP and 
YFP, or the respective enhanced variants such as Cerulean and Venus 142-145. 
A more sensitive method to detect FRET is fluorescence lifetime imaging (FLIM) 146. 
When a fluorophore is excited, it emits fluorescence in a decaying, typically exponential 
fashion from the time of activation. This fluorescence lifetime of a donor molecule is 
shortened when FRET occurs, allowing for quantitative measurements of FRET signal 
changes (FLIM-FRET). Moreover, the fluorescence lifetime is independent of the 
fluorophore concentration and the acceptor fluorescence and thus less prone to artifacts 
caused by changes in the local concentration of donor or acceptor. Although eGFP is often 
used as a donor molecule, mCitrine or mTurquoise are superior for fluorescence lifetime 
imaging due to their mono-exponential decay and higher fluorescence lifetime 142,143,147. A 
mono-exponential decay facilitates fitting of the obtained decay curves, simplifying the data 
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analysis and interpretation greatly 147. Moreover, higher donor lifetimes allow for a broader 
dynamic range when used in FRET probes.  
 
Based on their architecture FRET-based biosensors can be generally divided into two 
groups (Figure 1.6). While bimolecular probes consist of two chains, with one fluorophore 
attached to each chain, unimolecular probes contain both fluorophores within a single 
chain. Depending on the mode of action, the two fluorophores are brought in close 
proximity in one conformational state, allowing efficient FRET to occur, while the other 
state prevents FRET. To sense the activation event many biosensors utilize an affinity tag, 
which, in the case of small GTPases, is most commonly a specific binding domain of an 
effector protein. This strategy was initially developed to generate a specific bimolecular 
sensor for Rac1 activity and was further applied to other small GTPases 148. The affinity tag 
recognizes the different conformations of the small GTPase, allowing for discrimination 
between the two activity states. In the GTP-bound state, the effector binding domain can 
interact with the small GTPase, bringing the two fluorescent proteins in close proximity and 
enabling FRET (Figure 1.6). In contrast, nucleotide hydrolysis of GTP to GDP, and thereby the 
inactivation of the small GTPase, disrupts the interaction and prevents FRET. 
 
Figure 1.6: Design of FRET-based probes to monitor spatiotemporal small GTPase activity. A) The 
general design of bimolecular FRET-bases biosensors. These sensors consist of two separate chains, the 
small GTPase and its specific affinity tag (AT), each fused to a fluorescent protein (e.g. CFP and YFP). 
These two chains interact only in the GTP-bound state of the small GTPase, bringing the two fluorescent 
proteins in close proximity and enabling FRET. B) A general design of a FRET-based unimolecular probe 
to visualize small GTPase activity. The sensor consists of two fluorescent proteins, the small GTPase and 
its affinity tag, all units linked by spacers.   
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The most commonly used biosensors to monitor small GTPase activity are Ras and 
interacting protein chimeric unit (RAICHU) probes. RAICHU probes are FRET-based 
unimolecular sensors that were initially developed to assess the spatiotemporal Rap1 and 
HRas activity in cells 149. The basic architecture of these probes is similar to the calcium 
sensor Chameleon 150, consisting of two fluorescent proteins, the target protein and its 
respective affinity tag, linked by spacers (Figure 1.6 B) 149. For membrane targeting, the 
probe is fused to the native C-terminal prenylation motif of the respective small GTPase. 
This sensor design was successfully applied to several small GTPases, including members of 
the Rap, Rho, Rab, Ran and Ras families 151-157. The architecture of RAICHU probes for Rho 
GTPases was slightly altered to reduce the basal FRET-levels by interchanging the small 
GTPases and the effector unit 152,158. Most FRET probes conventionally use CFP as a 
fluorescence donor and YFP as an acceptor, allowing for ratiometric assessment to obtain 
the probe read-out 159. Since the FRET efficiency of RAICHU probes correlates with the 
nucleotide loading, the small GTPase activity can be calculated by the CFP/YFP fluorescence 
intensity ratio 149,152,154,158. 
Although widely used, RAICHU probes exhibit several disadvantages. The major pitfall 
of this sensor design is the use of an affinity tag. On the one hand, the tag allows for 
discrimination between the nucleotide states, but on the other hand, the affinity tag 
competes in binding to the small GTPase with endogenous proteins, such as effectors or 
GAPs. Moreover, effector binding is believed to stabilize small GTPases on membranes. 
Therefore, a RAICHU probe may be regulated differentially to the respective endogenous 
GTPase and the read-out may not reflect the native activity state. Furthermore, the RAICHU 
sensor design is limited to small GTPases with known effector proteins and cannot be 
applied to small GTPases for which no effector protein has been identified yet. Another 
disadvantage is the comparably huge size of the probe, containing the affinity tag, the two 
fluorescence proteins, the target GTPases and several linkers. In addition, the membrane 
targeting signal of the small GTPase has to be artificially reintroduced to the probe.  
To overcome the disadvantages of traditional probes, a new type of sensors for small 
GTPase activity was developed recently. These conformational sensors for small GTPase 
activity (COSGA) are unimolecular probes, consisting of a fluorescent protein, fused to the 
N-terminus of the small GTPase of interest, and a synthetic dye that is introduced to the 
protein fold by amino acid side chain labeling 160,161. Depending on the bound nucleotide 
and thus, the conformation of the small GTPase, the FRET signal is more or less efficient and 
can be assessed by fluorescence lifetime imaging. COSGAs have been previously developed 
and characterized as recombinant proteins and were later on applied for cellular studies 
using microinjection. Several mutation sites in Rab1b have been identified to tolerate the 
introduction of the acceptor molecule without interfering with protein folding or function 
(Figure 1.7 A) 160,161. Positioning of the acceptor in the small GTPase determined the type of 
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sensor read-out, e.g. whether the probe reports exclusively the activity state of the small 
GTPase, or both, activity and effector binding 160,161.  
 
 
Figure 1.7: Crystal structure of human Rab1 and KRas in complex with GDP. A) The mutation sites 
in Rab1 allowing for introduction of a synthetic dye via amino acid side chain labeling are highlighted in 
red. These sites are located either in the switch I region (T34 and S36), in the interswitch region (D53 and 
G54) or close to the nucleotide binding pocket (G18 and W102). The latter are suitable for the introduction 
of environment sensitive dyes, while the other positions were utilized to constitute a FRET-based 
conformational probe. GDP is colored blue. B) Alignment of the crystal structures of human Rab1a (grey) 
and KRas (dark teal), both in GDP-bound states (blue). PDB: Rab1a 2FOL; KRas 4OBE.  
 
Depending on their localization in the protein fold the mutation sites to introduce the 
FRET acceptor can be divided into three groups, the switch I region (T34 and S36), the 
interswitch region (D53 and G54) and positions in close proximity to the nucleotide binding 
pocket (G18 and W102). The first two groups are suitable to generate FRET-based 
conformational probes, whereas the last group was successfully used to introduce an 
environmental sensitive dye reporting the nucleotide state. 
Interestingly, the sensor read-out varies depending on the positioning of the acceptor 
within the protein and also within the same region. While the interswitch mutations, D53 
and G54, yield comparable sensor signals, reporting effector binding by an increase in FRET 
and protein activation by a FRET decrease, the two mutants in the switch I region differ. 
Positioning of the acceptor at S36 was found to report predominantly effector binding, 
whereas introduction of the acceptor at T34 yielded a probe that is insensitive to effector 
binding and reports exclusively nucleotide state 160,161. Due to the conserved structure that 
is shared by many small GTPases, the sensor design can be applied to other small GTPases. 
To demonstrate this versatility, the COSGA sensor approach was subsequently extended to 
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KRas, which shares high structural similarity with Rab1 (Figure 1.7 B). Similar to Rab1b, 
different mutation sites in KRas were successfully assessed for GEF-mediated activation and 
GAP-induced hydrolysis in vitro, as well as EGF-induced activation in vivo.  
Nevertheless, the major disadvantage of COSGA probes is the extremely labor-intensive 
preparation process. First, the sensor needs to be designed, a process which depends on 
the empirical evaluation of the probe. The respective position for introducing the acceptor 
dye has to be mutated to cysteine. Next, the construct requires heterologous expression, 
e.g. in bacterial expression systems, followed by protein purification and chemical 
modification. The acceptor is subsequently introduced by cysteine side-chain labeling with 
iodoacetamide-functionalized dyes. Unwanted, multiple labeling can only be avoided by 
replacement of non-essential cysteines or, if possible, via kinetic labeling 160,161. Following 
introduction of the acceptor fluorophore, the native C-terminus of the small GTPase, which 
was initially removed to avoid labeling of the cysteine residues in the prenylation motif, 
needs to be reintroduced by native chemical ligation. Finally, the sensor has to be 
introduced into cells by microinjection or electroporation to enable cellular studies. Thus, a 
broad range of biochemical and chemical methods and expertise is required to yield a 
COSGA sensor.  
 
1.3 Stop codon suppression and bio-orthogonal labeling  
Stop codon suppression, also named amber suppression, is a bioorthogonal approach 
to incorporate an unnatural amino acid (UAA) cotranslationally into a target protein in live 
cells. This unnatural amino acid carries a unique chemical handle which can then be 
specifically addressed by an orthogonal reaction. To this end, a nonsense codon, usually the 
amber stop codon (UAG) is reassigned by extending the endogenous translation system 
with an orthogonal system. The essential components for amber suppression are an 
orthogonal tRNACUA and a cognate aminoacyl-tRNA synthetase, which loads the UAA onto 
the tRNA (Figure 1.8). It is essential, that the orthogonal pair functions completely 
independent of the endogenous translation system. Thus, the orthogonal synthetase should 
aminoacylate only the orthogonal tRNA and should accept exclusively the UAA as a 
substrate. Moreover, neither the tRNA, not the UAA should be recognized as substrates by 
endogenous synthetases. If these criteria are fulfilled, the orthogonal pair can function in 
parallel to and without interfering with the endogenous translation system.  
In the absence of a stop codon suppression system, the translation process pauses 
when the ribosome reaches an amber codon. The release factor enters the ribosome and 
terminates the translation process by releasing the two ribosomal subunits, the mRNA and 
the peptide chain. In prokaryotes, the termination process is mediated by the release 
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factors 1 and 2 (RF1/RF2), which selectively terminate the translation in response to 
UAG/UAA and UGA/UAA stop codons, respectively 162,163. The termination process in 
eukaryotic cells is more complex and involves the two eukaryotic release factors 1 and 3 
(eRF1/eRF3) 164-166. eRF1 is an orthologue of the prokaryotic release factors and terminates 
the translation in response to all three stop codons. While eRF1 is the key factor for the 
termination, eRF3 plays only a stimulatory role 164-167. In contrast, the presence of an UAA 
and a cognate orthogonal pair allows for UAA incorporation into the target protein in 
response to the amber codon (Figure 1.8). However, the orthogonal process competes with 
the endogenous eRF1-mediated termination process. Thus, the expression yield of amber 
suppressed proteins depends strongly on the efficiency of the UAA incorporation process. 
Therefore the expression of amber proteins is usually lower than the expression of the 
respective wild type protein.  
 
 
Figure 1.8: Incorporation of an unnatural amino acid into a target peptide in response to an amber 
stop codon. The unnatural amino acid (UAA) is loaded onto an orthogonal tRNA by an orthogonal 
aminoacyl-tRNA synthetase. The orthogonal tRNA contains a CUA anticodon, allowing for UAA 
incorporation into the target protein at the ribosome in response to a UAG codon on the mRNA. Figure 
modified from Davis & Chin 63.  
 
Orthogonal synthetases are evolved by a two-step process (Figure 1.9) 63,168. First, a 
heterologous aminoacyl-tRNA synthetase/tRNA pair is imported from an evolutionary 
distinct organism into the target host. Then the active site of the synthetase is mutated to 
allow for recognition of an unnatural amino acid and functional candidates are selected 
(Figure 1.9 A). Generally, such synthetase candidates still recognize their natural substrate. 
Thus, libraries of synthetase candidates containing mutations in the active site are 
generated to remove the natural binding site for endogenous amino acids. These libraries 
are applied to a two-round selection process to identify mutants that accept exclusively 
unnatural amino acids as substrates (Figure 1.9 B). First, these libraries are subjected to a 
positive selection. An essential gene is modified with an amber codon and only synthetases 
incorporating an amino acid in response to the amber codon can express the gene in full 
length, allowing for host survival. These clones are applied to a second, negative selection. 
Here, the host organism is supplied with a toxic gene containing an amber codon. In the 
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absence of an UAA, this gene should not be translated in full length. Candidate synthetases 
that accept endogenous amino acids as substrate will incorporate those in response to the 
amber codon, resulting in the translation of the toxic gene and thereby host death. The 
scope of an established orthogonal pair can be further expanded by directed evolution 169. 
Although most orthogonal synthetases were discovered by import of a synthetase/tRNA 
pair into a heterologous host, a synthetase/tRNA pair can also be created de novo by 
directed evolution approaches 93.  
 
 
Figure 1.9: Evolution and selection process of an orthogonal pair for stop codon suppression. A) To 
generate an orthogonal pair, a natural synthetase and the respective tRNA are selected from an evolutionary 
distinct organism and transferred to the target host. Next, a library of mutants of this synthetase is generated 
to identify active site mutations allowing for binding of the unnatural amino acid. B) The generated library 
of active site synthetase mutants is selected in two rounds to achieve orthogonality of the 
synthetase/tRNACUA pair. Figure modified from Davis & Chin 63.  
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While the genetic code is highly conserved between distinct organisms, the sequence, 
structure and molecular specificity of aminoacyl-tRNA synthetases and tRNA differ. Thus, 
the orthogonality of amber suppression systems can depend on the host organism (Figure 
1.10). Four different orthogonal synthetase/tRNA pairs were developed and are commonly 
used for various applications. The first pair used to incorporate an unnatural amino acid was 
the Methanococcus jannaschii Tyrosyl-tRNA synthetase (MjTyrRS)/tRNACUA. This pair is 
bioorthogonal in Escherichia coli, but not to synthetases and tRNA in eukaryotes 170. In 
contrast, the E. coli Tyrosyl-tRNA synthetase (EcTyrRS)/tRNACUA and the E. coli Leucyl-tRNA 
synthetase (EcLeuRS)/tRNACUA are orthogonal in yeast and mammalian cells, but not in 
bacteria 171,172. The pyrrolysyl-tRNA synthetase (PylRS)/tRNACUA from Methanosarcina 
species is orthogonal in both, eukaryotes and prokaryotes and has even been used to 
incorporate unnatural amino acids in Drosophila melanogaster and Caenorhabditis elegans 
169,173-176. 
 
 
Figure 1.10: Orthogonality of the three different evolved aminoacyl-tRNA synthetase/tRNACUA pairs 
allowing for cotranslational incorporation of unnatural amino acids in response to stop codons. While 
the pyrrolysyl-tRNA synthetase (PylRS)/tRNA pair is orthogonal in bacteria and in eukaryotes, the 
Methanococcus jannaschii Tyrosyl-tRNA synthetase (MjTyrRS)/tRNACUA pair and the Escherichia coli 
Leucyl-tRNA synthetase (EcLeuRS) /tRNACUA pair are only orthogonal in bacteria and eukaryotes, 
respectively. Figure modified from Davis & Chin 63.  
 
The PylRS/tRNACUA system has two major advantages over the other orthogonal pairs. 
(1) The PylRS synthetase does not recognize any of the 20 canonical amino acids and 
therefore does not require an additional mutation of the natural binding site in organisms 
that do not use pyrrolysine. (2) Due to the orthogonality both in bacteria and eukaryotes, 
directed evolution and selection processes expanding the scope of recognized UAA can be 
performed in E. coli. This allowed for further evolution of the PylRS/tRNACUA pair to accept a 
variety of strained alkenes and alkynes as substrates 177-181.  
 
Genetic code expansion has become a wide-spread technique in the past decades, 
allowing for a broad range of applications, including photo-crosslinking of proteins 182-184, 
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installation of post-translational modifications 169,185-197, photo-activation 198-200 and 
introduction of biophysical probes 201-203 or labels 168,177,178,181,204-208. In addition to these 
research applications, amber suppression was also utilized to generate therapeutics, e.g. by 
protein conjugations (reviewed in 209). 
Introduction of minimal fluorescent tags into a target protein in live cells using UAA 
mutagenesis has several advantages over the more traditional genetic methods. 
Traditionally, a protein is fluorescently tagged by genetic fusion of the target protein and a 
fluorescent protein. Despite constant progress in the field and the generation of numerous 
variants of GFP, the available spectral ranges, as well as the biophysical properties of the 
respective fluorophores are limited. To overcome this issue, self-labeling protein tags such 
as the eDHFR- or SNAP-tag were developed 210. Even though these tags utilize synthetic 
fluorophores, which are superior in photostability and which are available in the whole 
spectral range, the tag size is comparable to that of fluorescent proteins. Moreover, these 
tags can be introduced exclusively to the target protein’s termini. Thus, proteins that 
require both termini for native folding or function are difficult to address by genetic fusion.  
 
Chemical biological approaches yielded numerous biocompatible strategies to 
overcome these disadvantages. One approach is the use of short peptide-motifs, e.g. the 
tetracysteine motif, which can subsequently react with biarsenical-functionalized 
fluorescent dyes 211-213. While tetracysteine motifs consist of only four amino acids, their 
introduction to the target protein is limited to fusion of the protein backbones and thus, the 
termini of the target protein. An alternative approach is the labeling of amino acid side 
chains, allowing for introduction of the fluorophore at a distinct position into the protein 
fold (reviewed in 214). The most frequent targets of this approach are lysine or cysteine 
moieties. Nevertheless, due to the biological abundance of these amino acids and the fact that 
all accessible target moieties can potentially react, the labeling specificity of these reactions is 
limited. Different bioorthogonal approaches were developed to enhance the labeling specificity, 
such as the site-specific introduction of an orthogonal group that is unique even in cellular 
systems, and which can specifically be addressed by a bioorthogonal chemical reaction. Several 
requirements need to be fulfilled in order to achieve biocompatibility and high specificity in 
cells. On the one hand, orthogonal reactions should take place under physiological conditions, 
e.g. in aqueous solution at physiological temperatures and under ambient pressure. Moreover, 
both reactants should be thermodynamically, metabolically and kinetically stable, and the 
reaction should yield covalently linked products. Neither the reactants, nor the product or any 
side product should be toxic to living systems. On the other hand, the orthogonal reaction 
partners must react exclusively with each other and not with any functional moiety present in 
cellular systems. Different reactions fulfilling these criteria were successfully used for live cell 
approaches (reviewed in 204,215), including the strain-promoted alkyne-azide cycloaddition 
(SPAAC) and the Diels-Alder cycloaddition between tetrazines and strained alkenes/alkynes 
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(Figure 1.11). Both reactions have been used to fluorescently label amber suppressed proteins 
with the respective functionalized dyes 179,207. Labeling via SPAAC was achieved using a variant 
of the E. coli Tyrosyl-tRNA synthetase (EcTyrRS) in combination with an engineered Bacillus 
stereathermophilus tRNATyr, allowing for incorporation of a variety of unnatural amino 
acids, including p-azido-L-phenylalanine (AzF) 216. AzF can subsequently react with 
bicyclononyne- (BCN) or dibenzocyclooctyl (DBCO)-modified dyes. In contrast, protein 
labeling by Diels-Alder cycloaddition between tetrazines and strained alkenes/alkynes was 
performed using the Methanosarcina mazei PylRS/tRNAPyl orthogonal pair. In the past the 
scope of substrates of this pair was extended continuously, resulting in a broad range of 
strained alkenes and alkynes that are accepted as substrates 178,179,217,218. Among these are 
bicyclo[6.1.0]-nonyne-lysine (BcnK) and Trans-cyclooctene–L-Lysine (TcoK*), which have 
been recently used to specifically label both extracellular and intracellular proteins 177-
179,181,217,219. However, although both reactions are bioorthogonal and generally applicable 
in live cells, due to the higher rate constant the Diels-Alder cycloaddition is superior to the 
SPAAC (103-104 and 10-1 M-1 s-1, respectively), allowing for rapid labeling even at low 
reactant concentrations. Another advantage is the use of tetrazine-functionalized dyes, 
which are often fluorogenic. Fluorogenic probes exhibit low intrinsic fluorescence emission 
which is massively increased after coupling to the target protein, facilitating the detection 
of specifically labeled target protein against the background signals 220-222. 
 
 
Figure 1.11: Reaction schemes of the labeling of unnatural amino acids incorporated into a protein 
with functionalized synthetic fluorophores (represented by green stars). A)  Strain-promoted alkyne-
azide cycloaddition (SPAAC) of the unnatural amino acid (UAA) p-azido-L-phenylalanine and a BCN-
functionalized fluorophore. B) Inverse-electron demand Diels-Alder cycloaddition of the UAA BCN-L-
Lysine incorporated into a protein and an H-tetrazine-functionalized dye.   
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Intracellular labeling poses a number of requirements on the dye. On the one hand, the 
functionalized probe requires high cell permeability, while on the other hand, it should not 
bind unspecifically to cellular components or accumulate in membranes. Most conventional 
small dyes including cyanine dyes and Alexa Fluor® probes, as well as their derivatives, carry 
charges and are thus not cell permeable. In contrast, tetramethylrhodamine (TMR) and 
fluorescein diacetate (FDAC) are highly cell permeable and have been used for several 
cellular applications in the past 177,181,205,223. Furthermore, boron-dipyrromethene (BODIPY) 
dyes have been used for various live cell approaches in the past and are thus promising 
candidates for intracellular labeling of amber suppressed proteins 210,221. However, the 
number of available cell permeable dyes and their spectral range are currently rather 
limited. A new series of TMR-derivates was developed by Atto-TEC 224. These probes exhibit 
excellent biophysical properties and cover the whole range of the visible spectra. 
Nevertheless, it has to be determined whether these Atto dyes are suitable for live cell 
application approaches and intracellular labeling.  
 
1.4 Objectives 
The aim of this work is to develop a new generation of the FRET-based conformational 
sensors for small GTPase activity (COSGA). These second generation probes will be 
genetically encoded and thus circumvent the extremely labor-intensive preparation process 
of the first generation of conformational sensors. This preparation process required 
expertise in a variety of methodologies, including protein expression and engineering, 
microinjection for cellular studies. To genetically encode COSGA probes, stop codon 
suppression mutagenesis, enabling incorporation of an unnatural amino acid into the target 
protein, and subsequent intracellular fluorescence labeling will be used. The first part of the 
work presented in this thesis focuses on the establishment of the UAA incorporation into 
small GTPases and the subsequent intracellular fluorescence labeling in live mammalian 
cells. While the incorporation of UAAs is nowadays a widely used technology, the 
subsequent site-specific intracellular fluorescent labeling remains challenging. Therefore, 
the well-characterized Rab1b conformational probe will serve as a target protein to allow 
direct comparison of the second generation COSGA probes with the in vitro and in vivo data 
obtained from the first generation sensor. Hence, the functionality of the genetically 
encoded sensors can be confirmed following the same strategies used for the recombinant 
probes, including effector binding studies and coexpression of GEF and GAP regulatory 
enzymes.  
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The second part of the work presented here targets the application of the COSGA 
approach to the small GTPase Rheb. Rheb is a particularly interesting target for biosensor 
development due to several reasons. First, it is the only known activator of mTORC1 and is 
indispensable for mTORC1 activation on lysosomes by virtually all stimuli (reviewed in 225). 
Second, the precise mechanism of mTORC1 activation by Rheb remains controversial and it 
is not known, whether this interaction is direct or mediated by another, yet unknown factor 
226-229. In fact, it has not been clearly shown whether mTORC1 activation under physiological 
conditions indeed depends on the nucleotide state of Rheb and if Rheb-GTP is sufficient to 
activate mTORC1 126,230. Third, although phosphorylation of the TSC complex, the Rheb GAP, 
is commonly thought to inhibit the GAP activity of TSC2 on Rheb, the mechanism of this 
inhibition, as well as the physiological relevance of the phosphorylation sites, have not been 
dissected yet 230-233. In addition, no Rheb GEF protein was yet indentified and the exact 
mechanism by which Rheb is supposed to adopt its active state in absence of the TSC 
complex on the lysosomal surface remains elusive. In fact, this event was neither monitored 
nor directly proven and is assumed solely because of the indirectly determined mTORC1 
activity. Moreover, several signals and protein interactions seem to regulate Rheb activity 
independent of its activity state, such as PDE4D or GAPDH binding in the absence of their 
substrates 138,139. Thus, the impact of the nucleotide state of Rheb on its function as an 
mTOR activator is barely understood. And fourth, due to the lack of known Rheb effector 
proteins, no specific Rheb effector binding is available. As traditional probes for small 
GTPase activity rely on such domains to differentiate the activity state of the small GTPase, 
at the present time no Rheb sensor is available. A biosensor reporting Rheb spatiotemporal 
activity would allow dissecting the role of Rheb activity during nutrient sensing on the 
lysosomal surface. Moreover, a Rheb probe would enable to shed light on the true 
regulation of Rheb by upstream signals such as the TSC complex, as well as the link to 
mTORC1 activation and downstream signals, such as autophagy.  
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2. Material and Methods 
2.1 Material  
2.1.1 Chemicals 
Table 2.1: Chemicals 
Chemicals Supplier 
2-Propanol  J.T. Baker 
4% PFA/PBS solution Morphisto 
Acetic acid Sigma-Aldrich 
Acetonitril   
Acrylamid 4 K - Lösung (30%) Diagonal 
Agarose Invitrogen 
Amersham ECL Prime Western Blotting Detection Reagent GE Healthcare 
Ammonium persulfate (APS) Serva 
Ampicillin Sodium Salt Gerbu 
Bovine serium albumin (BSA) Biomol 
Bromophenol Blue Serva 
Dimethylsulfoxide (DMSO) Serva 
Ethanol Thermo Fisher Scientific 
Ethylenediaminetetraacetic adic (EDTA) Gerbu 
Formic acid   
GeneRuler 1kb DNA ladder ThermoFisher Scientific 
Glycerol Gerbu 
Glycine Carl Roth 
HEPES Carl Roth 
Kanamycin Gerbu 
Methanol Sigma-Aldrich 
Phenylmethylsulfonylfluoride (PMSF) Serva 
Prestained protein marker (10-250kDa) '7712S New England BioLabs 
Protease Inhibitor cocktail, EDTA-free Roche 
Roti GelStain Carl Roth 
Skimmed Milk Powder Carl Roth 
Sodium azide  Sigma-Aldrich 
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Sodium Chloride Sigma-Aldrich 
Sodium dodecyl sulfate (SDS) Carl Roth 
Tris-(hydroxymethyl)-aminomethan (Tris) Santa Cruz 
Triton X-100 Thermo Fisher Scientific 
Tween-20 Serva 
β-Mercaptoethanol Serva 
 
 
Table 2.2: Unnatural amino acids 
Unnatural amino acid Supplier 
4-Azido-L-Phenylalanine (AzF) Chem-Impex International 
Endo-Bicyclononyne-Lysine (BcnK) SiChem 
Trans-Cyclooctene-L-Lysine (TcoK*) Kind gift by E.Lemke 
 
 
Table 2.3: Tetrazine-functionalized Dyes 
Dye Supplier 
6-Methyl-Tetrazine-BDP-FL Jena Bioscience 
6-Methyl-Tetrazine-FDAC synthesized by X. Chen, AG Wu 
Tetrazine-5-FAM Jena Bioscience 
Tetrazine-5-TAMRA Jena Bioscience 
Tetrazine-Atto 520 synthesized by L. Zhao, AG Wu 
Tetrazine-Atto 565 synthesized by L. Zhao, AG Wu 
Tetrazine-Atto 590 kind gift by Dep. 2 
Tetrazine-BDP-FL Jena Bioscience 
Tetrazine-Cy5 Jena Bioscience 
6-Methyl-Tetrazine-TAMRA synthesized by X. Chen, AG Wu 
 
 
2.1.2 Enzymes and Antibodies 
Table 2.4: Enzymes 
Enzyme Supplier 
FD XhoI ThermoFisher Scientific 
FD BamHI ThermoFisher Scientific 
FD NheI ThermoFisher Scientific 
DpnI ThermoFisher Scientific 
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FastAP Thermosensitive Alkaline Phosphatase ThermoFisher Scientific 
Phusion High-Fidelity PCR Master Mix HF New England BioLabs 
Red-Taq DNA Polymerase 2X MasterMix, 2,0 
mM MgCl₂ 
VWR 
T4 DNA Ligase ThermoFisher Scientific 
BigDye Terminator ThermoFisher Scientific 
 
 
Table 2.5: Antibodies 
Antibody Supplier 
Anti-Actin Chemicon 
Anti-GFP AnaSpec 
Anti-mouse HRP conjugate Dako 
Anti-rabbit HRP conjugate Millipore 
 
 
2.1.3 Oligonucleotides 
2.1.3.1 Cloning primers 
Table 2.6: Cloning primer 
Name Sequence 
1056_XhoI_Giantin_fwd AACCGCTCGAGgaaccgcagcaaagcttttctgaagc 
175 Rab1b rv TTCGGATCCTTAACAGCAACCACCACCCGCC 
665_NdeI_Citrine_fw GGAATTCCATATGGTGAGCAAGGGCGAGG 
757_XhoI_KX_fw CCGCTCGAGGATCCGGCGGTTCCG 
758_BamHI_KX_rv CGGGATCCTTACATAATTACACACTTTGTCTTTGACTTCTTTTTCTT
CT 837_BamHI_Rheb_fl_rv CGCAAGGATCCTTACATCACCGAGCATGAAGACTTGCCTT 
910_XhoI_Olisho_Rab1b_fwd 
AACCGCTCGAGGCCGCCTACAGCAGCATCCTGAACCCGGAATAT
GACTATCTGTTTAAACTGCTGCTGATCGGCG 
914_XhoI_mTurD11_rv AAGGCCTCGAGggcggcggtcacgaactccagcaggacc 
XhoI_D2Rab1b_fw AAAAACTCGAGGAATATGACTATCTGTTTAAACTGCTGCTGATCG
GCG 
XhOlisho_Rheb_fw 
AATTCTCGAGGCCGCCTACAGCAGCATCCTTCCGCAGTCCAAGTC
CCGGAAGATCGCG 
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2.1.3.2 Single site-directed mutagenesis primers 
Table 2.7: Single site-directed mutagenesis primer 
Name Sequence 
1213_Rheb_S20N_f GGGCTACCGGTCTGTGGGGAAAAACTCATTGACG 
1215_Rheb_Q64L_f CTTGTAGACACAGCCGGGCTGGATGAATATTCTATCTTTCCTC 
1217_Rheb_G63A_f 
CATCTTCAACTTGTAGACACAGCCGCCCAAGATGAATATTCTAT
CTTTCC 
1218_Rheb_G63V_f 
CATCTTCAACTTGTAGACACAGCCGTGCAAGATGAATATTCTAT
CTTTCC 
1219_Rheb_D60K_f 
CATCTTCAACTTGTAAAGACAGCCGGGCAAGATGAATATTCTAT
CTTTCC 
1220_Rheb_D122N_f 
CCTATTATGTTGGTTGGGAATAAGAAAAACCTGCATATGGAAA
GGG 
730_Rab1b_W102_TAG_fw 
TATGCCAACGTGAAACAGTAGCTGCAGGAAATTGATCGTTATG
CC 
731_Rab1b_G18_TAG_fw 
CTGCTGCTGATCGGCGATTCTTAGGTGGGTAAAAGCTGTCTGC
TGCTGCG 
732_Rab1b_S36_TAG_fw 
TTTGCTGATGACACGTATACCGAATAGTATATCAGTACCATTGG
CGTCGACTT 
733_Rab1b_I41_TAG_fw 
CGTATACCGAATCCTATATCAGTACCTAGGGCGTCGACTTCAAA
ATCCGTACGATCGAAC 
846_Rab1b_T34_TAG_fw 
GCGTTTTGCTGATGACACGTATTAGGAATCCTATATCAGTACCA
TTGGCG 
847_Rab1b_D53TAG_fw 
TCGACTTCAAAATCCGTACGATCGAACTGTAGGGTAAAACCAT
CAAACTG 
848_Rab1b_G54TAG_fw 
AATCCGTACGATCGAACTGGATTAGAAAACCATCAAACTGCAG
ATCTGGG 
890_aRheb D33TAG 
CGATTCAATTTGTTGAAGGCCAATTTGTGTAGTCCTACGATCCA
ACC 
891_aRheb S34TAG 
CGATTCAATTTGTTGAAGGCCAATTTGTGGACTAGTACGATCCA
ACC 
892_aRheb N50TAG 
GATCACAGTATAGGGACAAGAATATCATCTTCAACTTGTAGAC
ACAGCCG 
893_aRheb G51TAG 
ATCACAGTAAATTAGCAAGAATATCATCTTCAACTTGTAGACAC
AGCCGG 
898_aRheb G108TAG CCATGGCAAATTGTTGGATATGGTGTAGAAAGTACAAATACC 
899_Q67L_Rab1b_for GCAGATCTGGGATACCGCTGGTCTAGAACGTTTCCGTACC 
Rab1b D2_rv 
GTTATCTAGATCCGGTGGATCCTTATTATTAACCACCACCCGCC
GGTTTCACCGGGG 
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Rab1b_N121I_f CAACAAACTGCTGGTTGGTATCAAAAGCGATCTGACGACGA 
Rab1b_S22N_f CGATTCTGGTGTGGGTAAAAACTGTCTGCTGCTGCG 
 
2.1.3.3 Sequencing primers 
Table 2.8: Sequencing primer 
Name Sequence 
108_fwd_n_fluo CGACCACTACCAGCAGAACACC 
372_CMV_fw CGCAAATGGGCGGTAGGCGTG 
905_SV40_rev GGACAAACCACAACTAGAATGC 
 
 
2.1.4 Plasmids 
Unless indicated otherwise, plasmids were generated within this work. 
2.1.4.1 Plasmids for stop codon suppression 
Table 2.9: Plasmids for stop codon suppression 
Plasmid Source 
(U6-PylT )4 EF1α-BcnKRS  Kind gift by J.Chin 
pcDNA_SV40Bst-Yam_CMV(eCFP_P2A_AzF-RS)   
pcDNA-AzpRS (RS-V1) Kind gift by T.P.Sakmar 
pCMV PylRS AF Kind gift by E. Lemke and C. Schultz 
pSVBpUC-Yam Kind gift by T.P.Sakmar 
 
2.1.4.2 Rab1b plasmids 
Table 2.10: Rab1b plasmids 
Plasmid Source 
pCitrine_aRab1b fl. D53TAG   
pCitrine_aRab1b fl. G18TAG   
pCitrine_aRab1b fl. G54TAG   
pCitrine_aRab1b fl. I41TAG   
pCitrine_aRab1b fl. S36TAG   
pCitrine_aRab1b fl. T32TAG   
pCitrine_aRab1b fl. T34TAG   
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pCitrine_aRab1b fl. W102TAG   
pCitrine_Olisho_aRab1b fl. D53TAG   
pCitrine_Olisho_aRab1b fl. G54TAG   
pCitrine_Olisho_aRab1b fl. S36TAG   
pCitrine_Olisho_aRab1b fl. S36TAG N121I   
pCitrine_Olisho_aRab1b fl. S36TAG Q67L   
pCitrine_Olisho_aRab1b fl. S36TAG S22N   
pCitrine_Olisho_aRab1b fl. T34TAG   
pCitrine_Olisho_Rab1b fl.   
pCitrine_Rab1b fl.   
pCitrine_Rab1b fl. N121I   
pCitrine_Rab1b fl. Q67L   
pCitrine_Rab1b fl. S22N   
pCitrine_XPn_aRab1b S36   
pCitrine_XPn_Rab1b fl.   
pCitrineD11_LE_aRab1b S36   
 
2.1.4.3 Rheb plasmids 
Table 2.11: Rheb plasmids 
Plasmid Source 
pCitrine_Rheb fl.   
pCitrine_XhOlisho_aRheb fl. D33TAG   
pCitrine_XhOlisho_aRheb fl. G108TAG   
pCitrine_XhOlisho_aRheb fl. G51TAG   
pCitrine_XhOlisho_aRheb fl. N50TAG   
pCitrine_XhOlisho_aRheb fl. S34TAG   
pCitrine_XhOlisho_Rheb fl.   
pmCherry_Rheb fl.   
 
2.1.4.4 Plasmids for cellular markers and others 
Table 2.12: Plasmids for cellular markers and others 
Plasmid Source 
pCitrine-C1 Clontech 
pEGFP_182TAG   
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pEGFP_182TAG_Kx   
pKate2_Giantin 3131-3259 Kind gift by P.I.Bastiaens 
pmCherry_OCRL fl.  Kind gift by R.S. Goody 
pmCherry-C1 Clontech 
pTagBFP_2xFKBPF37V_DrrA 340-533  Ag Wu 
pTagBFP_OCRL 539-901   Ag Wu 
pTagBFP_TBC1D20 1-362   
pTagBFP-C Evrogen 
pTagBFP-C Evrogen 
 
 
2.1.5 Buffers and Solutions 
All buffers were prepared using double distilled MilliQ water. Unless indicated 
otherwise, all percentages are volume/volume.  
 
Table 2.13: Enzyme buffers 
Enzyme Buffer Supplier 
10x Fast Digest Buffer ThermoFisher Scientific 
10x T4 DNA Ligase Buffer ThermoFisher Scientific 
10x Tango Buffer ThermoFisher Scientific 
10x FastAP Buffer ThermoFisher Scientific 
5x Sequencing Buffer ThermoFisher Scientific 
 
 
Table 2.14: Transfer buffer 
Amount Component 
6.04 g Tris/HCl 
30 g Glycine 
1200 mL H2O 
400 mL Methanol 
ad 2 L H2O 
 
Table 2.15: 10x TBS-T buffer 
Amount Component 
48.46 g Tris/HCl 
160.12 g NaCl 
1600 mL H2O 
20 mL Tween 
ad 2 L H2O 
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Table 2.16: Stacking gel buffer 
Amount Component 
0.5 M Tris/HCl pH 6.8 
0.4 % (w/v) SDS 
 
Table 2.17: Separating gel buffer 
Amount Component 
1.5 M Tris/HCl pH 8.8 
0.4 % (w/v) SDS 
 
Table 2.18: 4x SDS Sample Buffer 
Amount Component 
130 mM Tris/HCl pH 6.8 
200 mM DTT 
4 % (w/v) SDS 
0.025 % (w/v) Bromophenol blue 
20 % Glycerin 
 
 
 
Table 2.19: RIPA Buffer 
Amount Component 
50 mM Tris/HCl pH 7.8 
150 mM NaCl 
0.1 % (w/v) SDS 
0.5 % (w/v) 
Sodium 
deoxycholate 
1 % Triton X-100 
 
Table 2.20: 10x SDS-Page Running Buffer 
Amount Component 
250 mM Tris/HCl 
2 M Glycin 
1 % (w/v) SDS 
 
 
Table 2.21: 50x TAE Buffer 
Amount Component 
242 g Tris base 
57.1 mL Acidic acid 
100 mL 0.5 M EDTA pH 8.0 
ad 1 L H2O 
 
Table 2.22: 5x DNA Loading Buffer 
Amount Component 
30 % (w/v) Sucrose 
20 % Glycerin 
0.2 % (w/v) Orange G 
 
2.1.6 Kits and Commercials 
Table 2.23: Kits and Commercials 
Kit Supplier 
E.Z.N.A. Cycle Pure Kit Omega bio-tek 
E.Z.N.A. Gel Extraction Kit Omega bio-tek 
E.Z.N.A. Plasmid Mini Kit  Omega bio-tek 
SuperSignal™ West Femto Maximum Sensitivity 
Substrate 
ThermoFisher Scientific 
Western Blotting Detection Reagent GE Healthcare 
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2.1.7 Bacterial strains 
Table 2.24: Bacterial strains 
Bacterial strain Supplier 
E.coli XL-1 blue (recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac ) Stratagene 
 
2.1.8 Mammalian cell lines 
Table 2.25: Mammalian cell lines 
Cell line ATCC no. Source 
CHO CCL-61™ Kind gift by AG Waldmann 
Cos-7 CRL-1651™ Kind gift by AG Bastiaens 
HEK 293 CRL-1573™ Kind gift by AG Waldmann 
HEK 293T CRL-3216™ Kind gift by AG Großmann 
HeLa CCL-2™  ATCC 
MCF7 HTB-22™  ATCC 
U2OS HTB-96™ Kind gift by AG Hennig 
 
2.1.9 Material  
Table 2.26: Frequently used Devices 
Device Supplier 
Accu-jet pro Brand 
Alpha Imager HP Alpha Innotec 
BioPhotometer Eppendorf 
Blotting Cassette GE Healthcare 
Centrifuge 5415R Eppendorf 
Centrifuge 5804R Eppendorf 
Countess® II Automated Cell Counter LifeTechnologies 
EPS 301 Power supply GE HEalthcare 
HeraSafe HS12 Hera 
IncuCyte Zoom Essen BioScience 
Invo2 Humidified CO2-supplemented Incubator Memmert 
Lyophilizer   
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Microwave Siemens 
MilliQ Water/Millipore Advantage A Merck Millipore 
Mini Trans-Blot® Bio-Rad 
Mini-PROTEAN® Tetra handcast system Bio-Rad 
NanoDrop 2000c Thermo Fisher Scientific 
OptiMax X-ray Flim Processor PROTEC 
PCR Cycler Analytik Jena 
Plasma Surface technology Femto Diener electronic  
PowerPac™ Universal Power Supply BioRad 
QBT Block Heater Grant Instruments 
Shaker ST5  Ingenieurbüro CAT 
Typhoon Trio+ Imager GE Healthcare 
VortexGenie2 ScientificIndustries 
Waterbath Memmert 
 
 
Table 2.27: Cell Culture Medium and Supplements 
Medium / Supplement Supplier 
DMEM, high glucose, phenol-red free ThermoFisher Scientific 
Dulbecco's Modified Eagle's Medium, D5796 Sigma-Aldrich 
Earle's Balanced Salt Solution, no phenol red ThermoFisher Scientific 
Fetal Bovine Serum ThermoFisher Scientific 
GlutaMAX Supplement ThermoFisher Scientific 
MEM Non-Essential Amino Acids Solution ThermoFisher Scientific 
Minimum Essential Medium Eagle, Hepes-modified (M7278) Sigma-Aldrich 
Opti-MEM ThermoFisher Scientific 
Penicillin-Streptomycin Solution P4333 Sigma-Aldrich 
Phosphate buffered saline, P4417 Sigma-Aldrich 
Poly-L-Lysine solution, 0.01%, P4832 Sigma-Aldrich 
Sodium Pyruvate  ThermoFisher Scientific 
Trypsin-EDTA solution, 0.25%, T4049 Sigma-Aldrich 
XtremeGene HP DNA Transfection Reagent Roche 
Insulin I9278 Sigma-Aldrich 
Trypan blue Invitrogen 
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Table 2.28: Frequently used Consumables 
Consumable Supplier 
TC-Flasche T75,Standard Sarstedt 
Cell Culture Plate 48-well, tc-treated Eppendorf 
Conical tube 15mL Sarstedt 
Conical tube 50mL Sarstedt 
CryoPure Tube 1.8mL Sarstedt 
Glass Bottom Dish 35mm MatTek 
Safe-Seal Reaktionsgefäße 0,5 mL Sarstedt 
Safe-Seal Reaktionsgefäße 1,5 mL Sarstedt 
Safe-Seal Reaktionsgefäße 2,0 mL Sarstedt 
Sterile serological pipets 10mL Sarstedt 
Sterile serological pipets 25mL Sarstedt 
Sterile serological pipets 5mL Sarstedt 
Falcon TC plate 24 well ThermoFisher Scientific 
TC plate 6 Well, Standard, F Sarstedt 
TC-dish 100, Standard Sarstedt 
x-well slides 4-well on cover glass Sarstedt 
x-well slides 8-well on cover glass Sarstedt 
Pipette tip 10µL  Sarstedt 
Pipette tip 200µL  Sarstedt 
Pipette tip 1250µL Sarstedt 
Cell scraper VWR 
Countess Cell Counting Chamber Slides Invitrogen 
Whatman cellulose chromatography paper Sigma-Aldrich 
Autoradiography Film Santa Cruz 
Forceps Carl Roth 
0.2 mL PCR tubes Sarstedt 
Multi PCR stripes (8-strip) Sarstedt 
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2.1.10 Equipment 
Table 2.29: Frequently used Microscopes 
Microscopes Supplier 
TCS SP5 Leica Microsystems 
SP2 Leica Microsystems 
TCS SP8 Leica Microsystems 
PrimoVert Inverted Microscope Zeiss 
 
Table 2.30: Frequently used Software 
Software Publisher 
Adobe Photoshop CS4 Adobe 
ImageJ 1.51p W.Rasband (NIH) 
IncuCyte Zoom 2016B Essen BioLabs 
JediFLIM Dr. K. Schuermann (Dep.2, MPI Dortmund) 
LasAF Lite Leica Application Suite 2.6.0 Leica Microsystems 
MatLab 2015a MathWorks 
Microsoft Office 2010 Microsoft 
Modified JediFLIM B. Scocozza (Dep.2, MPI Dortmund) 
OriginPro 9.0G OriginLab 
PyCharm 2017.1.4 JetBrains 
PyMol Schrödinger Suites 
SnapGene Viewer 3.1.4 SnapGene 
SymPhoTime v5.12 PicoQuant GmbH 
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2.2 Methods  
2.2.1 Biomolecular Methods  
2.2.1.1 Template PCR  
Single genes or sub genetic fragments were amplified and fused to restriction enzyme 
recognition sites by Polymerase chain reaction (PCR). Table 2.31 indicates the components 
and volumes of a standard PCR reaction.  
 
Table 2.31: Standard PCR reaction 
Volume Component 
10 µL 2x Phusion High-Fidelity PCR Master Mix HF 
0.5 µL Forward primer (10 pmol/µL) 
0.5 µL Reverse primer (10 pmol/µL) 
1.2 µL DMSO 
10-20 ng Template DNA 
ad 20 µL ddH2O 
 
All components were thawed on ice, the Phusion High-Fidelity PCR Master Mix HF, both 
primers, and DMSO were mixed with the PCR template in a 0.2 mL PCR tube and shortly 
centrifuged before running the program “Template PCR” (Table 2.32) in a PCR cycler. The 
annealing temperature (*) was selected accordingly to the melting temperature of the used 
primers, typically 2-4 °C below the lowest melting temperature. All primer pairs were 
designed to exhibit a maximum of 5 °C difference in melting temperature. Annealing time 
(**) was set accordingly to the lengths of the gene to be amplified. 
 
Table 2.32: Template PCR program 
Temperature Time Cycle 
98 °C 2 min - 
98 °C 30 sec 
30x 50-72 °C * 30 sec 
72 °C 15 sec/1kb** 
75 °C 10 min - 
4 °C ∞ - 
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Successful amplification of the target gene was verified by DNA gel electrophoresis. The 
PCR product was purified using a PCR purification kit or via gel extraction, and eluted from 
the columns in 30 µL elution buffer. 
 
2.2.1.2 Linker Insertion and Modification 
Engineering of the linker between the fluorescent protein and the small GTPase was 
performed by PCR amplification of the respective target gene using a prolonged forward 
primer encoding an XhoI restriction enzyme recognition site and the respective linker 
sequence. Linker sequences were manually codon optimized for mammalian cells using the 
NCBI-GenBank-based Codon Usage Database 234. 
 
2.2.1.3 DNA Gel Electrophoresis 
To confirm successful gene amplification and/or restriction enzyme digestion, the PCR 
product and/or the crude digestion reaction were analyzed by DNA gel electrophoresis. 
Therefore 1% (w/v) agarose was suspended into 1x TAE buffer and boiled in the microwave 
until the agarose was fully dissolved. 5 µL Roti-GelStain was added per 100 mL agarose and 
the solution was mixed intensively. Gels were cast by pouring the solution into a DNA gel 
electrophoresis device and inserting a comb to generate sample loading pockets. 2-5 µL of 
the DNA sample was mixed with the respective volume of 5x DNA loading buffer and the 
whole mixture was loaded onto the DNA gel. Gel electrophoresis was performed for 40 min 
at 90 V. 
 
2.2.1.4 Restriction Enzyme Digestion 
Complementary sticky ends on the PCR product and on the plasmid backbone were 
generated by restriction enzyme digestion. Table 2.33 and Table 2.34 show standard 
reactions for digestion of a PCR product and plasmid DNA, respectively. All components 
were thawed on ice and mixed in a 1.5 mL reaction tube. The digestion was performed for 
4-16 h at 37 °C. Successful digestions were controlled by DNA gel electrophoresis.  
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Table 2.33: Standard reaction for 
restriction enzyme digest of PCR products 
Volume Component 
3.5 µL 10x FD buffer 
1 µL Enzyme 1 
1 µL Enzyme 2 
30 µL  Purified PCR product 
 
Table 2.34: Standard reaction for restriction 
enzyme digest of plasmids 
Volume Component 
2 µL 10x FD buffer 
1 µL Enzyme 1 
1 µL Enzyme 2 
1 µL FastAP 
0.5-1.0 µg  DNA 
ad 20 µL ddH20 
 
 
The digested DNA fragments were purified using a PCR purification kit or via gel 
extraction. In both cases samples were eluted in 30 µL elution buffer.  
 
2.2.1.5 Ligation 
Digested plasmid backbones and the respective PCR products were ligated using T4 
DNA Ligase. Table 2.35 shows a standard ligation reaction. All components were thawed on 
ice, mixed in a 1.5 mL reaction tube, centrifuged shortly and incubated at 16 °C overnight.  
 
Table 2.35: Standard ligation reaction 
Volume Component 
1 µL 10x T4 DNA Ligase buffer 
1 µL T4 DNA Ligase 
1 µL Backbone DNA, digested and dephosphorylated 
3 µL Insert DNA, digested 
ad 10 µL ddH2O 
 
On the following day, the complete ligation reaction was chemically transformed into 
E. coli and positive clones were screened by Colony PCR. 
2.2.1.6 Single Site-Directed Mutagenesis 
Exchange of up to two amino acids and insertion of single amino acids into a target 
sequence were performed by single site directed mutagenesis using only one primer. 
Primers for this purpose were designed with at least 50 bp lengths and more than 20 bp on 
each side of the mutation site. To ensure selective and strong binding of the primer a 3’ GC 
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clamp was introduced and primers with melting temperatures higher than 68 °C were 
generated. Table 2.36 shows a standard single site-directed mutagenesis reaction. All 
components were thawed on ice, mixed in a 0.2 mL PCR tube and shortly centrifuged. The 
reaction was performed using the PCR program illustrated in Table 2.37. Annealing 
temperatures (*) were selected accordingly to the primers used, usually 3-5 °C below the 
primer melting temperature.  
 
Table 2.36: Standard reaction for single 
site-directed mutagenesis 
Volume Component 
10 µL 2x Phu HF MasterMix 
1.5 µL Primer (100 pmol/µL) 
1.2 µL DMSO 
0.4-0.6 µg  Plasmid DNA 
ad 20 µL ddH2O 
 
Table 2.37: Single site-directed mutagenesis PCR 
program 
Temperature Time Cycles 
98 °C  30 sec - 
98 °C 30 sec 
29x 65-72 °C * 30 sec 
72 °C 30 sec per 1kb 
72 °C 10 min - 
4 °C ∞ - 
 
 
Following the PCR reaction, 2.3 µL 10x Tango buffer and 1 µL DpnI were added to the 
reaction mix and incubated at 37 °C for 4-16 h. The whole reaction was subsequently 
transformed chemically into E. coli XL1 blue. Three to five clones were selected, the plasmid 
DNA was extracted and the sequence of the target gene verified by DNA sequencing 
 
2.2.1.7 DNA Sequencing 
Sequencing of plasmid DNA was performed by either sending the samples to external 
sequencing services (StarSeq GmbH or Eurofins), or performed manually using BigDye 
Terminator and submitted to the MPI in-house sequencing facility.  
For external sequencing services the plasmid of interest was mixed with an appropriate 
sequencing primer following sample submission guidelines of the respective company.  
For in-house submission, the sequencing reaction was performed as displayed in Table 
2.38. All components were mixed in a 0.2 mL PCR tube and the sequencing reaction was 
performed following the protocol shown in Table 2.39. 
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Table 2.38: Standard DNA sequencing 
reaction 
Volume Component 
2 µL 5x Sequencing buffer 
2 µL BigDye Terminator 
1.5 µL Primer (10 pmol/µL) 
0.4-0.6 µg Plasmid DNA 
ad 10 µL ddH2O 
 
Table 2.39: DNA sequencing PCR program 
Temperature Time Cycles 
96 °C 4 min - 
96 °C 10 sec 
25x 50 °C 5 sec 
60 °C 4 min 
4 °C ∞ - 
 
 
Following the sequencing reaction, the reaction mix was transferred into a 0.5 mL 
reaction tube and DNA was precipitated by adding 2 µL 4 M NaAc pH 4.0, 2 µL 100 mM 
EDTA pH 7.0, 16 µL ddH2O and 70 µL 100 % EtOH. The mixture was intensively mixed, 
incubated for 15 min at RT and centrifuged for 30 min at 14 000 rpm and 4 °C. The pellet 
was washed carefully with 0.5 mL ice cold 70 % EtOH and centrifuged again for 20 min at 14 
000 rpm and 4 °C. The supernatant was discarded; the pellets were dried at RT and 
submitted to the MPI in-house sequencing facility.  
 
2.2.1.8 Transformation into E. coli 
Transformation of plasmid DNA into E. coli allows amplification of whole plasmids with 
high efficiency and low error rate. 2-10 ng plasmid DNA or 10 µL crude ligation reaction was 
mixed with 30-300 µL solution of chemically competent E. coli XL-1 blue and incubated for 
1 h on ice, followed by a heat shock of 45 sec at 42 °C. 1 mL LB medium was added and the 
mixture incubated for 1 h at 37 °C and 170 rpm. The bacteria suspension was centrifuged at 
8000 x g for 3 min, the supernatant discarded and the bacteria pellet resuspended in 50 µL 
LB medium. The solution was spread on agar plates containing antibiotic for selection of 
positive clones and the plates were incubated overnight at 37 °C. 
 
2.2.1.9 Bacterial Cultures 
Single bacterial colonies were chosen from agar plates after antibiotic selection and 
transferred into pre-culture tubes containing 4 mL LB medium and the respective selection 
antibiotic (Ampicillin 125 µg/mL, Kanamycin 50 µg/mL). Bacterial cultures were grown 
overnight at 37 °C and 170 rpm. Plasmid DNA was extracted using the E.Z.N.A.® Plasmid 
Mini Kit I following the manufacturer’s protocol.  
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2.2.1.10 Colony PCR 
Bacterial clones obtained by antibiotic resistance selection were screened for the 
plasmid of interest by Colony PCR. Table 2.40 shows the composition of a single standard 
Colony PCR reaction, for analysis of multiple clones, a master mix solution was calculated 
based on the number of selected clones. All liquid components were thawed on ice, mixed 
in a 1.5 mL reaction tube and centrifuged shortly. The master mix was distributed into Multi 
PCR stripes with 10 µL per tube. Single bacterial colonies were selected and transferred into 
10 µL of the reaction mix. The same tips were used to plate the respective colony onto a 
fresh agar plate and the plates were incubated overnight at 37 °C. The reaction mix was 
placed in a PCR cycler and the Colony PCR program (Table 2.41) was performed. 
 
Table 2.40: Single Colony PCR reaction mix 
Volume Component 
5 µL 2x RedTaq MasterMix 
1 µL Forward primer (10 pmol/µL) 
1 µL Reverse primer (10 pmol/µL) 
1x Bacterial colony 
ad 10 µL ddH2O 
 
Table 2.41: Colony PCR program 
Temperature Time Cycles 
94 °C 2 min - 
84 °C 1 min 
29x 55 °C 2 min 
72 °C 30 sec 
72 °C 10 min - 
4 °C ∞ - 
 
 
Positive clones were inoculated in pre-cultures for plasmid extraction and DNA 
sequencing. 
 
2.2.2 Preparation and Storage of Click-Reaction Components 
2.2.2.1 Preparation of BcnK Solution 
BcnK stock solution aliquots were prepared by dissolving 25 mg BcnK powder in 500 µL 
30 % Acetonitrile / 1 % formic acid in water. The suspension was mixed intensively and 
distributed to ten 1.5 mL reaction tubes with 50 µL per tube (2.5 mg BcnK per tube). The 
aliquots were snap-frozen in liquid nitrogen, lyophilized and stored at -20 °C. Shortly before 
an experiment a 250 mM stock solution was prepared by adding 31 µL 0.1 M NaOH to one 
aliquot and dissolving the BcnK powder by pipetting. 250 mM stock solution aliquots were 
stored at -20 °C and, if not consumed immediately, thawed maximum up to three times 
after dissolving. 
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2.2.2.2 Preparation of AzF Medium 
AzF medium was prepared by dissolving 0.12 g AzF powder in plain 500 mL MEM 
HEPES-modified medium (1 mM final AzF concentration). To enhance dissolving, the 
solution was sonicated until all AzF aggregates dissolved completely. The medium was 
sterile-filtered over a 0.2 µM syringe filter and completed by addition of 57 mL FBS, 5.7 mL 
sodium pyruvate, 5.7 mL NEAA and 5.7 mL GlutaMAX. AzF medium was aliquotted and 
aliquots were stored at -20 °C.  
2.2.2.3 Preparation of Tetrazine-Functionalized Dyes 
Tetrazine dyes were dissolved in cell culture grade DMSO and distributed to 1.5 mL 
reaction tubes with each tube containing 50-100 µg. The aliquots were snap-frozen in liquid 
nitrogen, lyophilized and stored at -20 °C. 5-10 mM stock solutions were prepared freshly 
before an experiment by dissolving the dye in cell culture grade DMSO. Aliquots were 
stored at -20 °C and thawed maximum up to three times. 
 
 
2.2.3 Cell biological Methods 
2.2.3.1 Subculture of Mammalian Cells 
Mammalian cell lines were cultured in HEPES-modified Minimum Essential Medium 
Eagle (MEM) or Dulbecco’s modified Eagle’s Medium (DMEM), both supplemented with 
10 % (v/v) fetal bovine serum (FBS), 1 % (v/v) non-essential amino acids (NEAA), 1 % (v/v) 
sodium pyruvate and, if required, 1 % (v/v) GlutaMAX, in a humidified incubator at 37 °C 
and 5 % CO2, unless indicated otherwise. All mammalian cell lines were passaged two to 
three times a week by trypsinization and seeding of 1-3 x 105 cells in a fresh 10 cm dish. 
PenStrep was added to the growth medium only for certain experiments, such as reversible 
cryo-arrest experiments. 
2.2.3.2 Cryo-Preservation and Long-Term Storage 
Long-term storage of mammalian cells was performed in the gas phase of a liquid 
nitrogen tank in presence of 10 % DMSO in the growth medium. Therefore, 100 µL DMSO 
was mixed with 400 µL fully supplemented DMEM in a cryo vial and 500 µL of cell 
suspension (approximately 1 x 106 cells) were added. The cell stocks were stored for one 
week at -80 °C before being transferred into the vapor phase of a liquid nitrogen tank.  
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Cryo-preserved cells were thawed in a water bath at 37 °C. To remove DMSO from the 
growth medium, the cell solution was diluted into 10 mL medium and centrifuged for 5 min 
at 500 x g. The pellet was gently resuspended in 10 mL fresh medium and the cell solution 
transferred into a dish or flask for further cultivation.  
2.2.3.3 Cell Culture Vessel Surface Treatment 
Poly-L-Lysine coating 
To increase cell adherence to the culture vessel and ensure cell attachment even after 
multiple medium exchanges, HEK 293 and HEK 293T samples were seeded on culture 
vessels pre-coated with Poly-L-Lysine. Table 2.42 shows the respective amount of 
Poly-L-Lysine solution used per well for the different types of growth vessels. Coating was 
performed by addition of Poly-L-Lysine solution on the bottom of the culture vessel, gentle 
rocking to distribute the solution evenly and incubation for 15-30 min at RT. The 
Poly-L-Lysine solution was removed and each well was washed three times in PBS to 
remove residual solution. The vessels were kept openly in the laminar flow bench to dry the 
wells before seeding of the cells. 
 
Table 2.42: Coating of growth vessels with Poly-L-Lysine 
Vessel Type Poly-L-Lysine Volume / Well 
4-well chamber slide 300 µL 
8-well chamber slide 150  µL 
24-well plate 200  µL 
48-well plate 150  µL 
6-well plate 150  µL* 
* Only the growth channel was coated on cryo slides. 
 
Glow-discharge surface modification 
Samples for cryo experiments were treated by plasma treatment instead of Poly-L-
Lysine coating, as this allows for more even and stronger cell adherence. Glow-discharge 
modification is a plasma irradiation treatment resulting in oxygen incorporation into the 
irradiated surface. This increases the amount of negative charges of the surface, allowing 
strong cell adhesion. Plasma surface treatment was performed following the standard 
procedure using the Femto device from Diener Electronics. Treated cell culture vessels were 
rinsed three times in PBS before cell seeding. Experiments in plasma surface treated vessels 
were performed in presence of PenStrep to decrease contamination risk.  
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2.2.3.4 Transfection  
Transfection was performed using two different protocols: the traditional transfection 
and the fast-forward transfection for transfection of adherent an trypsinized cells, 
respectively.  
 
Traditional Transfection 
Traditional transfection was performed on adherent cells by seeding the cells one day 
before transfection. A 75-90 % confluent cell culture was rinsed once in 10 mL PBS (HEK 293 
and HEK 293T cells were rinsed in 2 mL Trypsin), 1 mL Trypsin was added and the dish was 
incubated at 37 °C until all cells detached from the vessel bottom. Cell detachment was 
monitored by light microscopy. After complete cell detachment, 9 mL medium was added 
and cell aggregates were separated by pipetting. The cell suspension was then transferred 
into a 50 mL conical tube. 10 µL cell suspension was mixed in a 1.5 mL reaction tube with 
10 µL Trypan blue and 10 µL of the mixture transferred on a Countess Cell Counting 
Chamber Slide. The cell number was counted using the Countess II Cell Counter. Based on 
the live cell count, the required volume for the cell number per well was calculated and 
added to each well. The total volume per well was adjusted using growth medium. Table 
2.43 indicates the number of cells that were seeded according to the growth area per well 
for different cell lines.  
 
Table 2.43: Cell numbers per growth area [cm²] 
Cell line Cell Number/cm² 
CHO 1.5 x 104 
Cos-7 1 x 104 
HEK 293 1.875 x 104 
HEK 293T 1.875 x 104 
HeLa 1.5 x 104 
MCF7 1.5 x 104 
U2OS 1.5 x 104 
 
Transfection was performed at approximately 60 % cell confluency judged by light 
microscopy on the morning following seeding of the cells.  
Opti-MEM was added into a sterile 1.5 mL reaction tube; the plasmids were diluted into 
Opti-MEM, and mixed intensively. After addition of the transfection reagent, the mixture 
was incubated for 15-30 min at RT to allow DNA:reagent complex formation. Meanwhile 
BcnK was diluted 1:5 in 1 M HEPES buffer pH 7.5 and added to amber suppression samples 
to a final BcnK concentration of 250 µM, unless indicated otherwise. After complete 
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incubation time, the transfection mixture was added to each sample. To achieve even 
complex distribution within each well, the culture vessel was rocked gently. Unless 
indicated otherwise, all amber suppression samples were incubated in presence of UAA for 
1.5 d post-transfection before further treatment. Table 2.44 shows the different culture 
vessels and the respective transfection conditions. 
 
Table 2.44: Transfection conditions in different culture vessels 
Application Vessel Type 
Total 
Vol./ 
Well 
Growth 
Area/ 
Well 
Opti-
MEM 
Total DNA 
Amount 
Xtreme 
Gene 
live cell 
microscopy 
4-well chamber 0.5 mL 1.9 cm² 80 µL 0.5 µg 0.8 µL 
8-well chamber 0.3 mL 0.8 cm² 40 µL 0.3 µg 0.4 µL 
Lysates 24-well plate 0.5 mL 2.0 cm² 100 µL 0.5-1.0 µg 1.5 µL 
IncuCyte 48-well plate 0.3 mL 0.64 cm² 40 µL 0.3 µg 0.4 µL 
Cryo-arrest 6-well plate 2.0 mL 8.87 cm² 200 µL 3.0 µg 3.0 µL 
 
Fast forward Transfection 
Fast forward transfection was performed on trypsinized cells immediately before cell 
seeding. First, the respective amount of DNA was incubated with the XtremeGene 
transfection reagent in OPTI-MEM for 15-30 min at RT. Meanwhile cells of a 75-90 % 
confluent culture were rinsed in 10 mL PBS, 1 mL Trypsin was added and the dish incubated 
at 37 °C until cell detachment was completed. 9 mL medium was added and the cell solution 
was transferred to a 50 mL conical tube. The cell number was counted by mixing 10 µL cell 
suspension with 10 µL Trypan blue solution, transferring 10 µL of the mixture into a 
Countess Cell Counter Chamber slide and using the automated cell counting machine 
Countess II. Based on the live cell number, the required cell number was calculated and the 
respective volume was transferred into a fresh cell culture vessel for live cell imaging. 
Growth medium was added to the final working volume of the vessel and the solution was 
mixed to achieve even distribution of the cells throughout the vessel. The DNA-Reagent 
complex was added drop wise and the vessel was agitated gently to allow even distribution. 
The required amount of BcnK was added directly to the cell suspension.  
2.2.3.5 Intracellular Chemical Labeling 
To remove residual BcnK from the cells and thereby decrease side reactions, the 
medium was exchanged to BcnK-free DMEM 16-20h before intracellular labeling. Labeling 
was performed by diluting 5-10 mM stock tzDye to the final concentration of 0.5 µM into 
DMEM, unless indicated otherwise. The solution was rigorously mixed to avoid local 
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concentration differences. Cells were rinsed once in the dye-containing medium and 
incubated for 30-45 min at 37 °C and 5 % CO2 in the humidified incubator. The dye-
containing medium was removed and cells were rinsed at least once in dye-free medium. To 
remove residual dye from the cells, the samples were washed for several hours before 
imaging or treatment. Frequent rinsing of the sample can enhance dye removal but, 
depending on the cell line, may affect cell adherence. For live cell microscopy and IncuCyte 
experiments, the growth medium was exchanged to phenol red-free medium before 
imaging or directly after the labeling step, respectively. 
2.2.3.6 Chemical Fixation of Cells 
Cells were chemically fixed using paraformaldehyde (PFA) fixation. The samples were 
prepared using the same protocol and culture vessels as for live cell imaging. The medium 
of respective samples was removed, the cells once rinsed in PBS and incubated in 
4 % PFA/PBS for 20 min at RT. The PFA solution was removed; the samples rinsed again in 
PBS and kept in PBS for imaging.  
 
 
2.2.4 Biochemical Methods 
2.2.4.1 Preparation of Whole Cell Lysates 
Whole cell lysates for in-gel fluorescence and Western blot analysis were prepared 
from mammalian cells cultured in a 24-well plate (Table 2.43 and Table 2.44). Lysis of 
intracellularly labeled samples was performed 2-8 h post-labeling to allow removal of excess 
dye. The cells were rinsed once in cold PBS and lysed in 50 µL RIPA-buffer supplemented 
with 1 mM PMSF and 1x c0mplete EDTA-free protease inhibitor. To enhance lysis, the wells 
were scratched using a cell scraper. The lysates were transferred to 1.5 mL reaction tubes 
and centrifuged for 15 min at 4 °C and 14 000  rpm. The supernatants were transferred to 
fresh tubes and the pellets were discarded. The lysates were stored at -20 °C. 
 
2.2.4.2 SDS-Page Gel Electrophoresis 
All SDS polyacrylamide gels were hand cast using the mini-PROTEAN® Tetra handcast 
system. The acrylamide concentrations in the separation gel was 15 %, for stacking gels 4 % 
acrylamide was used. Table 2.45 and Table 2.46 show the detailed composition.  
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Table 2.45: Composition of 15% Separation gel 
Separating Gel Concentration 15 % 
Total Volume 100 mL 
Acrylamide 50 mL 
Separating Gel Buffer 25 mL 
ddH2O 22.9 mL 
10 % APS 1 mL 
TEMED 100 µL 
 
Table 2.46: Composition of 4% Stacking gel 
Stacking Gel Concentration 4 % 
Total Volume 50 mL 
Acrylamide 6.67 mL 
Stacking Gel Buffer 12.5 mL 
ddH2O 31.5 mL 
10 % (w/v) APS 0.5 mL 
TEMED 50 µL 
 
To prepare the stacking and separation gel acrylamide, gel buffer and water were 
added to two separate 50 mL conical tube and mixed intensively. 10 % (w/v) APS was added 
and the solution mixed gently. TEMED was added to the separating gel solution, mixed 
quickly by inverting twice and distributed to the gel casting device and covered with 
Isopropanol. After complete solidification of the separating gel, the Isopropanol was 
removed by decanting. TEMED was added to the stacking gel solution, mixed quickly by 
inverting twice and pipetted on top of the solid separating gels. Gel combs were inserted. 
Unless used on the same day, the gels were wrapped in wet tissue paper and stored in a 
plastic bag at 4 °C. 
Whole cell lysates were thawed on ice. Unless indicated otherwise, 4x SDS-PAGE 
loading buffer was added and the samples were boiled at 95 °C for 10 min. Per slot 10 µL 
prestained protein standard and 10-30 µL lysate were loaded on the SDS-PAGE. The gels 
were run at 80 V until samples entered the separation gel, followed by 100-120 V for 
several hours. Proper separation was judged by separation of the prestained protein 
molecular weight standard.  
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2.2.4.3 In-gel Fluorescence Analysis 
The completed SDS polyacrylamide gels were kept in the glass plates and fluorescence 
was scanned using a Typhoon Trio+ Scanner with the following settings: 
 
Table 2.47: Settings for In-gel Fluorescence detection 
Probe Excitation Line Sensitivity Emission Filter 
PMT 
Voltage 
FAM 488 nm Medium 520BP40 600-700 V 
TMR 532 nm Medium 580BP30 600-700 V 
Cy5 633 nm Medium 670BP30 600-700 V 
Atto 565 532 nm Medium 580BP30 600-700 V 
Atto 590 532 nm Medium 580BP30 600-700 V 
 
Samples with low fluorescence intensity, e.g. TcoK incorporation experiments, were 
scanned with high laser sensitivity and/or increased PMT voltage (up to 750 V). 
2.2.4.4 Western Blot 
To verify the fluorescent bands’ identity, the scanned gels were used for western 
blotting. The samples were transferred from the gel onto a nitrocellulose membrane in 
transfer buffer in a wet blot module for 40 min at 100 V. All following steps were performed 
on a tilting shaker at 20 rpm, washing steps at 60 rpm. The membrane was incubated in 
5 % (w/v) milk in TBS-T for 1 h to block the residual protein binding sites of the membrane 
and incubated with rabbit anti-GFP primary antibody over night at 4 °C. The membrane was 
washed three times for 10 min in TBS-T and incubated with the HRP-conjugated anti-rabbit 
secondary antibody for 1 h at RT. After washing three times 10 min in TBS-T, the HRP-
dependent luminescence reaction was started using standard ECL and/or SuperSignal ECL 
solution. Luminescence was detected by exposure of X-ray films which were developed in 
an automated developing machine. Exposure times were varied from few seconds up to 1 h 
to achieve proper signal detection.  
To denature the HRP and thereby inhibit detection of the previously immunostained 
bands, the membrane was soft-stripped in 0.1 M NaN3 for 1 h at RT, washed three times for 
10 min in TBS-T and reblocked for 45 min in 5 % milk in TBS-T, followed by an overnight 
incubation with mouse anti-Actin antibody. The membrane was washed three times 20 min 
in TBS-T and incubated with HRP-conjugated anti-rabbit secondary antibody for 1 h at RT. 
Following three times 20 min washing steps at RT, the blots were incubated for 1 min with 
ECL substrate solution, transferred into a transparent plastic bag and fixed into a developing 
cassette. X-ray films were used to detect luminescence and subsequently developed in a 
developing machine.  
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Developed X-ray films were scanned; blots and fluorescence scans of the same gel were 
cropped, aligned and labeled using Photoshop CS4. 
2.2.4.5 Determination of the Intracellular Labeling Efficiency 
To determine the yield of the intracellular labeling reaction whole cell lysates of 
unlabeled and intracellularly TMR-labeled protein expressing cells were generated as 
described before (Chapter 2.2.4.1). 1 µM tetrazine FAM or tetrazine Cy5 were added to 
each lysate, the solution mixed intensively and incubated for 15 min at RT before adding 
SDS-PAGE loading buffer and further sample preparation. The samples were separated on 
SDS-PAGE and in-gel fluorescence of the different dyes was monitored. 
2.2.5 Microscopy 
2.2.5.1 Confocal Fluorescence Microscopy 
Confocal fluorescence images of live cells were obtained using a Leica SP2, Leica TCS 
SP5 or SP8 laser scanning microscope using a HCX PL APO (λ blue) 63x oil objective. All 
microscopes were equipped with an incubation chamber, enabling live cell imaging at 37 °C 
and 5 % CO2. Excitation wavelengths and emission detection bands of the respective 
fluorophores are listed in Table 2.48. FRET partners that have overlapping excitation 
spectra, e.g. Citrine and TMR, were imaged sequentially to ensure proper separation of the 
fluorescence signals. Unless indicated otherwise, all samples were imaged under live cell 
conditions.  
Table 2.48: Settings for confocal imaging of different fluorophores 
Type Fluorophore λexcitation λemission Laser Source 
Fluorescent 
protein 
mCitrine 514 nm 520-540 nm Argon/WLL 
eGFP 488 nm 503-530 nm Argon/WLL 
mTurquoise2 458 nm 468-511 nm Argon 
mCherry 587 nm 610-750 nm WLL 
TagBFP 405 nm 520-540 nm UV Diode 
mKate2 587 nm 640-790 nm WLL 
Organic 
Dye 
BDP FL 496 nm 506-600 nm WLL 
Fluorescein 496 nm 506-600 nm WLL 
Atto 565 565 nm 595-700 nm WLL 
Atto 590 590 nm 605-750 nm WLL 
Atto 520 514 nm 530-600 nm WLL 
TMR 552 nm 567-700 nm WLL 
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2.2.5.2 Fluorescence Lifetime Imaging 
Time domain fluorescence lifetime was performed at a TCS Leica SP5 or SP8 laser 
scanning microscope, both equipped with PciQuant’s compact FLIM and FCS upgrade Kit 
and White Light Lasers from Koheras. Excitation wavelengths and emission detection bands 
were set according to the settings for confocal microscopy for the respective fluorophore 
and the pinhole was kept half open at 300 µm. Before each FLIM image, a sequential 
confocal image was acquired first. Laser power was adjusted to keep the photon count rate 
stable, below 10 % of the laser frequency (20 MHz). FLIM images were captured at 200 Hz 
scan speed and 256x256 or 512x512 format. Depending on the protein of interest, a 
minimum of 500-1000 counts per pixel or at least 15 000 counts per image were acquired.  
2.2.5.3 Reversible Cryo-Arrest 
Samples for reversible cryo-arrest were prepared as described before, but cells were 
seeded on modified glass slides. Reversible cryo-arrest was performed in collaboration with 
Dr. J. Hübinger (Dep. 2, MPI Dortmund) as previously described using the Leica TCS SP5 or 
SP8 microscopes 235. Different stage inlays were tested to avoid frequent issues of sample 
movement post-freezing. 
2.2.6 Image Manipulation and Data Analysis 
2.2.6.1 Fluorescence Lifetime Image Analysis 
Time-domain FLIM data was analyzed using the customized MatLab script for Global 
analysis 147. Based on the obtained photon count images binary masks were generated using 
ImageJ and applied on the lifetime images. Single cells were selected manually and average 
lifetimes of whole cells or cellular segments, such as the Golgi apparatus or the Cytosol, 
were measured. FLIM images were false colored using the ImageJ look up table “royal” and 
data box charts were generated using OriginPro 9.0G.  
2.2.6.2 Intensity-based Fluorescence Quantification 
Microscopy experiments for image-based Fluorescence quantification were captured at 
16-bit depth and with stable microscope settings during sample acquisition. Fluorescence 
intensities were quantified using ImageJ. In-gel and western blot densitometry analysis 
were performed similarly using ImageJ. Data illustrations were generated using Microsoft 
Excel 2010 or OriginPro 9.0G. 
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2.2.6.3 Analysis of Reversible Cryo-Arrest Data 
FLIM data obtained from Cryo-arrest experiments was analyzed using either the 
MatLab-based Global Analysis script or the newly developed Python-based JediFLIM 
software by Dr. K. Schürmann (Dep.2, MPI Dortmund). XY-Correction of FLIM data was 
achieved by a modified version of JediFLIM, kindly developed by B. Scocozza (Dep.2, MPI 
Dortmund). Vesicle extraction was performed using a modified version of the ImageJ plugin 
“Vesicle extraction”, originally written by Dr. M. Massip (Dep.2, MPI Dortmund). This 
modified version is based on detection of local maxima in intensity images and was 
developed in the frame of this work.  
2.2.7 In silico Linker Optimization Strategies 
2.2.7.1 In silico Prediction of the Secondary Structure 
Secondary structures of the linker regions were predicted using the online PSIPRED 
Protein Sequence Analysis Workbench 236. 
2.2.7.2 Calculation of Linker Lengths 
Unstructured linker 
To calculate the maximal distance between the FRET partners the distance of the 
fluorophores to the C-terminus or N-terminus was measured in the crystal structure of 
mCitrine and Rab1, respectively. Next, the length of the linker was determined using 
Equation 2.1. mCitrine and Rab1 amino acids that were not resolved in the crystal structures 
were treated as part of the linker. The sum of the three values represents the maximal 
distance between the FRET partners, assuming that the linker region does not adapt a 
secondary structure and that the fusion protein adapts a linear conformation. The distance 
and orientation between the synthetic dye fluorophore and the protein backbone is not 
taken into account in this calculation. 
 
Equation 2.1 
𝑟 = √𝐶𝑛  ×  𝑏0  ×  √(𝑛) 
𝑟 = distance [Å] 
𝑛 = number of amino acids 
𝑏0 = 3.8 Å 
𝐶𝑛 = 2.3 
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Helical linker 
To determine the maximal distance between the FRET partners assuming a helical 
linker, the amino acid sequence of the linker region plus 15 amino acids each upstream and 
downstream of the linker were applied to secondary structure prediction. The number of 
amino acids forming an alpha helix was divided by 3.6 to determine the number of 
windings. The result was multiplied with 5.4 Å, which is the length of one winding. The 
result was added to the distance of the fluorophores to the termini of mCitrine and Rab1b, 
assessed by crystal structure as described before. Amino acids of mCitrine and Rab1 those 
were not resolved in the crystal structures as well as amino acids between secondary 
structures were treated as unstructured and their distance was calculated using Equation 
2.1. The sum of all values represents the maximal distance between the FRET partners 
assuming a helical conformation of the linker region and a linear conformation of the fusion 
protein.  
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3. Results 
The focus of the study presented in this thesis was to genetically encode the previously 
developed FRET-based conformational sensors for small GTPase activity (COSGA). These 
conformational probes consist of a fluorescent protein tag as FRET donor and a synthetic 
dye introduced to the protein fold as acceptor 160,161. Positioning of the acceptor position 
determines whether the sensor reports exclusively the nucleotide state of the small GTPase, 
or the nucleotide state as well as effector binding. The first generation of COSGA probes has 
been extensively characterized for Rab1b and KRas GTPases both in vitro and in vivo 160,161. 
The major limitation of COSGA sensors is the labor-intensive preparation process, which 
requires various methods ranging from protein expression and purification to chemical 
protein engineering. Moreover, cellular application of these recombinant probes requires 
microinjection or electroporation. Therefore, this work focused on the development of a 
second, genetically encoded generation of COSGA probes to facilitate the use of these novel 
sensors. To this end, amber suppression approach and subsequent intracellular fluorescent 
labeling are utilized to side-specific introduce the FRET acceptor into the small GTPase fold. 
The first target protein is Rab1b, allowing comparison of the sensor properties of the first 
and second generation probes. The principle was subsequently applied to the small GTPase 
Rheb, which is the only known activator for the mammalian target of rapamycin (mTOR) 
complex 1 126-128. The lack of known Rheb effectors and thereby a specific Rheb binding 
domain that could be exploited as affinity tags impeded the development of traditional 
probes to monitor spatiotemporal Rheb activity.  
 
3.1 Genetically Encoding of the Conformational Sensor 
Two major steps are essential to genetically encode COSGA probes, (1) the 
cotranslational incorporation of an unnatural amino acid (UAA) into the target protein in 
mammalian cells and (2) the subsequent intracellular fluorescence labeling reaction to 
embed the FRET acceptor into the small GTPase fold. While the first step, to incorporate an 
UAA, has become a well-established method within the last decades 63,237, the second step, 
where the UAA is dye-labeled intracellularly, was achieved only in single cases 177,181. As the 
labeling of intracellular proteins in mammalian cells remains challenging, the reaction and 
its major pitfalls were intensively assessed in this work.  
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3.1.1 Stop Codon Suppression in small GTPases 
Stop codon suppression of small GTPases in mammalian cells was performed using two 
different amber suppression systems. Due to its artificial nature, the UAA incorporation 
event competes with the termination of the translation process (see Chapter 1.3). In 
eukaryotic cells, translation is terminated by the eukaryotic release factors 1 and 3 
(eRF1/eRF3) 164-167. When exogenously expressed, the orthogonal aminoacyl-tRNA 
synthetase (RS) loads the orthogonal tRNACUA with the UAA, allowing UAA incorporation in 
response to an amber codon at the ribosome 63,237. The orthogonal incorporation process 
competes with the endogenous release factor-mediated termination of the translation, 
yielding a mixed expression of the amber protein as a full-length protein (UAA 
incorporation) and a N-terminal fragment (translational termination) 180,238,239. The 
incorporation efficiency, and thereby the expression rate of an amber protein, depends on 
the target protein, the incorporation site, the abundance of the orthogonal tRNACUA and the 
used cell line. Two different parameters were evaluated to estimate the UAA incorporation 
efficiency of a sample: (1) the number of incorporating cells per sample and (2) the ratio of 
full-length and fragment expression of the small GTPase.  
 
3.1.1.1 Evaluation of UAA Incorporation Efficiency 
To establish a general protocol for UAA incorporation in mammalian cells 
amber GFP182TAG (aGFP) and different amber mutants of mCitrine-Rab1b (hereafter 
referred to as aRab1b) were utilized. aGFP is a reporter construct consisting of an eGFP 
cassette modified with an internal TAG stop codon at position 182 240. The amber codon 
prevents the full-length expression and fluorophore maturation in the absence of an UAA, 
whereas UAA presence and incorporation result in a mature and fluorescent protein. 
Thereby, the reporter construct allows for precise detection of the UAA incorporation 
event. In contrast, the fluorescent protein (FP) of the COSGA sensor is fused to the 
N-terminus of Rab1b, positioning the FP upstream of the amber codon (Figure 3.1 A). On 
the one hand, this allows for native prenylation of the Rab1b C-terminus, a process essential 
for membrane targeting 46,47,241, while on the other hand, the mCitrine fluorophore can 
mature even in the absence of an UAA and without full-length expression of the construct. 
Therefore, fluorescence emission cannot serve as an indicator for UAA incorporation into 
aRab1b. Instead, the incorporation efficiency was estimated by phenotypic comparison of 
the cellular localization of aRab1b and the wild type protein. Rab1b localizes predominantly 
to the Golgi complex and the cytosol, but not to the nucleus (Figure 3.1 B). The membrane 
association of aRab1b mutants depends on the presence of the C-terminal prenylation motif 
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46,47,241 and thereby on the successful incorporation of the UAA and the full-length 
expression of the construct (Figure 3.1 A).  
To estimate the UAA incorporation rate of single cells the cellular localization of aRab1b 
constructs was compared with Rab1b wild type (WT) and soluble mCitrine as positive and 
negative controls, respectively (Figure 3.1 B). Three parameters can serve as indicators for 
the UAA incorporation into Rab1b, (1) the proper localization of aRab1b to the Golgi 
apparatus, (2) the amount of aRab1b in the cytosol and (3) the mCitrine fluorescence 
intensity in the nucleus.  
 
Figure 3.1: Subcellular localization of aRab1b depends on the presence of its C-terminus, and can 
therefore serve as an indirect for successful UAA incorporation. A) Schematic overview of the sensor 
architecture; the fluorescent protein mCitrine is fused to the C-terminus of Rab1b; the amber codon (red 
asterisk) in amber Rab1b allows for the incorporation of an unnatural amino acid, e.g. p-azido-L-
phenylalanine (AzF) or Bicyclo[6.1.0]-nonyne-L-lysine (BcnK). Full-length expression of the construct 
allows for prenylation of the C-terminus of Rab1b and thereby membrane targeting of the sensor. B) HeLa 
cells expressing amber Rab1b (aRab1b) S36 displaying three different incorporation efficiencies; mCitrine 
and Rab1b wild type (WT) served as negative and positive controls, respectively. aRab1b S36 grown in the 
absence of UAA (-UAA) lacks the typical Rab1b subcellular localization pattern and resembles the 
expression of soluble mCitrine.   
 
Expression of aRab1b S36 mutants in HeLa cells revealed various phenotypes, 
suggesting different incorporation efficiencies (Figure 3.1 B). Low UAA incorporation 
resulted in weak association of Rab1b to the Golgi complex and high cytosolic and nuclear 
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fluorescence intensity, resembling the phenotype of aRab1b expressed in the absence of 
UAA or expression of soluble mCitrine. High UAA incorporation efficiency yielded a 
subcellular localization pattern comparable to that observed for Rab1b wild type (WT) 
indicated by association of the construct to the Golgi complex and low fluorescence 
intensity in the nucleus (Figure 3.1 B).  
 
3.1.1.2 UAA Incorporation into Rab1b 
Two different amber suppression systems were tested for the UAA incorporation into 
Rab1b in mammalian cells. The first system is based on an E. coli tyrosine aminoacyl-tRNA 
synthetase variant and an engineered Bacillus stereathermophilus tRNATyr (Chapter 1.3 and 
Figure 1.10). This orthogonal pair allows for the incorporation of p-azido-L-phenylalanine 
(AzF) 171,216,242. The second system consists of an aminoacyl-tRNA synthetase (RS)/tRNACUA 
pair from Methanosarcina mazei and naturally encodes for pyrrolysine 243,244. As the wild 
type RS/tRNAPyl pair did not efficiently incorporate cyclooctene lysine derivatives, two 
mutations based on rational design were introduced to the RS 179,217. The Y306A and Y384F 
mutant synthetase (PylRSAF, here after referred to PylRS) efficiently incorporated different 
strained alkenes and alkynes, including Bicyclo[6.1.0]-nonyne-lysine (BcnK) and Trans-
cyclooctene–L-Lysine (TcoK*) 178,179,217,218. The PylRS system can be operated in both, 
prokaryotes and eukaryotes, whereas the AzF system is restricted to eukaryotic cells 
(Chapter 1.3). 
The incorporation of AzF into the reporter construct aGFP suffered from extremely low 
efficiency and high cytotoxicity (data not shown). Although the transfection of HeLa cells for 
the AzF system and different amber Rab1b mutants revealed a small but detectable number 
of transfected cells, only few cells exhibited the expected Rab1b subcellular localization 
pattern indicating UAA incorporation (data not shown). In addition to the low incorporation 
efficiency, the system caused massive cytotoxicity. Intensive optimizations of transfection 
and cultivation conditions neither enhanced the UAA incorporation efficiency nor decreased 
the cytotoxicity, raising the question of suitability of the AzF system for the development of 
genetically encoded COSGA sensors (data not shown).  
In contrast, the BcnK/TcoK* system exhibited surprisingly high transfection efficiency 
(up to 90 %) for several proteins of interest (POIs) with moderate to low cytotoxicity (data 
not shown). The BcnK incorporation efficiency varied between different amber proteins and 
different incorporation sites within the same protein, causing high heterogeneity of the 
fluorescence intensity and the Rab1b localization pattern (data not shown). In contrast, the 
TcoK* incorporation into aRab1b produced comparable numbers of incorporating cells per 
sample, but all cells exhibited a low to moderate fluorescent intensity (data not shown). 
Due to the high efficiency, the comparably low cytotoxicity and the rapid labeling reaction 
57 
 
with tetrazine-functionalized probes, the BcnK/TcoK* system was selected for the 
establishment of the genetically encoded COSGA sensor.  
Figure 3.2 illustrates the newly established general protocol for the UAA incorporation 
into small GTPases in mammalian cells using the amber suppression technique. The 
protocol spans three days; the cells were seeded on day 1, transfected the following 
morning and imaged or lysed on day 3. The UAA was added during transfection on day 2 
and kept in the growth medium for the whole time. The expression time in presence of the 
UAA can be prolonged for an additional one to two days but should be evaluated 
empirically to avoid cytotoxicity or, depending on the used cell line, over confluency of the 
culture. 
 
Figure 3.2: Scheme of the established protocol for UAA incorporation into small GTPases in 
mammalian cells.  The cells were seeded on the evening of day 1 and transfected with the orthogonal pair 
and the amber protein plasmids on the following morning. 250 µM of the UAA was added during 
transfection. The samples were incubated at least for 24 h post-transfection and imaged or lysed on day 3.   
 
Unless indicates otherwise, BcnK was used as the standard UAA for all experiments 
and, if not specified differently, all amber proteins were grown in the presence of 250 µM 
BcnK. In certain cases, BcnK and TcoK* were used in parallel to compare their different 
properties.  
 
3.1.1.3 Comparison of Different Amber Rab1b Mutants 
To compare the UAA-dependent localization pattern of different aRab1b mutants, the 
constructs were coexpressed with a cellular Golgi marker. The marker consists of a far-red 
fluorescent protein, mKate2, and the C-terminal membrane anchor of the Golgi-resident 
transmembrane protein Giantin (amino acids 3131-3259). On the one hand, 
mKate2-Giantin3131-3259, hereafter revered to as GntC, enables the identification of the 
Golgi-localized fraction of aRab1b, while on the other hand, the marker allows for 
visualization of homeostasis of the Golgi apparatus. Inactive Rab1 mutants, such as the 
dominant negative Rab1b S22N or N121I mutants, act as dominant suppressors of 
endogenous Rab1b function 245-247. Exogenous expression of inactive Rab1 mutants in cells 
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causes partial or complete disintegration of the Golgi complex, resulting in redistribution of 
Golgi-localized proteins to perinuclear fragments and the ER 245,248,249. If Rab1b function is 
impaired due to the incorporation of the UAA, a similar or comparable phenotype would be 
expectable. In contrast, mutations that impair nucleotide hydrolysis, e.g. the constitutively 
active Rab1b Q67L mutant, localize natively to the Golgi apparatus and do not impair Golgi 
biogenesis. Figure 3.3 A illustrates the different amber Rab1b mutants coexpressed with the 
Golgi marker in HeLa cells.  
The colocalization between Rab1b and GntC was quantified to identify the Golgi-bound 
fraction of the different Rab1b mutants (Figure 3.3 B). Rab1b wild type (WT), the empty 
mCitrineN1 vector (mCitrine) and the aRab1b mutant S36 grown in the absence of BcnK 
served as phenotype controls for the cellular localization of Rab1b. The non-amber 
suppressed Rab1b WT/S22N mutant served as a control for the disruption of the Golgi 
complex.  
All examined amber mutants, except for the G18 construct, exhibited the typical 
subcellular localization pattern of Rab1b, displaying a clearly visible Golgi apparatus and 
varying fractions of cytosolic and nuclear fluorescence (Figure 3.3 B). This distribution is 
abolished in the absence of BcnK, resulting in a diffuse cytosolic localization resembling the 
expression of soluble mCitrine. Cells expressing aRab1b exhibited a well-structured Golgi 
apparatus as indicated by the marker GntC. mCitrine fluorescence intensity varied between 
cells expressing different amber mutants, suggesting differences in the expression levels 
among the mutants. Cells expressing aRab1b S36 showed the highest fluorescence intensity, 
whereas cells expressing D53 and G54 exhibited only moderate fluorescence intensity. T34, 
I41 and W102 expression was low, resulting in hardly visible fluorescent signals. The D53 
and G54 constructs which contain an amber mutation in the interswitch region, exhibited a 
larger nuclear fraction than the other mutants, potentially indicating a mixture of mCitrine-
Rab1b fragment and full-length protein. No Golgi association was found for the aRab1b G18 
construct, suggesting a lack of UAA incorporation. 
These results demonstrate that UAA incorporation into different sites of Rab1b was 
successful and yielded functional proteins that did not interfere with Golgi homeostasis. An 
exception is the mutation site G18, which seemed to lack stop codon suppression, and 
thereby full-length expression of the construct, completely. A possible explanation could be 
that G18 is equivalent to the oncogenic KRas G12D mutation and UAA incorporation at this 
position might impair the protein’s function, causing rapid degradation of the construct 250.  
The varying fluorescent intensity of the different amber Rab1b mutants indicates 
differences in expression levels. In order to establish the FRET-based conformational sensor 
the aRab1b T34, S36, D53 and G54 constructs were used for further experiments, whereas 
the G18 and W102 mutants as well as I41 constructs were not further assessed. 
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Figure 3.3: Amber Rab1b mutants localize to the Golgi complex in a UAA-dependent fashion. 
A) HeLa cells coexpressing different amber mutants of Rab1b and the Golgi marker (GntC). 
B) Quantification of the colocalization of the Golgi marker and the different aRab1b mutants. Rab1b WT, 
mCitrineN1 and aRab1b S36 in the absence of BcnK served as controls. Scale bars: 10 µm.  
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3.1.1.4 Evaluation of Amber Rab1b Expression Levels 
Next, the expression yields of the different amber Rab1b mutants were determined. To 
this end, aRab1b expression in the presence and the absence of an UAA was analyzed by 
western blot (Figure 3.4 A). The bands indicating full-length aRab1b expression were 
extremely faint and their detection required prolonging of the exposure time. Therefore, 
two different exposure times are illustrated. The prolonged exposure resulted in the 
detection of an unspecific band around 42 kDa. Although full-length expression of aRab1b 
mutants was detectable, the obtained expression yields were much lower than observed for 
the wild type protein. Moreover, the expression levels varied between the mutants. 
aRab1b S36 showed the highest full-length expression, whereas D53 expression was 
moderate and G54 and T34 yielded comparable low amounts of full-length constructs. 
Moreover, the mCitrine-Rab1b fragment was detected in all amber suppression samples 
and its size varied with the position of the mutation site within Rab1b. Interestingly, the 
presence or absence of an UAA did not affect its abundance.  
 
Figure 3.4: Evaluation of the expression yields of different amber Rab1b mutants in HEK 293T cells. 
A) Western blot analysis of Rab1b WT and four aRab1b mutants in the presence and absence of BcnK 
(GFP). Two different exposure times are displayed. Full-length expression of the mCitrine-Rab1b 
construct (49 kDa) is indicated by a black arrow head; mCitrine-Rab1b fragment expression (approx. 
30 kDa) is marked by a white arrow head; the asterisk indicates an unspecific band (~42 kDa). 
Untransfected cells and PylRS expressing cells served as negative controls; immunoblotting of Actin 
(Actin) served as a loading control. B) Densitometric quantification of the expression yield of the 
different amber mutants and Rab1b WT in the presence and absence of BcnK normalized on Actin.   
 
The same experiment was performed using TcoK* (data not shown). TcoK* was 
incorporated in a similar fashion observed for the incorporation of BcnK into aRab1b 
mutants, but the observed expression yields were generally lower (data not shown). 
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3.1.1.5 UAA Incorporation into Rheb 
In parallel to amber suppression of Rab1b, the newly established protocol for the UAA 
incorporation into small GTPases was applied to different amber mutants of mCitrine-Rheb 
(hereafter referred to as aRheb).  
The mutation sites in Rheb were selected by two strategies. On the one hand, the 
previously described sites for introduction of the FRET acceptor into Rab1b were applied to 
Rheb by structural alignment of the two proteins (Figure 3.5). This approach yielded the 
mutation sites D33, S34, N50 and G51. On the other hand, a RMSF modulation, a measure 
of the average atomic mobility of backbone atoms, was performed by collaborators, 
suggesting the additional mutation site G108 as a candidate (data not shown). 
 
Figure 3.5: Structural alignment of Rab1a and Rheb small GTPases. GTP-bound Rab1a (PDB: 3TKL) 
is illustrated in grey, the previously characterized mutation sites for introduction of the FRET acceptor 
fluorophore are highlighted in blue. The active state of the small GTPase Rheb (PDB: 1XTS) is depicted in 
cyan. The structural equivalents of the mutation sites of Rab1b in Rheb are highlighted in red. The 
additional mutation site, G108, was identified by RMSF modulation.  
 
In contrast to Rab1b, the small GTPase Rheb does not localize predominantly to one 
cellular compartment 101,106,108,111,113,251,252. Consequently the phenotype of Rheb expression 
is not as clearly defined as for Rab1b. The largest fraction of mCitine-Rheb localized in a 
diffuse cytosolic pattern with faintly visible endomembrane systems and dense 
fluorescence signals in the perinuclear area (Figure 3.6 A). A smaller fraction of Rheb 
localized to the nucleus. The difference in fluorescence intensity of the nucleus and the 
cytoplasm was similar between Rheb WT and the amber mutants when expressed in 
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presence of BcnK, but was abolished in its absence (Figure 3.6 A). Some aRheb mutants, e.g. 
D33 and G108, exhibited irregular punctate structures, suggesting unspecific accumulation 
of the constructs. Although all aRheb expressing cells showed fluorescence differences 
between nucleus and cytosol, perinuclear densities as displayed by Rheb WT expressing 
cells were hardly detectable. Moreover, most cells expressing aRheb constructs displayed 
elevated nuclear fluorescence levels than observed for the expression of Rheb WT, 
suggesting abundance of non-suppressed mCitrine-aRheb fragment (Figure 3.6 A). 
Incorporation of TcoK* into Rheb yielded comparable results to incorporation of BcnK but 
suffered of low efficiency. 
 
Figure 3.6: Stop codon suppression of amber Rheb. A) Five different incorporation sites were tested for 
BcnK and TcoK* incorporation in HeLa cells. Rheb WT and aRheb S34 in the absence of UAA served as 
controls. B) Western blot of HEK 293T cells expressing Rheb WT and different aRheb mutants in the 
presence of BcnK (GFP); immunoblotting ofActin served as a loading control (Actin). Full-length Rheb 
expression (48.2 kDa) is indicated by an arrow head. The asterisk indicates an unspecific band. The loading 
of Rheb WT was reduced to avoid over-exposure. Expression yields were quantified to allow for the direct 
comparison of the mutants and the wild type constructs. Scale bar: 10 µm.  
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To determine the expression yield, western blot analysis of aRheb expression in the 
presence of an UAA was performed (Figure 3.6 B). The densitometric quantification of the 
bands representing full-length expressed Rheb construct revealed 12 % expression yield for 
the highest expressed mutant, aRheb N50, in comparison to the natural translation control 
Rheb WT. In contrast, full-length expression of aRheb S34 and G51 was hardly detectable 
and no full-length expression was obtained for aRheb D33 and G108. 
The determined expression yields of aRheb were lower than those observed for the 
expression of aRab1b (Figure 3.4 B), suggesting that the UAA incorporation process into 
Rheb is not as efficient as UAA incorporation into aRab1b. Moreover, the observed diffuse 
fluorescent pattern of aRheb mutants may indicate a mixed expression of aRheb in full 
length and as a non-suppressed fragment.  
 
3.1.2 Establishment of the intracellular chemical labeling 
The intracellular labeling of amber suppressed proteins in mammalian cells has 
remained challenging despite the progress in the field in the last years. Consequently, a 
major part of this study focused on the establishment of a robust and reproducible protocol 
allowing for intracellular labeling of various proteins with high specificity and yield in 
mammalian cells.  
 
3.1.2.1 Fluorescent probes for intracellular labeling 
The intracellular labeling of proteins with synthetic fluorophores poses several 
requirements on the functionalized dye. While on the one hand, the probe needs to be 
highly cell permeable, on the other hand, it should not bind to cellular components or 
accumulate in membrane systems unspecifically. Furthermore, the probe needs to be fully 
removable from the cell and should not cause cytotoxicity even at higher concentrations. 
Numerous H-tetrazine (tz) and methyl-tetrazine (mtz) functionalized dyes in the green and 
red spectral range were screened for these parameters (data not shown). Fluorescein 
diacetate (FDAC) and BODIPY FL (BDP) in the green spectral range, as well as 
tetramethylrhodamine (TMR), Atto 590 and to a lesser extend Atto 565 in the red spectral 
range, were identified as optimal candidates for intracellular labeling applications (data not 
shown). These four probes exhibited high cell permeability and were fully removable from 
the cell lumen, allowing for the precise detection of specific labeling with good signal-to-
noise ratios. In addition to the cell permeability and the removal capacity, the choice of dye 
for intracellular labeling may also depend on the cellular localization of the target protein. If 
the protein of interest localizes to the nucleus, it might not react with e.g. BDP, as this 
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probe seemed to remain exclusively in the cytosol (data not shown). Moreover, the 
application of interest may affect the choice of dye as some dyes, including Atto 565 and 
Atto 590, attached to the glass surface of the culture vessel (data not shown). This 
unspecific accumulation might hinder analysis by e.g. Total Internal Reflection (TIRF) 
microscopy.  
Thus, the choice of dye is a critical factor to achieve specific labeling of intracellular 
proteins with high yields. 
 
 
3.1.2.2 Intracellular labeling of Rab1b in HeLa cells 
To identify the optimal conditions for intracellular labeling of aRab1b, a range of 
different incubation times and dye concentrations for the labeling step were assessed 
(Figure 3.7 A).  
Although the typical Rab1b subcellular localization pattern, indicating UAA 
incorporation into aRab1b, was observed in all samples, no colocalization of the TMR and 
the mCitrine fluorescence signals was detected. Higher dye concentrations and/or longer 
incubation times only increased the fluorescence background signals, but did not yield any 
specific labeling. To circumvent potential sterical hindrance due to protein-protein 
interactions, the screen was repeated using aRab1b D53, an interswitch mutant. However, 
similar to the labeling of S36 only unspecific TMR background signals were observed for the 
labeling of aRab1b D53 (data not shown).  
Furthermore, BcnK was exchanged to TcoK*, which led only to an increase of unspecific 
puncta-like structures in the cell lumen (Figure 3.7 B). 
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Figure 3.7: Intracellular labeling of amber Rab1b with TMR in HeLa cells. A) Overview of the 
titration of TMR concentration and incubation time for the labeling of aRab1b S36. B) HeLa cells 
expressing aRab1b S36 and D53, each suppressed with BcnK or TcoK*, labeled with TMR.  
Scale bars: 10 µm. 
As the incubation of aRab1b S36 or D53 with Atto 565 or Atto 590 did also not yield any 
specific labeling, we speculated whether the biophysical properties of red dyes might 
impede the intracellular labeling reaction. Therefore two green probes, BODIPY FL (BDP) 
and fluorescein diacetate (FDAC) were selected as alternative candidates for the 
66 
 
intracellular labeling of aRab1b. Green dyes are generally smaller in size and less 
hydrophobic than red fluorophores, which may reduce the observed unspecific 
accumulation in endomembranes. To test green fluorophores, the fluorescent protein of 
the sensor construct was exchanged to either mCherry or mTurquoise2, which can both 
serve as FRET partners for green fluorophores. Figure 3.8 illustrates the results of the 
intracellular labeling of aRab1b S36 and D53 with BDP, each fused to mCherry or 
mTurquoise2. 
 
 
Figure 3.8: Intraccellular labeling of aRab1b with green dyes. HeLa cells expressing aRab1b S36 and 
D53 in the presence of BcnK were labeled with BODIPY FL (BDP). Rab1b wild type and 
aRab1b S36 (-UAA) served as positive and negative controls, respectively. Scale bar: 10 µm. 
 
The localization of aRab1b to the Golgi complex confirming BcnK incorporation was 
detected for both amber mutants and was independent of the fluorescent protein tag. 
Moreover, the incubation with BDP resulted in highly specific labeling of aRab1b, indicated 
by the colocalization of the fluorescent signals. This specific labeling was comparable 
between the two different amber mutants and the respective mCherry and mTurquoise2 
constructs. In contrast, no labeling was observed for the two negative controls Rab1b WT 
and aRab1b (-UAA). Exchange of BDP to FDAC yielded comparable results (data not shown). 
Unfortunately, the observed specific labeling signals were rather weak and bleached 
rapidly during confocal imaging. In fact, the same labeling protocol yielded a diverse 
labeling efficiency and high heterogeneity of the labeling, ranging from visible specific 
labeling to only dye background signals. Numerous protocol optimizations did neither 
enhance the labeling homogeneity nor improve its intensity or the reproducibility. 
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In summary, these results demonstrate specific intracellular labeling of aRab1b with 
FDAC and BDP in HeLa cells. The observed labeling was highly specific and UAA-dependent, 
but exhibited low fluorescence intensity and high photo-bleaching. In contrast, labeling of 
the same aRab1b mutants under identical conditions with three different red probes did not 
result in any detectable labeling. Besides the difference of the biophysical properties of 
green and red fluorophores, the reasons for this discrepancy remain unclear. 
 
3.1.2.3 Intracellular labeling in different mammalian cell lines 
To assess whether mammalian cell lines differ in their suitability for intracellular 
labeling applications, several cell lines with cancer and non-cancer-related background were 
tested for the intracellular labeling with red fluorescent probes. The reporter gene aGFP182 
was modified with a C-terminal linker and a CAAX box (hereafter referred to as aGFP-Kx), 
targeting the construct to the cytosolic side of the plasma membrane. The cytoplasma 
membrane targeting circumvents unspecific dye accumulations in the cell lumen, allowing 
for the precise detection of specific labeling (Figure 3.9 A). In parallel to aGFP-Kx, labeling of 
aRab1b S36, the highest expressing Rab1b amber mutant, was assessed (Figure 3.9 B). 
Fluorescence emission and membrane association was observed for both target proteins in 
all examined cell lines, indicating successful stop codon suppression. HEK 293T cells 
exhibited specific labeling with high fluorescence intensity for both target proteins, whereas 
only moderate to low labeling intensities were observed in COS-7 and CHO cells. 
Interestingly, U2OS cells displayed a weak but specific labeling of the Golgi compartment 
but no labeling of the cytoplasma membrane. Neither aRab1b, nor aGFP-Kx labeling was 
detected in HeLa and MCF7 cells. In fact, these two cell lines exhibited non-specific 
accumulations of the dye, which were hardly observed in HEK 293T cells.  
Based on the detected plasma membrane labeling, the assessed cell lines can be 
divided into two groups. The first group comprises HeLa, MCF7 and U2OS, which did not 
exhibit any specific labeling, while the second group, CHO, COS-7 and HEK 293T, displayed 
specific labeling of the plasma membrane. In fact, the first group consists only of cell lines 
with a cancer-related background, whereas the cell lines of the second group do not 
originate from cancer tissues. However, specific labeling of aRab1b was also observed in 
U2OS cells, suggesting that intracellular labeling may also be possible in cancer-derived cell 
lines. Since COS-7 and HEK 293T cells exhibited the strongest labeling and the lowest TMR 
background signals, further experiments were performed exclusively in these two cell lines. 
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Figure 3.9: Intracellular labeling in different mammalian cell lines. A) Labeling of the reporter 
construct aGFP-Kx with TMR Specific plasma membrane labeling was observed only in CHO, COS-7 and 
HEK 293T cells. B) Labeling of amber Rab1b S36 with TMR in different cell lines. U2OS, CHO, COS-7 
and HEK 293T cells displayed highly specific labeling of the Golgi complex, whereas only TMR 
background signals were detected in HeLa and MCF7 cells. Scale bars: 10 µm. 
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3.1.2.4 Red dyes for intracellular labeling  
To determine an optimal FRET pair, labeling in HEK 293T cells was assessed using three 
different red dyes, TMR, Atto 565 and Atto 590 (Figure 3.10 A). Specific labeling with a high 
signal-to-noise ratio was obtained with for all three probes, but the labeling homogeneity 
differed. The incubation with TMR resulted in the most efficient labeling and the highest 
sample homogeneity, whereas labeling with Atto 590 yielded a similar homogeneity but 
lower labeling intensity. In contrast, samples labeled with Atto 565 exhibited only a small 
fraction of specifically labeled cells. In all three cases the intensity of the specific labeling 
correlated with the mCitrine fluorescence signals, resulting in a strongly labeled Golgi region 
and lower TMR fluorescence intensity in the cytoplasm (Figure 3.10 A). Fluorescence 
lifetime analysis revealed a lifetime reduction of +TMR = 290 ± 75 ps for the TMR-labeled 
sample in comparison to the unlabeled control (Figure 3.10 B). In contrast, labeling with 
Atto 565 or 590 decreased the donor lifetime by only +Atto = 90 ± 40 ps. The decrease in 
fluorescence lifetime correlated spatially with the labeling intensity, displaying low lifetimes 
in the Golgi region and higher lifetimes in the cytoplasm (Figure 3.10 A). Although this 
spatial distribution was similar in all labeled cells, the average fluorescence lifetime differed 
between the three dyes used. On the one hand, this difference may be due to the spectral 
properties of the dyes, allowing for distinct FRET efficiency when paired with mCitrine. On 
the other hand, this difference may be due to potential variations in labeling efficiency. A 
low labeling efficiency results in a minor fraction of donor-acceptor pairs and leaves a large 
amount of aRab1b unlabeled, which represents donor only fraction in fluorescence lifetime 
imaging. As both fractions are acquired equally, the obtained lifetime of a sample 
represents the average of these fractions. Hence, high labeling efficiency causes a major 
reduction in fluorescence lifetime, whereas the lifetime of samples exhibiting low labeling 
efficiency is closer towards the donor only lifetime (mCitrine = ~3.0 ns ).  
In addition to HEK 293T cells, labeling of aRab1b S36 with TMR, Atto 565 and Atto 590 
was performed in COS-7 cells (data not shown). Similar to the findings in HEK 293T cells, 
specific aRab1b labeling was observed for all three dyes, but the observed signal-to-noise 
ratio and the decrease of fluorescence lifetime upon labeling was generally lower in COS-7 
cells (data not shown).  
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Figure 3.10: Intracellular labeling of aRab1b S36 in HEK 293T cells using three different red dyes. 
A) Fluorescence lifetime analysis of HEK 293T cells expressing aRab1b S36 labeled with TMR, Atto 565 
and Atto 590. B) Single cell fluorescence lifetime analysis of the same experiment. Scale bars: 10 µm.  
 
In conclusion, these findings identified TMR as the most potent dye for the intracellular 
labeling of amber Rab1b. Labeling of aRab1b with TMR was homogenous, highly specific 
and yielded a reproducible decrease of mCitrine fluorescence lifetime in comparison to 
unlabeled control samples, indicating the presence of the acceptor on the unimolecular 
sensor. Moreover, the labeling did not affect the cellular localization of aRab1b, Golgi 
biogenesis or the cell phenotype evidentially in HEK 293T cells. Labeled HEK 293T cells 
exhibited no apparent stress indications such as vacuole formation, blebbing or rounding as 
observed for the labeling of intracellular proteins in COS-7 cells (data not shown). 
Therefore, TMR was used primarily in further experiments.  
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3.1.2.5 Optimization of the intracellular labeling 
Using different cell lines raised the question of the cell culture medium and the nutrient 
requirements to ensure maintenance of robust and viable cells for efficient amber 
suppression and intracellular labeling. The standard medium used for initial experiments 
was a low glucose/low vitamin medium. The comparison of two equally treated amber 
suppression samples, one cultivated in low glucose medium, the other one in high glucose 
medium, revealed lower cytotoxicity in samples grown in nutrient rich medium. The 
nutrient rich medium comprises 4-fold more glucose and essential nutrients in comparison 
to the low glucose medium, allowing for rapid proliferation. However, the enhanced 
proliferation emerged as a pitfall, as the established protocol for UAA incorporation and 
intracellular labeling spans over four days, resulting in over-confluent samples on the day of 
imaging. Therefore the number of initially seeded cells was gradually reduced to identify the 
optimal cell number yielding 80-90 % cell confluency on the day of imaging. These samples 
were transfected at 50-60 % confluency, instead of 70-80 %, but did not exhibit increased 
cytotoxicity. The concentration of BcnK in the growth medium did not affect the labeling 
efficiency. Nevertheless, an attempt to identify the cause of the puncta structures revealed 
their dependency on the presence of UAA in the culture medium (Figure 3.11). While 
untransfected cells incubated with BDP did not display any punctate structures, cells grown 
in the presence of BcnK exhibited a high abundance of punctate structures following 
labeling with BDP. Therefore we speculated that removal of the excess of residual BcnK 
before labeling may reduce the number of puncta and potentially augment the specific 
labeling, as the effective dye concentration would not be reduced by side reactions. 
Although BcnK has been previously reported to be removed from cells within one hour 181, 
this time frame was not sufficient for the intracellular labeling of aRab1b and aRheb. 
Prolongation of the BcnK removal time to 16 h pre-labeling resulted in highly specific 
labeling with a high signal-to-noise ratio and a negligible amount of punctate structures in 
HEK 293T cells (Figure 3.10 A). In fact, the BcnK removal time was found to depend strongly 
on the number of incorporating cells per sample and on the cell line (data not shown). As 
protein expression levels vary between different cell lines and as the BcnK consumption 
depends on the number of consuming cells and the stop codon suppression efficiency of 
these cells, the BcnK removal time should be empirically determined for each application to 
ensure complete removal or consumption of BcnK before the intracellular labeling step.  
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Figure 3.11: Excess UAA during intracellular labeling causes high abundance of punctate structures. 
Untransfected HeLa cells cultured in the presence and absence of BcnK and cells expressing the orthogonal 
pair (PylRS), as well as the orthogonal pair and aRab1b, were labeled with BODIPY FL (BDP). 
Scale bars: 10 µm. 
 
Due to the high reaction rate of the inverse electron-demand Diels-Alder reaction, dye 
concentrations in the nanomolar range are sufficient for intracellular labeling 
168,178,179,181,204,253. We found that increasing the dye concentration up to 1 µM increased the 
labeling efficiency noticeable. However, higher dye concentrations required longer wash-
out time post-labeling to achieve good signal-to-noise ratios. Furthermore, prolonging of 
the incubation time from 15-20 min to 1 h increased the labeling efficiency dramatically 
(data not shown). Longer incubation of up to 3 h did not further enhance the specific 
labeling but increased the background signal massively (data not shown). 
Based on these findings the previously established protocol for UAA incorporation into 
small GTPases (Figure 3.2) was extended, allowing for robust and specific labeling of 
intracellular proteins with high reaction yields (Figure 3.12). 
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Figure 3.12: Scheme of the established protocol for intracellular labeling of small GTPases in live 
mammalian cells. The adherent mammalian cells were seeded on the first day and transfected in the 
following morning (~ 16 h post-seeding). 250 µM of the UAA was added to the growth medium during the 
transfection and kept in the medium over night. The UAA was removed from the samples the following day 
to achieve complete removal of residual UAA from the cell lumen before labeling (> 12-16 h). Intracellular 
labeling was performed in the morning on day 4; cells were washed for 2-8 h and analyzed.  
  
3.1.3 Labeling of amber Rab1b 
Furthermore, the observed intracellular labeling of amber Rab1b was assessed to 
confirm the covalent binding of the acceptor to the sensor construct and to determine 
whether the observed change in fluorescence lifetime indeed depends on the presence of 
the acceptor. Moreover, the intracellular labeling reaction was characterized intensively to 
ensure the bioorthogonality of the reaction.  
 
3.1.3.1 Intracellular labeling of Rab1b is bioorthogonal 
To confirm that the intracellular labeling reaction is indeed bioorthogonal, HEK 293T 
cells expressing Rab1b WT with and without the components of the amber suppression 
system, or different aRab1b mutants, were labeled with TMR (Figure 3.13 A). Specific 
labeling of the Golgi apparatus was clearly visible in both samples transfected for an aRab1b 
mutant, but no TMR fluorescence signal was detected in cells expressing Rab1b WT. The 
presence of the components of the amber suppression system in Rab1b WT samples 
increased the TMR background signals mildly but did not yield any labeling as observed for 
the amber mutants. These findings were consistent with the mCitrine fluorescence lifetime 
analysis of the samples (Figure 3.13 B). Rab1b WT samples exhibited fluorescence lifetimes 
comparable to donor only lifetime (Rab1b WT = 2.97-3.01 ns), whereas both amber mutants 
displayed significantly lower lifetimes (S36 = 2.71 ± 0.07 ns and D53 = 2.82 ± 0.11 ns).  
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Figure 3.13: The intracellular labeling of amber Rab1b is bioorthogonal. A) HEK 293T cells 
expressing Rab1b WT and amber Rab1b mutants in the absence and presence of the components of the 
amber suppression system and TMR. B) Single cell lifetime analysis of the respective samples.  
Scale bar: 10 µm. 
 
Next, labeling of aRab1b was assessed by denaturing in-gel fluorescence analysis to 
verify covalent binding of the dye to the amber construct and to further confirm the 
specificity and the UAA-dependency of the reaction (Figure 3.14). To this end, HEK 293T 
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cells expressing Rab1b WT or different amber mutants were cultured in the presence and 
absence of either BcnK or TcoK*. Two fluorescent bands were detected in all aRab1b 
samples in the presence, but not in the absence of an UAA (Figure 3.14, indicated by arrow 
heads). The lower band, at the heights of 46 kDa molecular weight marker band, represents 
the full-length expressed and TMR-labeled mCitrine-aRab1b (49.9 kDa, black arrow head), 
whereas the upper band was identified as the PylRS (50.8 kDa, white arrow head, see Figure 
3.18). The fluorescence intensities of labeled full-length constructs varied between the 
different amber mutants, suggesting differences in expression levels or the labeling 
efficiency. The most intense bands were detected for aRab1b S36 and D53, whereas T34 
and G54 exhibited weaker fluorescence intensities. This order of the mutants is in 
agreement with the previously determined expression levels of the different aRab1b 
mutants (Figure 3.4). Although TcoK* containing samples exhibited generally fainter bands, 
the same order among the mutants was observed. The lower signals observed for labeling 
of TcoK*-containing aRab1b may be due to the lower incorporation efficiency that was 
previously determined (data not shown), but could also be caused by a less efficient labeling 
reaction.  
 
 
Figure 3.14: In-gel analysis of Rab1b WT and amber variants suppressed for BcnK or TcoK*. The 
back arrow heads indicate the UAA-dependent full-length expression and labeling of the aRab1b constructs 
(49.9 kDa), whereas the white arrow heads mark the PylRS (50.8 kDa), which was frequently observed 
during in-gel fluorescence analysis. Immunoblotting of Actin (Actin) served as a loading control.   
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3.1.3.2 Comparison of different UAA for intracellular labeling 
Furthermore, the intracellular labeling of BcnK and TcoK* was compared by 
fluorescence lifetime analysis to determine which UAA is more suitable for the genetically 
encoding of the conformational probes for small GTPase activity (Figure 3.15).  
 
 
Figure 3.15: Comparison of two different UAA for the intracellular labeling of aRab1b. 
A) TMR-labeled HEK 293T cells expressing Rab1b WT and aRab1b S36 in the presence of BcnK or 
TcoK*. B) Single cell analysis of the fluorescence lifetime of these samples. Rab1b WT served as a donor 
only control. Scale bar: 10 µm. 
 
The subcellular localization observed in both UAA samples indicated successful 
incorporation of BcnK and TcoK* into aRab1b S36 (Figure 3.15 A). Moreover, both UAA 
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allowed for specific labeling of the amber constructs. In contrast to the labeling of BcnK 
containing amber proteins, punctate structures and unspecific dye accumulations were 
frequently observed in TcoK* containing samples. The fluorescence lifetime analysis showed 
a significant difference between labeled samples and the unlabeled control Rab1b WT 
(Figure 3.15 B). While the labeling of aRab1b S36-BcnK resulted in an average lifetime of 
BcnK = 2.76 ± 12 ns, the lifetime of TcoK*-labeled samples was in average higher 
(TcoK* = 2.83 ± 0.06 ns).  
These findings are in agreement with the previous results demonstrating a discrepancy 
of the UAA incorporation efficiency and the labeling between the two UAA (Chapters 3.1.1.1 
and 3.1.3.1). Generally, TcoK* incorporation into aRab1b and the subsequent labeling 
seemed to be less efficient than observed for BcnK. Moreover, TcoK* samples displayed 
large amounts of unspecific dye background signals after labeling, which may be due to the 
higher hydrophobicity of TcoK*.  
 
3.1.3.3 The intracellular labeling of aRab1b is time- and dose-dependent 
To verify the direct dependency of the decrease of the donor fluorescence lifetime on 
the presence of the acceptor, the labeling reaction was monitored over time in live cells. To 
this end, Rab1b WT and aRab1b S36 expressing HEK 293T cells were analyzed by confocal 
and fluorescence lifetime microscopy before and after the addition of 1 µM TMR (Figure 
3.16).  
In both samples the dye entered the cell lumen within two minutes and distributed 
evenly throughout the cell lumen in Rab1b WT expressing cells. In contrast, specific labeling 
of the Golgi-bound fraction of aRab1b S36 was clearly visible against the background 
fluorescence within five minutes (Figure 3.16 A, indicated by arrow heads). The 
fluorescence lifetime of aRab1b S36 expressing cells decreased continuously within 
5 minutes post-dye addition and stabilized after 40 minutes at a total difference of 
 = 400 ± 30 ps in comparison to the Rab1b WT control (Figure 3.16 B). In contrast, the 
fluorescence lifetime of Rab1b WT expressing cells remained almost constant, even in the 
presence of 1 µM TMR. 
To determine the effects of the labeling efficiency on the sample lifetime, the same 
experiment was performed using different TMR concentrations (Figure 3.16 C). A dose-
dependent decrease of the fluorescence lifetime on the used TMR concentration was 
observed (Figure 3.16 C). 
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Figure 3.16: The intracellular labeling of Rab1b is time- and dose-dependent. A) HEK 293T cells 
expressing Rab1b WT or amber Rab1b S36 were monitored by confocal and fluorescence lifetime 
microscopy before and after the addition of 1 µM TMR. White arrow heads indicate the specific labeling of 
the Golgi apparatus which was detectable within 5 min post dye addition. B) The average of single cell 
lifetime analysis of unlabeled Rab1b WT as well as Rab1b WT and S36 incubated with 1 µM TMR. 
C) Single cell lifetime analysis of aRab1b S36 expressing cells incubated with different concentrations of 
TMR. D) Scatter plot of TMR-labeled HEK 293T cells expressing either Rab1b WT or aRab1b S36. The 
TMR fluorescence was quantified after intense washing and plotted against the fluorescence lifetime of the 
respective cell. Each data point represents a single cell. Scale bars: 10 µm. 
  
These time-resolved lifetime measurements of aRab1b S36 labeling demonstrate a 
clear dependency of the change in fluorescence lifetime on the specific labeling. Moreover, 
the intracellular labeling reaction was titratable using different concentrations of TMR, 
indicating a dose-dependency of the labeling reaction on the abundance of the dye. The 
observed change in lifetime correlated with the respective dye concentration, confirming 
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the influence of the labeling yield on the fluorescence lifetime of the sensor construct. In 
contrast, presence of even 1 µM dye in Rab1b WT control samples did not affect the sample 
lifetime, verifying that even high abundance of the dye did not alter the fluorescence 
lifetime in the absence of amber protein. The labeling reaction seemed to be completed 
within 30-40 minutes in the presence of 500 nM TMR, whereas lower dye concentrations 
seemed to prevent completion of the labeling reaction within the same time period. Hence, 
the availability of the dye may be the rate-limiting factor for intracellular labeling. To 
achieve saturation of the labeling reaction and thereby the highest possible yield of labeled 
amber protein, the intracellular labeling was performed using 500 nM TMR and at least 
45 minutes incubation for all further experiments.  
 
3.1.3.4 Determination of the labeling yield 
Another important factor for the establishment of the genetically encoded 
conformational sensor is the yield of the labeling reaction, which directly affects the 
fluorescence lifetime of a sample and thereby the accuracy and the dynamic range of the 
sensor. To determine the reaction yield, and thus, the efficiency of the intracellular 
reaction, HEK 293T cells expressing aRab1b S36 were labeled with TMR and lysed after 
intense washing. The lysates were divided in a half and a second, spectrally isolated dye was 
added to one aliquot. This second dye can react only with the previously unlabeled fraction 
of amber protein and can thereby serve as a direct indicator for the size of this fraction. 
Thus, fluorescence quantification of both fluorophores by in-gel fluorescence imaging 
allows for an indirect determination of the labeling yield (Figure 3.17 A). Subsequent 
western blot analysis was performed to identify the amount of full-length Rab1b, enabling 
the normalization the dye fluorescence on the amount of amber Rab1b per sample (Figure 
3.17 B). While the labeling reaction in cells might be impaired by various factors, such as 
protein-protein interactions or activation state of the target protein, the labeling site should 
be fully accessible after cell lysis and protein denaturation. Thus, labeling of intracellularly 
unlabeled lysates should allow for a complete labeling reaction and served as a positive 
control. The experiment was performed using two different cell-impermeable fluorescent 
dyes for the second, in-lysate labeling, FAM and Cy5. Two single-labeled lysates, one labeled 
only with TMR in live cells and one labeled only post-lysis with FAM/Cy5, served as controls 
for the total intracellular labeling and the complete post-lysis labeling, respectively.  
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Figure 3.17: Evaluation of the intracellular labeling yield of the reaction of aRab1b S36-BcnK with 
TMR. A) In-gel fluorescence and western blot analysis (GFP) of HEK 293T cells labeled with TMR 
pre-lysis and/or labeled post-lysis with FAM (left panel) or Cy5 (right panel). Asterisks indicate unspecific 
bands; Immunoblotting of Actin (Actin) served as a loading control. B) Quantification of the fluorescence 
intensity of the fluorescent signals of each fluorophore, normalized on the respective amount of full-length 
aRab1b S36 per sample. The upper graph illustrates the results of the post-lysis labeling with FAM and the 
lower panel the post-lysis labeling with Cy5. 
  
The in-gel fluorescence analysis revealed the two previously described bands for full-
length and labeled aRab1b S36 (49.9 kDa) and the PylRS (50.9 kDa), independent of the 
used dye (Figure 3.17 A). Intracellular labeling with TMR resulted in strong fluorescent 
bands in all labeled samples, while the labeling post-lysis with FAM or Cy5 exhibited high 
labeling in the previously unlabeled samples, but only faint secondary labeling in the 
intracellularly TMR-labeled samples. The quantification of the fluorescent band intensity, 
normalized on the respective amount of full-length aRab1b, revealed labeling yields of 
85.0 ± 14.5 % for sole TMR-labeling in live cells and 86.1 ± 16.8 % for TMR-labeling in live 
cells followed by post-lysis FAM labeling. The samples labeled with Cy5 as a secondary dye 
displayed yields comparable to the labeling with FAM (81.83 ± 9.90 % and 86.76 ± 10.96 %, 
respectively).  
These data demonstrate that the intracellular labeling of aRab1b S36 with TMR in live 
cells allows for high reaction yields using the protocol established in this work. The reaction 
yields were robust and reproducible, but depended strongly on the quality of the dye 
solution. Multiple freeze-thaw cycle of the dye stock solution were found to reduce the 
labeling yield up to 50% after the third cycle (data not shown). 
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3.1.4 Intracellular labeling of amber Rheb 
In parallel to the establishment of the intracellular labeling of aRab1b, the same 
strategy was followed to achieve specific labeling of amber suppressed Rheb. Comparable 
to aRab1b labeling (Figure 3.7), the labeling of aRheb in HeLa cells with red probes did not 
result in any detectable specific labeling (data not shown). Furthermore, labeling with green 
dyes, e.g. FDAC or BDP, did also not succeed, neither for BcnK nor for TcoK* incorporation 
(data not shown). Moreover, the six mammalian cell lines that were tested for aRab1b 
labeling were also examined for the labeling of aRheb S34 and N50, the structural 
equivalents to aRab1b S36 and D53, respectively. Specific labeling of aRheb with TMR was 
not observed in any of the six cell lines, including HEK 293T cells, which is surprising 
considering the previously observed BcnK-dependent full-length expression of aRheb N50 
detected by Western blot (Figure 3.6 B). To further assess whether any full-length expressed 
aRheb is labeled, in-gel fluorescence analysis was performed for the different amber Rheb 
mutants (Figure 3.18).  
 
 
Figure 3.18: Intracellular labeling of different amber Rheb mutants with TMR. In-gel fluorescence 
analysis of TMR-labeled HEK 293T cells expressing Rheb WT and different amber variants in the presence 
and absence of BcnK. Fluorescent bands were detected for the PylRS (50.9 kDa, white arrow head) and 
full-length amber Rheb (48.2 kDa, black arrow head). Immunoblotting of Actin (Actin) served as a 
loading control.  
 
Similar to in-gel analysis of the aRab1b mutants, two major UAA-dependent fluorescent 
bands were detected. The upper band representing the PylRS (50.8 kDa, indicated by the 
white arrow head) and a marginally lower band, indicating full-length expressed and 
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TMR-labeled aRheb (48.2 kDa, black arrow head). The labeling intensity varied for the 
different aRheb mutants; the strongest band was detected for labeling of aRheb N50 and 
only faint fluorescent bands indicating labeling of D33 and S34. No respective band was 
observed for the G108 labeling; G51 incubation with TMR caused massive cell detachment, 
resulting in complete cell loss before the lysis. The order of the mutants is in agreement 
with the previous findings for UAA-incorporation into aRheb (Figure 3.6 B), which 
demonstrated a yield of full-length expressed aRheb N50 of 12 % of the natural translation 
control, Rheb WT. In contrast, UAA incorporation into other Rheb mutants was hardly 
detectable. 
 
To further assess these findings on the single cell level, HEK 293T cells expressing 
aRheb N50 were screened by confocal microscopy for specific TMR labeling. Only a small 
number of cells exhibited low but still detectable dye fluorescence against the background 
signals. These cells were analyzed by fluorescence lifetime microscopy to confirm the 
specificity of the labeling (Figure 3.19 A and B).  
As previously described, the lack of clearly visible subcellular localization pattern of 
Rheb impedes the precise determination of the UAA incorporation efficiency of aRheb by 
microscopy. Direct comparison of the localization patterns of Rheb WT and aRheb N50 in 
HEK 293T cells revealed only minor differences. While the wild type protein localized almost 
exclusively in the cell lumen and displayed only a small nuclear Rheb fraction, the difference 
between the cytosolic and nuclear fluorescence was less distinct in aRheb expressing cells 
(Figure 3.19 A). Moreover, Rheb WT expression showed diffuse membranous patterns and 
high fluorescence densities in the perinuclear area, which were not observed in cells 
expressing aRheb, suggesting either functional impairment caused by the mutation or a low 
UAA incorporation efficiency. Low UAA incorporation efficiency would cause a mixed 
expression of mCitrine-Rheb fragment and full-length expression construct. Depending on 
its abundance, the fragment could mask the specific localization of the full-length expressed 
and prenylated aRheb mutants, further impeding the verification of the UAA incorporation 
process by the subcellular localization of the full-length construct. In fact, the fluorescence 
intensity of the detected TMR-labeling signals was rather low and did not evidently 
correlate with aRheb abundance, which raises the question of the specificity of the 
observed TMR signals. In addition, high fluorescence of the dye was observed in the 
nucleus, indicating unspecific side reactions.  
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Figure 3.19: Intracellular labeling of aRheb N50 with TMR in HEK 293T cells. A) Confocal and 
fluorescence lifetime microscopy of aRheb N50 and Rheb WT. Arrow heads indicate the perinuclear 
fluorescence densities observed for Rheb WT but not for the amber mutant. B) Single cell lifetime analysis 
of the respective experiment. C) In-gel and western blot analysis of TMR-labeled HEK 293T (GFP) cells 
expressing Rheb WT and aRheb N50 in presence and absence of BcnK. The black arrow head indicates 
full-length expressed and TMR-labeled aRheb (48.2 kDa); the white arrow head indicates the PylRS 
(50.9 kDa); the asterisk marks an unspecific band. Immunoblotting of Actin (Actin) served as a loading 
control. Scale bar: 10 µm. 
  
mCitrine fluorescence lifetime analysis showed an average decrease of 
 = 73.4 ± 41 ps for aRheb N50 in comparison to the unlabeled Rheb WT sample (Figure 
3.19 B). This lifetime reduction is only a minor change in comparison to the observed 
decrease in lifetime of aRab1b after labeling ( = 300 - 400 ps). Although the lifetime 
difference is rather marginal, it indicates the presence of the acceptor on the amber 
construct and thus, the specific labeling of at least a small fraction of aRheb. Furthermore, 
western blot and in-gel fluorescence analysis of aRheb N50 demonstrated full-length 
expression and specific TMR-labeling of the construct (Figure 3.19 C, black arrow head). 
 
To confirm that the decrease of lifetime is due to the specific labeling of the construct, 
the labeling reaction was followed over time by fluorescence confocal and lifetime 
microscopy (Figure 3.20).  
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 Figure 3.20: Time-resolved monitoring of the intracellular labeling reaction of aRheb N50 and TMR 
in HEK 293T. A) Confocal and lifetime analysis of HEK 203T cells expressing Rheb WT and aRheb N50 
pre- and post- addition of 1 µM TMR. White arrow heads indicate the perinuclear fluorescence densities in 
cells expressing aRheb N50. The asterisks indicate unspecific nuclear TMR-labeling. B, C) Single cell 
analysis of the change in lifetime of HEK 293T cells expressing Rheb WT (B) or aRheb N50 (C) pre- and 
post- addition of 1 µM TMR. Grey lines indicate single cells; the black line the sample average. 
Scale bar: 10 µm. 
 
Only few cells expressing aRheb N50 exhibited the perinuclear Rheb fraction as 
observed in Rheb WT expressing cells, indicating the native localization of the construct 
(Figure 3.20 A, indicated by arrow heads). The majority of cells displayed a more diffuse 
localization throughout the cytoplasm and partially the nucleus. In both samples the dye 
entered the cells rapidly but, in contrast to the labeling of aRab1b, no specific labeling of 
aRheb was visible against the background signal. However, transfected cells, but not 
neighboring untransfected cells or Rheb WT expressing control cells, exhibited a nuclear 
TMR staining resembling nucleoli structures (Figure 3.20 A, marked by asterisks). Single cell 
fluorescence lifetime analysis revealed a change in the lifetime of aRheb N50 expressing 
cells post-dye addition, whereas the lifetime of the Rheb WT sample remained constant. 
The detected change in the lifetime of the aRheb N50 samples represented the 
heterogeneity of observed phenotypes; cells exhibiting a diffuse cytosolic Rheb pattern 
showed an average decrease in lifetime of  = 100-150 ps, whereas the lifetime of cells 
with perinuclear densities decreased up to  = 350 ps depending on the size of this fraction 
(Figure 3.20 C). In both cases no further decrease of the lifetime was observed after 
30 minutes, indicating completion of the labeling reaction. In comparison, labeling of 
aRab1b S36 expressing cells with 1 µM TMR caused an average change in lifetime of 
 = 350-400 ps within 45 minutes. 
In summary, these findings demonstrate the specific labeling of aRheb N50 with TMR 
using the recently established protocol in HEK 293T cells. Nevertheless, the aRheb N50 
labeling exhibited high heterogeneity both in the TMR labeling signals and in the lifetime 
reduction during labeling. Monitoring the labeling reaction over time identified a direct 
dependency of the lifetimes of single cells on the cellular localization of the aRheb 
construct, suggesting low incorporation efficiency as the major pitfall for amber suppression 
and labeling of aRheb N50. In contrast to aRab1b labeling, strong nuclear staining was 
observed for aRheb labeling, indicating unspecific side reactions similar to the previously 
reported nuclear labeling observed for the labeling of cytoplasmic BcnK-suppressed amber 
proteins 218. Further optimization of both, the UAA incorporation efficiency and the labeling 
yield may allow for higher expression yields of full-length aRheb and thereby higher 
homogeneity of the sample, allowing for precise monitoring of Rheb spatiotemporal activity 
in live cells.  
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3.2 Characterization of the Genetically Encoded Sensors 
3.2.1 Rab1b Conformational Sensor 
The recombinant Rab1b conformational probes have been shown to report nucleotide 
exchange, effector binding or both events, depending on the position of the acceptor within 
the small GTPase 160,161. Moreover, the probe read-out also depends on the labeling site. 
Labeling of mutation sites within the switch I region resulted in an increase of the sensor 
lifetime upon activation or effector binding, whereas introduction of the acceptor into the 
interswitch region caused a decrease in lifetime upon activation. Except for T34, a mutation 
site located in the switch I region, all previously characterized Rab1b mutants allowed for 
the detection of effector binding and activation events simultaneously. Nevertheless, due to 
the low expression and fluorescence brightness the amber variant of Rab1b T34 was not 
suitable for fluorescence lifetime analysis and was therefore not further assessed within this 
study. Unless indicated otherwise aRab1b S36 was used in all further experiments.  
 
3.2.1.1 Sensing effector binding 
To confirm the functionality of the genetically encoded conformational sensor, Rab1b 
effector binding was assessed. Introduction of the acceptor at the position S36 in Rab1b has 
been demonstrated to efficiently report effector binding events both in vitro and in vivo 
160,161. In this study a truncated version of the inositol-5-phosphatase OCRL1, a Rab effector 
protein, was used to confirm the signal change of the conformational sensor upon effector 
binding 160,161. OCRL1 is a multi-domain membrane-bound protein that has been shown to 
interact in a nucleotide state dependent manner with different Rab proteins, including 
Rab1b 54,254-257. Therefore, the C-terminus of OCRL1, which contains the Rab binding domain 
255,256, was fused to the fluorescent protein TagBFP (TagBFP-OCRL1539-901, hereafter referred 
to as OCRL) and was coexpressed with aRab1b S36 (Figure 3.21). Expression of Rab1b WT in 
the absence and the presence of OCRL and the expression of aRab1b S36 in the presence of 
soluble TagBFP served as negative controls.  
In both samples the OCRL localization correlated with the Rab1b localization, resulting 
in a cytosolic and a Golgi-bound fraction (Figure 3.21 A). Neither the Rab1b localization nor 
the intracellular labeling reaction seemed to be affected by the presence of OCRL.  
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Figure 3.21: The genetically encoded conformational Rab1b sensor reports effector binding. 
A) HEK 293T cells expressing Rab1b WT and aRab1b S36 in the presence and absence of 
TagBFP-OCRL539-901 (OCRL). B) Single cell fluorescence lifetime analysis of HEK 293T cells 
expressing Rab1b WT or aRab1b S36 in the absence and presence of OCRL. C) Fluorescence lifetime 
analysis of HEK 293T cells expressing Rab1b WT and aRab1b S36 in the absence and presence of 
TagBFP. Scale bar: 10 µm. 
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The presence of OCRL increased the average fluorescence lifetime of aRab1b S36 
significantly by S36+OCRL = +120 ps, whereas the coexpression of OCRL and Rab1b WT 
resulted in a minor decrease in lifetime (WT±OCRL = -60 ps, Figure 3.21 B). The lifetime 
increase of aRab1b correlated spatially with the OCRL localization, resulting in a change in 
lifetime especially for the Golgi-bound aRab1b (Figure 3.21 A). In contrast, expression of the 
soluble TagBFP fluorescent protein did not affect the lifetime of aRab1b S36 noticeably 
(S36±TagBFP = 35 ps), excluding potential fluorophore cross-talk or side effects due to the 
presence of the third fluorophore. 
These findings demonstrate that the labeled aRab1b S36 protein functions as a sensor 
for effector binding events. The sensor read-out and its dynamic range are in agreement 
with the previous studies demonstrating that the recombinant Rab1b S36C sensor displayed 
an increase of the fluorescence lifetime of eGFP upon binding to effectors 160,161.  
 
3.2.1.2 Linker optimizations 
To optimize the dynamical range of the sensor, the linker between the fluorescent 
protein and the small GTPase was engineered. This linker is a short peptide sequence 
encoded by the expression plasmid, allowing for rapid and simple optimizations of the linker 
properties by cloning. Two parameters influencing the sensor’s dynamic range were 
assessed. The first parameter is the linker length, which defines mainly the distance 
between the two fluorophores. The second parameter is the linker flexibility, which can 
affect the orientation of the fluorophores towards each other. A highly flexible linker allows 
for a high number of different conformational states, whereas a more rigid linker locks the 
two FRET partners in distinct orientation states. Each conformational state of the sensor 
possesses its own fluorescence lifetime, thus, the acquired fluorescence lifetime represents 
an average of the different conformational states during signal acquisition. To reduce the 
number of conformational states, the linker rigidity was increased already in the beginning 
of this study. To this end, the native linker sequence, deriving from the insertion of the 
Rab1b gene into the pCitrineC1 backbone, was exchanged to a nine amino acid peptide 
sequence (Figure 3.22 A). This sequence has been reported to form an alpha helix258,259 and 
in silico analysis indicated that the mCitrine C-terminus participates in the helix formation, 
extending the alpha helix towards the beta barrel of mCitrine (data not shown)236. Only five 
amino acids predicted to be unstructured are located on each side of the linker helix, both, 
towards the end of the mCitrine beta barrel and the first beta sheet in Rab1. When 
expressed in mammalian cells, this construct localized natively to the Golgi compartment 
and was comparable to the aRab1b construct with the more flexible linker (data not 
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shown). Unless indicated otherwise, all amber Rab1b and Rheb constructs used within this 
work contain the helical nine amino acid linker.  
In addition to the helical linker, two shorter linker sequences, a two amino acid linker 
and a proline rich rigid linker, were assessed (Figure 3.22 B and C). The first one aims for an 
increase of the FRET efficiency and the dynamic range of the sensor by bringing the two 
fluorophores in closer proximity. Depending on the helicity of the linker, a maximal distance 
of 8.4-9.4 nm between the fluorophores was calculated for the helical nine amino acid 
linker constructs (Chapter 2.2.7). To bring the two fluorophores closer to the optimal 
distance R0, the linker length was shortened to two amino acids and the last C-terminal 
eleven amino acids of mCitrine were removed. Previous studies showed that the C-terminal 
depletion of up to eleven amino acids of GFP did neither affect the protein fold, nor the 
fluorophore maturation or the biophysical properties 150,260-262. These truncated fluorescent 
proteins allowed improving the dynamic range of orientation-dependent FRET-based 
sensors significantly 150,160,161,261.  
The maximal distance calculated for the Rab1b construct containing the shortened 
linker is 6.0 nm, which is close to the R0 value for the mCitrine-TMR FRET pair (est. 5.57 nm 
263). The expression of this construct in HEK 293T cells revealed a cytosolic and partially 
nuclear localization, but no association to the Golgi apparatus (Figure 3.22 B). In addition, 
no labeling was observed for the short linker construct, whereas the control, aRab1b S36, 
showed strong and specific labeling. Moreover, the Golgi marker GntnC localized in a diffuse 
pattern throughout the cell lumen, indicating perturbance of the Golgi homeostasis and 
thus, potential malfunction of the Rab1b short linker construct.  
The second linker is a proline-rich linker (XPn). Proline is a unique amino acid which has 
a restricted backbone conformation due to the cyclization of its backbone 264. Linkers 
consisting of multiple repetitions of proline and another amino acid, preferentially alanine, 
lysine or glutamine, have been shown to possess high stiffness due to the formation of 
proline helices 253,265-267. The Rab1b_XPn linker construct localized to the Golgi 
compartment and displayed a labeling specificity comparable to the control sample, but 
with lower labeling intensity (Figure 3.22). In fact, the number of incorporating cells per 
sample was reduced in comparison to the helical linker control sample. mCitrine 
fluorescence lifetime analysis revealed an average lifetime of XPn_S36 = 2.91 ± 0.04 ns, 
resulting in  = 100 ps difference between the two linker constructs 
(helical_S36 = 2.82 ± 0.08 ns). However, whether this difference is due to the altered 
orientation of the fluorophores or their distance towards each other remains unclear. 
Further characterization of this constructs may give more insights into the influence of the 
linker rigidity on the dynamic range of the conformational sensor.  
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Figure 3.22: Optimizations of the proteinogenic linker between the fluorescent protein and Rab1b 
small GTPase. A) Scheme of the conformational sensor’s architecture. The black box marks the linker 
region between the fluorescent protein and Rab1b; the respective linker sequences are illustrated below. 
B) HEK 293T cells expressing Rab1b WT and different linker variants of aRab1b T34. GntnC served as a 
marker for the Golgi compartment. C) Confocal microscopy and mCitrine lifetime analysis of HEK 293T 
cells expressing Rab1b WT and different linker variants of aRab1b S36. Scale bars: 10 µm.  
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3.2.1.3 Viability of sensor expressing cells 
During the establishment and the optimization of the intracellular protocol aRab1b 
expressing samples exhibited lower fluorescence intensity and a more diffuse localization 
pattern when imaged one day post-labeling. To determine the potential time range for 
imaging of an amber sample, treatment and other applications, time-course experiments 
were performed. To this end, the fluorescence emission and the total cell confluency of 
Rab1b WT and sensor expressing cells were monitored for 48 h following the intracellular 
labeling with TMR (Figure 3.23). 
mCitrine fluorescence was detectable for both samples despite the lower expression 
levels of the amber mutant in comparison to Rab1b WT (Figure 3.23 A). Although the 
number of fluorescent cells was higher in the aRab1b S36 sample, the observed 
fluorescence intensity was generally lower. Moreover, mCitrine fluorescence decreased 
over time in the aRab1b sensor sample but not for Rab1b WT. Quantification of the average 
fluorescent area per sample revealed that the fluorescence started to decay 6 h 
post-labeling and reached the level of background signals at 40 h post-labeling (Figure 
3.23 A). In contrast, the Rab1b WT fluorescence remained constant over the whole 
measurement. As indicated by the microscopy images this fluorescence decrease of the 
Rab1b sensor was not due to a sudden loss of transfected cell, but due to a constant 
reduction of fluorescence intensity over time, especially within the first 12 h after labeling. 
One explanation for this decay may be the cellular Rab1b turn-over, which results in a 
continuous decrease of the protein over time. Due to the lack of UAA in the growth 
medium, expression of aRab1b S36 is prevented after the removal of the UAA prior to 
labeling, whereas Rab1b WT expression does not depend on the presence of the UAA and 
thus may compensate for the protein degradation by turn over. On the other hand, cells 
transfected for aRab1b did not notably divide during this experiment and were partially 
overgrown by neighboring untransfected cells. Repetitions of this experiment demonstrated 
that the decrease in fluorescent area can be delayed by using lower initial cell numbers, 
which prevents the overgrowths of untransfected cells and thereby the loss of fluorescent 
cells (Figure 3.23 B). However, the reduction of aRab1b S36 fluorescent area over time was 
monitored in all amber Rab1b samples, independent of the presence of TMR or its 
concentration.  
Whether this fluorescence decay was also present in other amber proteins, e.g. amber 
Rheb mutants, remains unclear. However, depending on the cellular turn-over rate of a 
protein it is likely that all amber proteins may suffer from this pitfall. Consequently, all 
samples, independent of the protein of interest, the cell line or the dye used for labeling 
were imaged or lysed within 2-8 h post-labeling.  
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Figure 3.23: Viability and proliferation assay of TMR-labeled HEK 293T cells expressing 
TMR-labeled aRab1b S36. A) Bright field and fluorescence microscopy of HEK 293T cells expressing 
Rab1b WT and aRab1b S36 over 48 h post-labeling with TMR. The fluorescent area and cell confluency 
per sample were quantified to illustrate viability and proliferation. Data points represent the mean of three 
technical replicates over time. Error bars illustrate the SD. B) Fluorescent area and cell confluency of cells 
expressing aRab1b S36 labeled with different concentration of TMR. Lower initial cell numbers were used 
for this experiment to avoid loss of transfected cells due to overgrowth of neighboring cells. 
Scale bars: 200 µm. 
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3.2.1.4 Determination of the sensor’s dynamic range 
Different strategies can be utilized to ascertain the dynamic range of a sensor, e.g. 
(1) using mutations that affect the protein’s activity or that lock the protein in a respective 
activity state, (2) regulation by coexpression of activating or inactivating proteins or 
(3) exploiting the cognate signaling pathway and thereby activating the target protein by a 
known stimulus. Because of the lack of stimuli for Rab1b activation due to its role in ER-to-
Golgi vesicular transport, the last option is not applicable for the conformational Rab1b 
sensor. Therefore, the two first strategies were followed, using Rab1b mutants that affect 
the nucleotide state and regulating the sensor by coexpression of GEF and GAP proteins. 
 
 
 
Regulation of the nucleotide state by GEF and GAP 
To determine the lifetime of the active Rab1b sensor, the Legionella protein DrrA was 
exploited. During infection Legionella injects a number of proteins into the host cell of 
which many have been shown to modulate the function of Rab GTPases (reviewed in 268). 
Among these proteins is DrrA, which has been reported to act as a Rab1 GEF. DrrA consists 
of three domains and the central domain possesses the catalytic GEF activity towards Rab1 
29,269. Therefore, coexpression of DrrA should result in predominantly GTP-loaded Rab1b 
protein, allowing for the determination of the Rab1b sensor’s ‘ON’ signal. To this end, 
Rab1b WT and aRab1b S36 were coexpressed with DrrA340-533 fused to TagBFP 
(TagBFP-DrrA340-533, hereafter referred to as DrrA, Figure 3.24).  
The DrrA presence caused a reduced Golgi association and relocalization of Rab1b to 
the cytosol and partially the nucleus (Figure 3.24 A). In Rab1b WT expressing cells this 
phenotype correlated with the abundance of DrrA. Low DrrA expression allowed for partial 
Rab1b localization to the Golgi compartment, while high expression levels induced 
predominantly cytosolic Rab1b localization. Coexpression of DrrA and amber Rab1b S36 
resulted in a variety of phenotypes, ranging from cytosolic to partially Golgi-associated 
aRab1b and did not depend on the DrrA expression level. Furthermore, DrrA presence 
increased signs of cytotoxicity in the amber suppression samples noticeably, whereas 
Rab1b WT and DrrA coexpressing cells were viable and healthy. Moreover, cells expressing 
aRab1b S36 and DrrA displayed a drastic reduction of TMR-labeling, which in fact correlated 
with DrrA abundance (Figure 3.24 A). Quantification of TagBFP (indicating DrrA expression 
level) and TMR (indicating specific labeling) fluorescence intensities within single cells 
revealed a strong dependency of the TMR amount of a cell on the abundance of DrrA 
(Figure 3.24 C). mCitrine fluorescence lifetime analysis showed an increase in lifetime of 
aRab1b S36 in the presence of DrrA in comparison to its absence (S36±DrrA = +77 ps, Figure 
94 
 
3.24 B). In contrast, coexpression of DrrA and Rab1b WT sample caused a minor 
fluorescence lifetime reduction (WT±DrrA -20 ps).  
 
 
Figure 3.24: Directing the Rab1b sensor’s nucleotide state by coexpression of the Rab1 GEF DrrA. 
A) HEK 293T cells expressing Rab1b WT and the amber mutant S36 in the absence and presence of 
TagBFP-DrrA340-533 (DrrA). B) Single cell lifetime analysis of the respective experiment. 
C) Quantification of the TagBFP and TMR fluorescence intensity of HEK 293T cells expressing 
Rab1b WT and aRab1b S36 in the absence and presence of DrrA. Each data point represents a single cell; 
the dashed line represents the linear fit of the aRab1b S36+DrrA. Scale bar: 10 µm 
  
As the activation of the Rab1b S36 sensor is reported by an increase of the fluorescence 
lifetime, an augmented fluorescence lifetime of mCitrine-aRab1b S36 is expected in the 
presence of DrrA. However, in this case, it cannot be excluded that the detected increase in 
sensor lifetime is indeed due to the DrrA-mediated activation and not caused by an 
impaired intracellular labeling reaction. Impairments in the labeling reaction and thereby a 
lower labeling yield would artificially decrease the donor-acceptor population, resulting in 
an increase of the average sample lifetime. The observed dependency of the TMR 
fluorescence on the TagBFP fluorescence intensity supports this possibility. Another 
95 
 
possibility is that the DrrA coexpression causes degradation of the sensor construct. If fully 
intact, single mCitrine displays an even distribution throughout the cell, which cannot be 
reliably distinguished from the cytosolic Rab1b localization caused by DrrA coexpression. 
This possibility is supported by the complete lack of labeling in respective cells and the 
sample lifetime that is comparable to the donor only lifetime. Nevertheless, a full-length 
expression of the construct but a lack of labeling would also yield similar lifetimes and 
cannot be differentiated from protein degradation.  
 
Furthermore, coexpression of Rab1 GAP TBC1D20 was performed. TBC1D20 functions 
as a Rab1b and Rab2a GAP protein, regulating the ER-to-Golgi vesicular transport and 
maintaining the homeostasis of the Golgi complex 90,91,93. Overexpression of the catalytically 
active TBC1D20 has been reported to maintain Rab1b in its inactive, GDP-loaded state, 
causing disruption of the ER-to-Golgi trafficking and the loss of the Golgi structure 89,91. To 
determine the sensor’s ‘OFF’ state, a truncated version of TBC1D20, fused to TagBFP, was 
coexpressed with aRab1b S36. TBC1D201-362 contains the catalytic RabGAP domain, but 
lacks the C-terminal transmembrane domain and thereby the protein’s localization signal 90. 
Hereafter, TagBFP-TBC1D201-362 is referred to as TBC1D20. 
The presence of TBC1D20 caused a predominantly cytosolic and partially nuclear 
localization of Rab1b WT and prevented the localization of Rab1b to the Golgi apparatus. In 
contrast, aRab1b S36 localized mainly to the cytosol (Figure 3.25 A). Rab1b WT and 
TBC1D20 coexpressing cells were markedly rounded in comparison to TBC1D20-negative 
samples. As observed for DrrA coexpression, specific labeling of aRab1b S36 was not 
detectable in the presence of TBC1D20, although aRab1b S36 expressing cells displayed low 
TMR fluorescence. These signals were above the background signals of untransfected 
neighboring cells, but the TMR fluorescence intensity did not correlate with the localization 
of aRab1b. Moreover, TBC1D20 and aRab1b S36 coexpression yielded extremely dim 
fluorescent cells which were hardly detectable. mCitrine fluorescence lifetime analysis 
revealed an average lifetime of S36+TBC1D20 = 2.85 ± 0.10 ns of aRab1b S36 in the presence of 
TBC1D20 and S36 = 2.75 ± 0.09 ns in its absence.  
Due to its GAP activity towards Rab1, coexpression of TBC1D20 maintains Rab1b 
predominantly in its GDP-loaded state 89,91. Inactivation of the Rab1b sensor has previously 
been shown to decrease the lifetime of the eGFP-Rab1b recombinant sensor by 
approximately 10 % 160,161. Thus, the observed increase in mCitrine lifetime is not in 
agreement with the previous findings. However, similar to DrrA coexpression, it cannot be 
excluded that the lifetime increment was due to the lack of specific labeling, resulting in a 
larger donor only fraction and thereby a higher average lifetime. 
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Figure 3.25: Determining the Rab1b sensor’s ‘OFF’ state by the coexpression the Rab1 GAP 
TBC1D20. A) HEK 293T cells expressing Rab1b WT or aRab1b S36 in the presence and absence of 
TBC1D20. B) and C) Single cell fluorescence lifetime analysis of aRab1b S36 (B) and Rab1b WT (C) in 
the absence and presence of TBC1D20. Cells expressing only Rab1b were segmented for analysis  
(Cell = whole cell, Gol. = Golgi, Cyt. = Cytoplasm). Scale bar: 10 µm. 
  
In summary this data demonstrates that coexpression of regulatory proteins can affect 
the intracellular labeling reaction of an amber protein, potentially causing artificial changes 
in the fluorescence lifetime of a sample. In fact, coexpression of the Rab1 binding domain of 
the effector OCRL did not affect aRab1b labeling which raises the possibility that aRab1b 
must be fully functional and requires free cycling between the two different nucleotide 
states to allow for complete labeling.  
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Amber Rab1b nucleotide state mutants 
To avoid exogenous expression of regulatory proteins, three nucleotide state affecting 
mutations of Rab1b, S22N (SN), Q67L (QL) and N121I (NI), were assessed to determine the 
different activation states of the sensor. The Q67L mutation of Rab1 lowers the intrinsic 
nucleotide hydrolysis and impairs the GTPase-GAP interaction, leading to a dominant active 
protein which exhibits 2-3 fold higher GTP-loading than the wild type protein in vivo 21,63,249. 
The Rab1b S22N mutant has a lower affinity for GTP than GDP, resulting in a predominantly 
GDP-loaded protein, whereas N121I exhibits low affinity for both nucleotides 245,246,249. The 
two inactive mutants act as dominant suppressors of endogenous Rab1b function and their 
exogenous expression causes a partial or complete disruption of the Golgi complex 245-249.  
First, the BcnK incorporation and TMR-labeling was assessed for the active and inactive 
mutants of aRab1b S36 (Figure 3.26). Similar to aRab1b S36 wild type (S36/WT) the 
dominant active mutant aRab1b S36/QL (S36/QL) localized to the Golgi apparatus and 
exhibited comparable TMR-labeling with high specificity (Figure 3.26 A and C). Expression of 
the two dominant negative mutants aRab1b S36/SN and S36/NI resulted in low 
fluorescence signals and an even distribution within the cytosplasm and nucleus. No specific 
labeling with TMR was detectable for the two inactive amber mutants (Figure 3.26 A and C). 
Single cell mCitrine fluorescence lifetime analysis of the samples revealed an average 
lifetime of S36/QL = 2.82 ± 0.05 ns for S36/QL which is slightly lower than the lifetime of 
S36/WT (S36 = 2.85 ± 0.06 ns, Figure 3.26 B). In contrast, the S36/SN and S36/NI samples 
exhibited drastically higher lifetimes (S36/SN = 2.96 ± 0.03 and S36/NI = 2.97 ± 0.03) that were 
comparable to the unlabeled Rab1b WT/WT control (WT/WT = 2.99 ± 0.03). In combination 
with the observed lack of acceptor fluorescence, this increase in lifetime suggests a 
complete lack of TMR-labeling. To further assess, whether the lack of labeling is due to 
failure of BcnK incorporation into the inactive amber mutants, in-gel fluorescence and 
western blot analysis were performed (Figure 3.26 C). Full-length expression and specific 
labeling were detected for aRab1b S36/WT and /QL mutant, whereas the /SN and /NI 
variants lacked any full-length expression detected by western blot. Interestingly, the more 
sensitive in-gel fluorescence analysis revealed very faint bands, indicating low abundant but 
full-length expressed and labeled /SN and /NI mutants (Figure 3.26 C, black arrow head).  
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Figure 3.26: Determining the dynamic range of the conformational sensor using dominant active and 
inactive mutants of Rab1b. A) HEK 293T cells expressing Rab1b WT and three different amber 
Rab1b S36 nucleotide state mutants, S22N (SN), Q67L (QL) and N121I (NI). B) Single cell fluorescence 
lifetime analysis of the different amber nucleotide state mutants and aRab1b S36/WT. Rab1b WT 
(WT/WT) served as the donor only control. C) In-gel fluorescence and western blot analysis of the different 
mutants. The white arrow head marks the PylRS, the black arrow head labeled aRab1b, the asterisk 
indicated an unspecific band. Immunoblotting of Actin served as a loading control (Actin). 
Scale bar: 10 µm. 
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Characterization of the sensor’s ‘ON’ state 
Following verification of the BcnK-dependent full-length expression and the labeling of 
the dominant active mutant aRab1b S36/QL, the sensor signal was analyzed in a higher 
spatial resolution in live cells. To this end, lifetime images of S36/WT and S36/QL expressing 
cells were segmented into three regions of interest (ROI): whole cell (Cell), cytoplasm (Cyt.) 
and Golgi apparatus (Gol.) and the average lifetime was determined for each region (Figure 
3.27).  
Segmentation of Rab1b expressing cells revealed different lifetimes for cytosolic and 
Golgi-bound Rab1b fractions in all samples (Figure 3.27 B). The Golgi region exhibited a 
lower lifetime than the cytoplasm. While this difference amounted to WT Gol-Cyt. = 90 ps in 
Rab1b WT/WT and WT/QL samples, the gap between Golgi complex and cytoplasm was 
larger in TMR-labeled aRab1b S36 samples (S36 Gol-Cyt. = 250 ps). Interestingly, although 
S36/QL mutant expressing cells displayed a minor increase of the fluorescence lifetime in 
comparison to S36/WT (Cell (S36/WT-S36/QL) = 32 ps), the lifetime of the Golgi-bound aRab1b 
fraction was higher (Gol.(S36/WT-S36/QL) = 170 ps). Thus, the lifetime difference between Golgi 
and cytoplasm (S36/QL Gol-Cyt. = 90 ps) is 2.5-fold less than observed for S36/WT and is 
comparable to the difference observed in Rab1b WT cells.  
Although the average sample lifetimes of S36/WT and /QL differed by only  = 40 ps, 
the labeling of the two constructs was further assessed to exclude varying labeling 
efficiency as a cause for the detected lifetime increment. The amount of TMR fluorescence 
of S36/WT and /QL expressing cells was quantified and plotted against the lifetime of the 
respective cell (Figure 3.27 C). Both samples, aRab1b S36/WT and S36/QL, displayed a 
similar dependency of the lifetime on the abundance of the acceptor. Moreover, the linear 
fitting of the two data sets was comparable, indicating similar labeling and lifetime 
distribution of the two constructs. Furthermore, in-gel fluorescence and western blot 
analysis of the amber wild type protein and the QL mutant revealed similar expression 
levels and labeling intensity, excluding a reduced labeling efficiency as an artificial cause for 
the observed fluorescence lifetime differences of the two samples (Figure 3.27 D).  
In summary, the dominant active QL mutant of amber Rab1b S36 was expressed in full-
length and labeled comparably to the amber wild type protein. Moreover, the 
predominantly active QL mutant displayed an increase in fluorescence lifetime of the 
Golgi-bound aRab1b fraction, which is consistent with previous studies using the 
recombinant COSGA sensor 160,161. Nevertheless, the lifetime increment observed for the 
Golgi region of the genetically encoded sensor, about 6.5 %, is slightly less than reported for 
the active recombinant sensor (10 %).  
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Figure 3.27: Characterization of the sensor’s ‘ON’ state using the dominant active Q67L mutant. 
A) HEK 293T cells expressing Rab1b WT and aRab1b S36, both as wild type protein and Q67L variant. 
B) Single cell fluorescence lifetime analysis of Rab1b WT and aRab1b S36 and their respective QL 
mutants. The lifetime was quantified for whole cells (Cell), Golgi apparatus (Gol.) and cytoplasm (Cyt.). 
C) Comparison of the dependency of the lifetime on the abundance of the acceptor for aRab1b S36 WT and 
/QL. The black lines shows the linear fit for S36/WT, the dashed line for S36/QL. D) Comparison of the 
aRab1b S36/WT and /QL expression and labeling by in-gel fluorescence and western blot analysis. The 
white arrow head marks the PylRS, the black arrow head indicates labeled aRab1b and the asterisk an 
unspecific band. Scale bar: 10 µm. 
 
 
 
 
Determining the sensor’s ‘OFF’ state 
As previously determined by western blot analysis, the inactive amber Rab1b mutants 
S22N and N121I lacked BcnK incorporation and thus full-length expression of the construct 
(Figure 3.26). Furthermore, the reliable detection of BcnK incorporation by fluorescence 
microscopy was impaired by the cytosolic localization of the inactive mutants which cannot 
be distinguished from the expression of the non-suppressed mCitrine-Rab1b fragment. 
However, if full-length expressed, inactive Rab1b mutants cause a dispersion of the Golgi 
apparatus, allowing for an indirect detection of BcnK incorporation. To identify any full-
length expression of SN or NI amber mutants, the Golgi marker GntC was coexpressed with 
both inactive mutants of aRab1b S36 or D53 and the samples were screened for 
fragmentation of the Golgi complex (Figure 3.28). Rab1b WT/SN and /NI mutants served as 
phenotype controls. 
The compact and defined Golgi structure detected in WT/WT sample was not observed 
in any cell expressing Rab1b WT/SN or /NI mutant. Even low expression of these constructs 
resulted in complete dispersion of the Golgi apparatus as indicated by the diffuse 
localization of GntC (Figure 3.28 A). Comparison of the inactive amber mutants with the 
control samples revealed several differences. Despite the cytosolic and partially nuclear 
localization of aRab1b S36 and D53 /SN and /NI mutants, the Golgi structure remained 
intact and tightly packed, similar to the wild type protein control samples. Additionally, cells 
expressing amber /SN and /NI mutants seemed less rounded than the respective controls. 
The same results were found in HeLa and Cos7 cells, and are consistent with the lack of full-
length expression of the dominant negative aRab1b mutants as detected by western blot. 
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Figure 3.28: Phenotypic screen to identify full-length expressed dominant negative Rab1b amber 
variants. GntC served as a Golgi marker. The expression of the dominant negative mutants S22N (SN) and 
N121I (NI) was assessed for Rab1b WT (A), aRab1b S36 (B) and aRab1b D53 (C). Scale bar: 10 µm.  
  
An alternative strategy to determine the lifetime of the predominantly GDP-loaded 
sensor is the deletion of the C-terminal double cysteine motif of Rab1b (C2), which 
prevents its prenylation and thereby the membrane association of the sensor. 
Consequently, the construct remains cytosolic and does not underlie regulation by GEF 
proteins 30. Figure 3.29 A illustrates HEK 293T cells expressing aRab1b S36 and the truncated 
protein S36/C2 before and after labeling with TMR.  
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Figure 3.29: UAA incorporation and labeling of full-length and C-terminal truncated 
aRab1b S36 (C2). A) TMR-labeled and unlabeled HEK 293T cells expressing aRab1b S36 full-length 
and C2 variant. B) In-gel fluorescence and western blot analysis of aRab1b S36 full-length (fl.) and 
C-terminal truncated (C2). Fluorescent bands indicating the PylRS and aRab1b are marked with white and 
black arrow heads, respectively. The asterisk indicates an unspecific band. Scale bar: 10 µm. 
  
As expected, the C-terminal deletion prevented the Golgi localization of the construct 
and resulted in an even cytosolic and partially nuclear distribution of the sensor. 
aRab1b S36 displayed clearly visible TMR-labeling, whereas no labeling was detectable for 
the C2 mutant. In fact, the labeling step seemed to affect the localization of the truncated 
construct (Figure 3.29 A). While unlabeled cells displayed clear fluorescence intensity 
differences between nucleus and cytosol, cells transfected under the same conditions, but 
labeled with TMR, revealed even fluorescence throughout the cell lumen and nucleus. 
Furthermore, in-gel fluorescence and western blot analysis demonstrated a lack of full-
length expression and specific labeling of the truncated protein S36/C2 (Figure 3.29 B). 
Similar to the inactive mutants, this lack of full-length expression may be due to failure in 
BcnK incorporation. Another possibility is that the labeling step may affect the fate of the 
amber protein, e.g. causing rapid degradation of the construct. 
In conclusion these results demonstrate that the sensor’s ‘OFF’ state was not 
assessable by coexpression of TBC1D20 Rab1b GAP, utilizing inactive Rab1b mutants or 
C-terminal truncation. Furthermore, the findings show that introduction of mutation sites 
into an amber protein may affect stop codon suppression or the proteins fate, potentially 
resulting in reduction or complete degradation of the construct. On the other hand, 
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interfering with the protein function, e.g. by coexpression of regulatory proteins, may cause 
deficiencies in the labeling reaction. 
 
3.2.1.5 Monitoring Rab1b vesicular transport by reversible cryo-arrest 
Since Rab1b is involved in ER-to-Golgi membrane trafficking, the conformational Rab1b 
sensor was investigated in vesicular transport. Initial UAA incorporation experiments 
already showed that amber suppressed and labeled Rab1b participated in vesicular 
transport by formation of vesicles comparably to the wild type protein. These vesicles were 
traceable by confocal microscopy, but determination of the lifetimes of single vesicle was 
hindered by the comparably long acquisition periods during fluorescence lifetime imaging 
and the relatively fast vesicle movement. Therefore a new strategy, the reversible cryo-
arrest of live cells, was applied to lock live cells in a temporary state by freezing, allowing for 
even prolonged measurements without biological interferences in the sample during 
acquisition 235. 
 
 
 
The Rab1b sensor participates in vesicular transport 
First, labeled aRab1b S36 was monitored before and after freezing by fluorescence 
microscopy to confirm that the fluorescence emission of TMR is not affected by the change 
in temperature or the drastic increase in DMSO concentration during freezing (Figure 3.30). 
Cryo-arrest of the samples at -45 °C revealed a large number of Rab1b-positive vesicles 
which were not visible at 37 °C, but clearly distinguishable from the cytosolic fraction after 
freezing. Rab1b is known to participate in ER-to-Golgi transport, mediating vesicle tethering 
and fusion of COP-coated vesicles 59. These vesicles exhibit a rapid traveling speed under 
physiological conditions, impairing their detection by common fluorescence lifetime 
microscopy in live cells.  
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Figure 3.30: Monitoring Rab1b vesicular transport by reversible cryo-arrest. Confocal microscopy 
images and close-ups of HEK 293T cells expressing TMR-labeled Rab1b S36 at 37 °C and -45 °C.  
Arrow heads indicate labeled Rab1b vesicles; labeling of the Golgi apparatus is indicated by asterisks. 
Scale bars: 5 µm.  
  
Despite the low temperatures and the increased DMSO concentration during 
cryo-arrest, TMR remained fluorescent. However, TMR fluorescence signals showed a 
diffuse pattern throughout the cell post-freezing, lowering the signal-to-noise ratio in 
comparison to 37 °C. These TMR background signals may be caused by an excess of dye that 
was solubilized by the increase in DMSO concentration during freezing. Nevertheless, 
specific labeling of the Golgi apparatus, as well as labeling of single vesicles was detectable 
against the background fluorescence. Thus, the amber suppressed and labeled Rab1b 
protein indeed seems to function in vesicular trafficking.  
 
Rab1b sensor read-out pre- and post-freezing 
Precise determination of the fluorescent lifetime of subcellular Rab1b sensor fractions 
during cryo-arrest was impaired by movement of the sample during fluorescence lifetime 
image acquisition. Mechanic improvements of the cryo-arrest set up did neither solve nor 
improve this issue. Therefore the acquired lifetime data was in silico corrected by 
XY-alignment of the fluorescence intensity frames and application of the correction vectors 
onto the respective fluorescence lifetime frame set, before fitting of the average lifetime 
per pixel. This correction method provided sharp fluorescence intensity and lifetime images 
which displayed single Rab1b vesicles and well defined Golgi structures after freezing 
(Figure 3.31 A). mCitrine fluorescence lifetime analysis of whole cells, Golgi and cytoplasmic 
segments of the Rab1b sensor pre- and post- freezing revealed the previously described 
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lifetime distribution between the three segments (Figure 3.31 B and C). The fluorescence 
lifetime of the Rab1b sensor was comparable at 37 °C and -45 °C ( -45 °C (Gol-Cyt) = 260 ps and 
 37 °C (Gol-Cyt) = 280 ps). In contrast, Rab1b WT expressing cells displayed lifetime differences 
between the Golgi region and the cytosol before and after freezing (Gol (-45 °C-37 °C) = -140 ps 
and Cyt (-45 °C – 37 °C) = 60 ps).  
These data demonstrate that TMR was not only fluorescent at -45 °C and in the 
presence of 50 % DMSO, but also functioned as a FRET acceptor. Moreover, the 
fluorescence lifetime analysis indicated comparable FRET efficiency between mCitrine and 
TMR before and after freezing. In fact, plotting of the lifetime of Golgi-bound Rab1b against 
the lifetime of the cytoplasmic fraction of the respective cell revealed no differences in the 
Golgi/Cytoplasm ratio of the Rab1b sensor at the two different temperatures (Figure 
3.31 D). Interestingly, mCitrine and TMR fluorescence was massively increased at -45 °C in 
comparison to 37 °C. The acquisition of fluorescence lifetime images required about 
100-fold less laser power to achieve the same photon count rate at -45 °C in comparison to 
37 °C (data not shown).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.31: Determination of Rab1b sensor lifetimes on single vesicles by reversible cryo-arrest. 
A) Intensity image of a HEK 293T cell expressing the Rab1b sensor illustrating sample movement during 
fluorescence lifetime image acquisition during cryo-arrest at -45 °C. Arrow heads mark single vesicles 
which are blurred before and well defined after the in silico correction. B) HEK 293T cells expressing the 
Rab1b sensor at 37 °C and at -45 °C. C) Segmented single cell fluorescence lifetime analysis of Rab1b 
sensor and Rab1b WT at 37 °C and at -45 °C. D) Ratio and linear fitting of the Golgi and cytoplasmic 
lifetimes of single cells expressing Rab1b sensor or WT protein at 37 °C and -45 °C. Scale bars: 5 µm. 
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Lifetime analysis of single Rab1b vesicles 
To determine the sensor signal on single vesicles Rab1b intensity images were masked 
on local intensity maxima representing the observed vesicle structures. The binary mask 
was transferred onto the respective XY-corrected lifetime image and mean lifetime values 
were calculated for each vesicle (Figure 3.32 A). mCitrine lifetime analysis of the extracted 
Rab1b vesicles revealed a broad range of mean fluorescence lifetimes for the Rab1b sensor 
on vesicles in different cells (Ves. (Sensor) = 2.54 - 2.71 ns). Despite the difference in average, 
the lifetime distribution of mean vesicle values correlated with the lifetime of the Golgi 
region and the cytoplasm within the same cell (Figure 3.32 B). Moreover, the four analyzed 
Rab1b sensor expressing cells showed a similar range of single vesicle mean lifetimes, which 
was comparable to that observed for Rab1b WT vesicles. (σ = 0.12 - 0.17 ns, Figure 3.32 B). 
Nevertheless, the mean vesicle lifetimes of vesicle-bound Rab1b sensor were significantly 
different from Rab1b WT vesicles (Figure 3.32 C).  
In summary, these results demonstrate that the genetically encoded Rab1b 
conformational sensor participates in the vesicular trafficking, allowing for the detection of 
single Rab1b vesicle lifetimes. A range of mean vesicle values was observed in different cells 
expressing the Rab1b sensor. This range was comparable within different samples and 
similar to the lifetimes observed for Rab1b WT vesicles, but single vesicle lifetimes of the 
Rab1b sensor differed significantly. However, further investigation is required to correlate 
the detected signals with the spatiotemporal Rab1b activity. One possibility may be the 
coexpression of the Golgi-localized tether protein p115, which is a Rab1b effector. 
Colocalization of p115 and Rab1b sensor on vesicles may enable the determination of the 
effector bound sensor fraction. Another possibility is the identification of ER exit sites 
(ERES), highly specialized ER areas from where COPII vesicles are budding 270,271. Rab1b is 
known to localize to ERES, regulating cargo sorting and targeting the budded vesicles to the 
Golgi complex, where is subsequently functions in tethering and fusion of the vesicles 62-65. 
As it is not clearly known at which distinct point during ER-to-Golgi trafficking Rab1b 
becomes activated, the conformational sensor could give further insights into the 
mechanism of ER-to-Golgi vesicular transport.  
 
 
 
Figure 3.32: Extraction of the Rab1b sensor lifetime on single vesicles in live cells. A) Identification of 
vesicles by intensity based binary masking of the lifetime image. The identified vesicles were extracted and 
a mean lifetime value was determined for each vesicle. B) Lifetime histograms of measured vesicles in 
different cells expressing Rab1b sensor or Rab1b WT control. The black line and the dashed line mark the 
average lifetime of the cytoplasm and the Golgi region of the corresponding cell, respectively. C) Mean 
vesicle lifetime values for one cell expressing Rab1b WT and four cells expressing the Rab1b sensor. All 
Rab1b sensor vesicle populations were significantly different from the WT vesicle 
population (p < 6.0 x 10-14). Scale bars: 5 µm. 
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3.2.2 Rheb Conformational Sensor 
In parallel to the characterization of the conformational Rab1b sensor, preliminary 
experiments were performed to assess whether the TMR-labeled aRheb N50 protein also 
functions as a Rheb sensor. To this end, HEK 293T cells expressing aRheb N50 were 
serum-starved overnight to induce inactivation of the lysosomal Rheb fraction. Cells were 
labeled in serum-free medium, washed intensively and screened for specific TMR labeling. 
In fact, few cells displayed TMR signals above background levels and the fluorescence 
intensity correlated only partially with the localization and abundance of aRheb N50. 
Fluorescence lifetime analysis of those cells revealed a lifetime decrease of  = 270 ps in 
comparison to the Rheb WT control sample. These cells were analyzed first in starved 
condition, then treated with insulin and analyzed again 15 minutes post-treatment (Figure 
3.33). Insulin stimulation activates the PI3K/AKT signaling pathway and results in a rapid and 
enduring activation of the lysosomal Rheb fraction124.  
 
 
Figure 3.33: Insulin stimulation of HEK 293T cells expressing the Rheb sensor. A) HEK 293T cells 
were serum-starved overnight (> 16 h) and the same cells were analyzed before and after treatment with 
insulin. B) Single cell lifetime analysis of A). Scale bar: 10 µm. 
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mCitrine lifetime analysis revealed an average change of lifetime of = -65 ps 
following insulin stimulation, indicating a response of the sensor signal to the activation of 
the signaling pathway. Positioning of the acceptor in the interswitch region of aRheb is 
expected to report protein activation as a decrease in sensor lifetime, which is in agreement 
with these findings. Thus, these preliminary data showed that the labeled amber Rheb 
construct indeed reports Rheb activity upon stimulation with insulin. However, further 
investigation is required to confirm that the observed alteration of fluorescence lifetime of 
the Rheb sensor is indeed due to the insulin-induced activation.  
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4. Discussion and Perspectives 
4.1 UAA incorporation into small GTPases 
This study demonstrates the successful and specific UAA incorporation into Rab1b and 
Rheb GTPases. Both proteins were subsequently labeled specifically in live mammalian cells 
and the labeled constructs allowed for spatiotemporal detection of the protein activity. The 
observed UAA incorporation was fully orthogonal, despite the frequent abundance of 
amber stop codons within eukaryotic cells. Six different incorporation sites of Rab1b 
tolerated the UAA incorporation and yielded functional proteins. In contrast, UAA 
incorporation and full-length expression was achieved for only one of the five mutation 
sites of Rheb GTPase. The expression yields of the amber mutants of both GTPases were 
rather low, maximum 12-20 % of the respective wild type protein (Chapters 3.1.1.4 and 
3.1.1.5). Low protein expression is a major pitfall of the stop codon suppression approach 
and has been subject to various studies 239,272-274. The limited expression is largely due to 
two reasons, (1) the availability of the orthogonal tRNACUA (PylT) and (2) the competition 
between the UAA incorporation event and the termination of the translation process at the 
ribosome 273-275. The first possibility has been successfully addressed by amplification of the 
PylT expression cassette and optimizations of the promoter region 180,198. In contrast, the 
competition between the UAA incorporation and the translational termination remained 
more challenging. If the translation machinery reaches a stop codon, the ribosome pauses, 
a release factor enters the ribosome and releases the translated peptide by separation of 
the two ribosomal subunits 164. In the presence of an orthogonal pair, the orthogonal tRNA 
can enter the ribosome, allowing for the incorporation of the UAA in response to a stop 
codon 171. Nevertheless, the endogenous release factor-mediated termination process can 
still operate and thereby competes with the orthogonal UAA incorporation process. 
Depending on the efficiency of each process, the amber protein is expressed as a mixture of 
fragment (translational termination) and full-length protein (UAA incorporation). In 
prokaryotes the termination process is mediated by the release factors 1 and 2 (RF1/RF2), 
which selectively terminate translation in response to UAG/UAA and UGA/UAA stop codons, 
respectively 162,163. Several studies successfully augmented the UAA incorporation efficiency 
in bacteria by disruption of RF1 function 162,238,239,272,273,276,277. In contrast, translational 
termination in eukaryotic cells is more complex, involving the eukaryotic release factors 1 
and 3 (eRF1/eRF3)164-166. eRF1, an orthologue of the two prokaryotic release factors, 
recognizes all three stop codons. While eRF1 is the key protein in the translation 
termination process, eRF3 possesses only a stimulatory role 164-167. A recent study targeted 
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eRF1 function to enhance UAA incorporation process, while maintaining low read-through 
of opal and ochre stop codons 180. The resulting engineered eRF1 allowed for 17-20-fold 
higher expression levels of UAA containing proteins using the PylRS/PylT amber suppression 
system in mammalian cells. Besides the significantly higher yields, which were comparable 
to the respective natural translation controls, the engineered eRF1 also enabled efficient 
multiple stop codon suppression within the same protein 180.  
Furthermore, the incorporation efficiency has been shown to depend on the local 
sequence context of the amber codon in bacteria 274,278. Pott et al. investigated the effects 
of two random codons, one upstream and one downstream of the amber codon, on the 
incorporation efficiency and found a strong preference of the UAA incorporation efficiency 
on the local sequence context 274. Moreover, the dependency on the local sequence context 
was versatile between different proteins and allowed for expression yields of 70-110 % of 
the respective natural translation control 274. In fact, the local sequence context seems to 
also affect the endogenous termination of the translation in yeast and human 164,279,280. 
Studies identified the nucleotide immediate downstream of the stop codon, at +1 position, 
as a key factor for the translation termination efficiency. Thereby the stop codon partially 
holds characteristics of a quadruplet codon, where the fourth base determines the 
efficiency of a process 164,279,280. Thus, a dependency of the UAA incorporation process on 
the local sequence context is also like to exist in mammalian cells.  
Another relatively new approach to enhance the UAA incorporation is the construction 
of orthogonal ribosomes that do not function with eRF1 273,275. This engineered ribosome 
selectively binds modified mRNA encoding amber proteins and also allowed for utilizing 
quadruplet codons, enabling encoding of multiple different UAA within one protein 253,275.  
However, most of these approaches were developed in parallel to the work presented 
in this thesis and therefore were not assessed here. Further investigations will show 
whether these strategies may also improve UAA incorporation into small GTPases, 
especially in the case of Rheb GTPase. 
 
 
4.2 Intracellular labeling of small GTPases  
Following the UAA incorporation into the small GTPases Rab1b and Rheb, both proteins 
were subsequently labeled intracellularly in live cells. Highly specific and covalent labeling 
was confirmed for the full-length expressed amber Rheb mutant, as well as for four amber 
Rab1b mutants. The intracellular labeling reaction with different fluorophores and the 
effects of the protein labeling on its function and on the cell health were intensively 
characterized in this work, providing vast insights into major pitfalls and challenges of the 
114 
 
approach. Among those are the findings that intracellular labeling depends not only on the 
target protein and the choice of dye, but also on the cell line and potentially the protein’s 
activity state. Intracellular labeling of Rab1b was highly specific, bioorthogonal and resulted 
in up to 90 % reaction yield (Chapter 3.1.3.4). These observed high yields of the labeling 
reaction opposes the previous assumption that utilizing the PylRS AF/PylT orthogonal pair in 
the absence of the engineered eRF1 allows only for ‘sparse labeling’ of intracellular 
proteins 181. Nikic et al. have reported the specific labeling of an extracellular loop region of 
IGFR using the PylRS AF/PylT pair to incorporate strained alkynes and alkenes 178,281. The 
extracellular labeling was performed using 1.5 µM tetrazine-functionalized dye for 10 min at 
37 °C, a much shorter incubation time than required for efficient intracellular labeling of 
aRab1b observed during this study. Nevertheless, the 3-fold higher dye concentration may 
accelerate the reaction sufficiently to compensate for the short labeling period. Moreover, 
labeling of extracellular proteins does not require the dye to enter the cell lumen, a process 
which may decrease the efficient dye concentration due to potential hydrophobic 
interactions with endomembranes. Uttamapinant et al. have recently demonstrated highly 
specific labeling of several intracellular proteins using BcnK and TcoK* incorporation in 
HEK 293T and COS-7 cells 181. In that study, intracellular labeling was performed using 
0.4 µM tetrazine-FDAC and 20 min incubation time, which is comparable to the labeling 
conditions initially used in this work. Nevertheless, complete labeling of aRab1b required 
more than 30 min in presence of 0.5 µM dye, as monitored for the labeling reaction over 
time by fluorescence lifetime imaging (Chapter 3.1.3.3). One possible explanation for the 
prolonged labeling time might be the high expression levels of the amber protein 281. 
However, the highest expressing amber Rab1b mutant, aRab1b S36, was expressed only 
about 20 % of the wild type protein (Chapter 3.1.1.4). In contrast, Uttamapinant et al. 
utilized the engineered eRF1 release factor allowing for expression levels of amber proteins 
comparable to the respective wild type protein 180,181. Consequently, the expression levels 
of the two amber proteins used within that study were much higher than expression yields 
of aRab1b in this work. A second possibility for the prolonged labeling times for intracellular 
labeling of aRab1b may be the choice of dye. Uttamapinant et al. used fluorescein diacetate 
(FDAC) for intracellular labeling, whereas Rab1b and Rheb amber proteins were labeled 
with TMR or other red fluorophores. FDAC has been shown to enter the cell rapidly and 
spread evenly throughout the cell (Chapter 3.1.2.1). Cell permeability of TMR was 
comparably fast, but TMR distributed exclusively within the cytosol and exhibited a partially 
membranous localization pattern within the cell, suggesting unspecific membrane 
association of the dye. In addition to cell permeability, the unspecific accumulation of dyes 
in the endomembrane system has been a limiting factor for intracellular labeling 
approaches 178,281. In order to be highly cell permeable, fluorescent probes require a certain 
hydrophobicity, which in turn may cause the unspecific membrane binding after cell entry. 
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Nevertheless, the choice of dye for the establishment of the genetically encoded 
conformational sensor for small GTPase activity was not only limited by their cell 
permeability and suitability for intracellular labeling, but also to the demand to serve as a 
FRET acceptor for a fluorescent protein. 
It has to be noted that the observed high labeling yields of Rab1b may be partially due 
to its intrinsic cycling between membrane-associated and membrane-independent state. In 
fact, Rab1b is not only targeted to one compartment, but localized to the Golgi apparatus, 
to ERES and to COP-coated vesicles during vesicular transport (Chapter 3.1.3.4). Thus, the 
presence of aRab1b at different membrane systems may enhance the labeling reaction by 
promoting the encounter between amber protein and tetrazine-dye. Linked to the change 
in localization, Rab1b also cycles between the active and inactive state, enabling interaction 
with effectors and other proteins. The rapid nature of this cycle may allow for the observed 
high efficiency of the labeling reaction, as not only one conformational state of the protein 
is exposed to the dye. In addition, interactions of Rab1b with other proteins may be limited 
to the time frame a vesicle requires from budding to tethering and may thereby not affect 
the labeling reaction e.g. by sterical hindrance. In contrast, Rheb is a less flexible GTPase 
concerning cycling and subcellular localization under normal growth conditions. Rheb 
resides on a number of endomembranes including the ER, Golgi, Mitochondria, peroxisomes 
and lysosomes 101,106,108,111,113,251,252. The lysosome-located Rheb fraction was intensively 
investigated in the last decades due to its role as an activator of the mTOR complex 1 in 
nutrient sensing (reviewed in 282). In presence of amino acids and growth factors, the 
lysosomal Rheb fraction is thought to be GTP-bound, allowing activation of mTORC1 
113,124,125. The absence of amino acids causes a RagGTPase-mediated recruitment of the TSC 
complex, the Rheb GAP, to the lysosomal surface 119-123. The TSC complex consists of TSC1, 
TSC2 and TBC1D7 and is also regulated by the growth factor-dependent PI3K-AKT pathway 
113,120,124,283. In order to avoid sterical hindrance of the labeling reaction by continuous 
interaction of Rheb and mTORC1 on the lysosomal surface, intracellular labeling was 
performed in serum-starved condition (Chapter 3.1.4), causing Rheb dissociation from the 
lysosomes 124,125. However, the effects of the localization of Rheb and its nucleotide state on 
the labeling reaction were not further investigated.  
While intracellular labeling of Rab1b was highly specific and did not yield any visible 
side reactions, aRheb expressing cells labeled with TMR displayed high TMR fluorescence 
intensities in the nucleus (Chapter 3.1.4). Side reactions of the intracellular labeling in the 
nucleus are a well-known issue that has been successfully addressed by fusion of the PylRS 
AF to a nuclear export signal (NES) 218. In addition to lower PylRS AF accumulation in the 
nucleus, the NES modification also increased the UAA incorporation rate significantly 218. 
Although the yields of intracellular labeling of aRheb were not determined, the change in 
mCitrine fluorescence lifetime upon incubation of aRheb with TMR was comparable to 
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intracellular labeling of aRab1b, indicating similar reaction yields ( = 300 – 400 ps, 
Chapter 3.1.4). However, unlike aRab1b, aRheb labeling was highly heterogeneous and only 
a small fraction of aRheb expressing cells displayed the large lifetime changes indicating 
complete labeling. These cells also exhibited perinuclear fluorescence densities, suggesting 
successful BcnK incorporation and proper localization of the construct. Nevertheless, the 
localization pattern of aRheb was not as clearly defined as observed for the wild type 
protein, suggesting low UAA incorporation rate.  
In conclusion, our data, together with the few previously reported cases of UAA-based 
labeling of intracellular proteins, leads to a better understanding of the major pitfalls and 
challenges of this approach. Vast insights into the effects of diverse parameters on the 
intracellular fluorescence labeling were achieved, including a screen for potential 
fluorophores for intracellular labeling, labeling of different target proteins and in different 
cell lines. Moreover, the intracellular labeling reaction was time-resolved monitored by 
fluorescence lifetime imaging, demonstrating that the reaction is not only time but also 
highly dose-dependent. Labeling and microscopic analysis were performed in live cells and 
cells expressing TMR-labeled aRab1b or aRheb have been shown to remain viable and 
healthy even over longer time periods (Chapter 3.2.1.3). 
 
 
4.3 Characterization of the genetically encoded Rab1b 
sensor 
Following successful establishment of the UAA incorporation and labeling protocol for 
small GTPases, functionality of the Rab1b sensor was confirmed by effector binding studies. 
Moreover, the sensor’s dynamic range was investigated by coexpression of regulatory 
enzymes, nucleotide state affecting mutants and deletion of the C-terminal prenylation 
motif.  
Previous studies showed that introduction of the acceptor at position S36 in Rab1b 
yields a probe reporting predominantly effector binding both in vitro and in vivo 160,161. In 
fact, coexpression of the Rab binding domain of the Rab1 effector protein OCRL1 resulted in 
a significant change of sensor lifetime. The observed lifetime increase in presence of OCRL 
(~ 5 %) demonstrates that the labeled Rab1b protein reports effector binding events in a 
comparable manner to the recombinant probe 160,161. Despite the intracellular labeling step, 
which did not yield 100 % labeled protein (Chapter 3.1.3.4), the dynamic range of the 
genetically Rab1b sensor was similar to the recombinant conformational sensor (~ 5 % and 
~ 6 % signal change, respectively) 160,161. Incomplete labeling may leave a distinct fraction of 
aRab1b construct unlabeled, increasing the donor only fraction in fluorescence lifetime 
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imaging and thereby the samples average lifetime. Depending on the size of the donor only 
fraction, the sensor’s dynamic range could be narrowed.  
Although the observed change in signal in presence of OCRL was stable and 
reproducible, it remains unclear whether the change in FRET is due to conformational 
changes within the small GTPase or due to binding of the effector. The preceded study 
establishing the recombinant, first generation of COSGA sensors found, that probes with 
acceptors introduced at position S36, D53 and G54, but not at T34, report effector binding 
in the same manner. Thus, a common sensing mechanism for effector binding is likely. One 
possibility is that effector binding limits the space available for the N-terminal fluorophore. 
This notion is supported by the observation, that larger effectors caused a larger change in 
sensor signal, but does not explain why the FRET signal of the T34 probe is not altered by 
effector binding 160,161.  
 
While OCRL coexpression did not affect the specific labeling of aRab1b, coexpression of 
the Rab1 GEF protein DrrA impaired the labeling reaction massively. Presence of the 
catalytic Rab1 GEF domain of DrrA caused Rab1b to localize predominantly in the cytosol 
and partially in the nucleus. This phenotype was similar for Rab1b sensor and wild type 
protein, but no specific labeling of aRab1b was detectable (Figure 3.24 A). In the same 
sample cells expressing aRab1b but not DrrA displayed strong and specific TMR-labeling, 
suggesting the presence of DrrA as cause for the impaired labeling reaction. In fact, TMR 
fluorescence intensity (indicating specific labeling) correlated with TagBFP fluorescence 
intensity (indicating DrrA expression levels), revealing a direct dependency of the two 
parameters (Figure 3.24 C). This correlation raises the possibility, that the incorporated UAA 
may not be accessible for labeling due to interaction of aRab1b and DrrA. In fact, the 
incorporation site S36 is located in the switch I region, one of three regions involved in the 
interaction interface of Rab1 and DrrA 126,284. Nevertheless, the interaction of small GTPases 
with their cognate GEF proteins is rather transient and generally terminated by the 
nucleotide exchange of GDP to GTP. Thereby the interaction should not affect specific 
labeling of aRab1b. On the other hand, although both proteins are exogenously 
overexpressed, aRab1b is most likely less abundant due to the amber suppression 
approach. Thus, the bulk of DrrA protein might shift the equilibrium towards complex 
formation, reducing the availability of free aRab1b for the labeling reaction. To circumvent 
this, DrrA mutants with lowered GEF activity could be used. These mutants show reduced 
complex formation with Rab1b which may enable aRab1b to become labeled 126. Another 
approach may be to incorporate BcnK at position D53 in Rab1b instead of S36. In contrast to 
S36, D53 is not involved in the interaction interface with DrrA and should hence be 
accessible for labeling 126.  
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Coexpression of the Rab1 GAP TBC1D20 revealed a similar lack of aRab1b labeling, but 
the phenotype differed from DrrA coexpression (Figure 3.25). While aRab1b/DrrA 
expressing cells displayed high mCitrine fluorescence intensities, aRab1b and TBC1D20 
positive cells exhibited only faint fluorescence, indicating low levels of mCitrine-aRab1b 
fusion protein. Due to the competition of translational termination and incorporation event, 
the population of amber protein can be divided into two fractions. The first fraction, and in 
case of aRab1b the major fraction, is the amber protein expressed in full-length. The second 
fraction is the non-amber suppressed mCitrine-aRab1b fragment. The observed mCitrine 
fluorescence comprises both fractions, but since full-length expressed aRab1b is the major 
fraction, its abundance may proportionally constitute for the fluorescence intensity. 
Hypothetically, if the amber protein expressed in full length and as a fragment are degraded 
differentially, mCitrine fluorescence intensity would decrease massively, leaving the 
mCitrine-aRab1b fragment as the predominant source for fluorescence emission. Moreover, 
degradation of only full-length aRab1b fraction would eliminate the labeled fraction and, 
due to reduction of the donor acceptor population, the sample’s fluorescence lifetime 
would be shifted to donor only signal. All three parameters of the above scenario are in 
agreement with the observations made for aRab1b and TBC1D20 coexpression, suggesting 
possible degradation of the full-length amber construct (Figure 3.25 C). However, it is 
striking, that presence of TBC1D20 did not affect fluorescence intensity of mCitrine-
Rab1b WT expressing cells, indicating that presence of the GAP does not alter Rab1b WT 
abundance. This raises the possibility of amber suppression and/or intracellular labeling as 
cause for degradation of aRab1b. One possibility to dissect whether aRab1b is degraded due 
to the labeling of the GDP-bound state or due to presence of the GAP could be coexpression 
of the catalytically inactive mutant TBC1D20 R105A 89-91. This mutant binds Rab1b, but 
cannot catalyze nucleotide hydrolysis. 
Another approach to coexpress regulatory enzymes while enabling complete labeling of 
the amber construct may be to utilize an inducible expression system, such as the 
tetracycline-controlled transcriptional activation 170,172. In combination with the established 
protocol for amber suppression and intracellular labeling an inducible system may allow for 
induction of exogenous GEF or GAP expression post-labeling. Consequently, the amber 
protein would first be labeled and then be regulated by its cognate enzyme. However, due 
to the reduction in aRab1b abundance within -labeling and the required additional 
expression time for the GEF or GAP protein this strategy might be challenging. 
 
As a second strategy to determine the dynamic range of the genetically encoded 
conformational sensor, three nucleotide mutants of aRab1b were assessed. Amber 
suppression and fluorescent labeling was successful for the dominant active Q67L (QL) 
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mutant, whereas both steps failed for the two constitutively inactive aRab1b mutants 
(Figure 3.26).  
The dominant active amber suppressed Rab1b S36 mutant QL was expressed and 
labeled comparably to the wild type amber protein, allowing comparison of the constructs. 
In contrast to the inactive Rab1b mutants, the active QL mutant allows for functional ER-to-
Golgi transport and does not impair Golgi homeostasis. The segmentation of sensor 
expressing cells revealed a fluorescence lifetime difference for the sensor QL mutant and 
the wild type amber protein. Interestingly, the greatest change in sensor signal was 
detected for the Golgi region, which displayed a significant increase. In contrast, lifetimes of 
the cytosolic aRab1b fraction and the whole cell lifetime were comparable to the wild type 
amber protein. The fluorescence lifetime alteration in the Golgi region is in agreement with 
previous studies reporting that microinjection of an active mutant of the recombinant 
sensor Rab1b T34C results in elevated sensor lifetime predominantly in the Golgi region 
160,161. However, the preceded studies used the T34C probe, which does not sense effector 
binding and reports exclusively nucleotide state. In contrast, introduction of the acceptor at 
position S36 in Rab1b, which was mainly used in this work, reports majorly effector binding 
events and has only a minor read-out for nucleotide state. In fact, the elevated sensor 
lifetime of aRab1b S36/QL in the Golgi region (QL(Golgi) = 170 ps) was similar to the increase 
observed for coexpression of the Rab1 effector OCRL (+OCRL(Cell) = 120 ps). It is thus 
possible, that the detected increase in sensor lifetime is due to binding of endogenous Rab1 
effectors, e.g. p115 or Giantin which are localized in the Golgi complex 62,66-68,285. The Rab1 
QL mutant has a lower intrinsic hydrolysis rate and is predominantly GTP-loaded in cells, 
allowing for interactions with effector proteins63,248,286.  
In contrast to the active aRab1b QL mutant, determining the sensor’s ‘OFF’ state using 
the constitutively inactive aRab1b mutants S22N (SN) and N121I (NI) was not successful. 
In-gel fluorescence analysis of cells expressing aRab1b S36/SN and /NI mutants revealed 
faint bands at the size of full-length expressed aRab1b, but western blot analysis failed to 
confirm the bands’ identity (Figure 3.26 C). Although faint, the detected fluorescent bands 
hint at low but successful stop codon suppression and specific labeling of both amber 
constructs. The low intensity of the bands in combination with the faint mCitrine 
fluorescence of aRab1b S36/SN and /NI expressing cells observed by fluorescence 
microscopy indicate low abundance of the amber construct. While low abundance of the 
target constructs may have different reasons, in this case, a degradation of the full-length 
constructs similar to the observations made for TBC1D20 coexpression, is likely. Differential 
degradation of the full-length expressed and labeled aRab1b fraction would reduce mCitrine 
fluorescence intensity, and eliminate the labeled aRab1b fraction. An alternative for the lack 
of full-length amber protein might be failure of BcnK incorporation into the target proteins. 
However, the two mutation sites yielding constitutively inactive Rab1b proteins are located 
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both upstream and downstream of the amber codon. While mutation of S22 to asparagine 
may affect BcnK incorporation, e.g. by altering the conformation of the partially translated 
fusion protein, the N121I mutation is translated identically as the wild type protein when 
reaching the amber codon at position S36. Consequently, differential UAA incorporation 
might be a possible reason for the lack of aRab1b S36/SN expression, but not for the lack of 
full-length expressed aRab1b S36/NI, whereas selective protein degradation would affect 
both constructs. The extended phenotypic screen for full-length expression of inactive 
mutants of aRab1b S36 and D53 in three different mammalian cell lines demonstrated that 
this pitfall is independent of the cell line (data not shown). 
Interestingly, UAA incorporation was observed for both, SN and NI mutants, in 
combination with a different linker between aRab1b and the FP. In this setup, the two 
amber mutants mTuquoise211-aRab1b S36 and D53 caused Golgi fragmentation when 
expressed in HeLa cells (data not shown). There are two differences between the above 
constructs and the constructs described before (Figure 3.26 and Figure 3.28), (1) the type of 
fluorescent protein (FP) and (2) the linker connecting the FP and aRab1b. The linker used in 
mTurquoise2-tagged constructs was modified by truncation of the fluorescent protein’s 
flexible C-terminus, resulting in a shorter and less flexible linker that brings the two proteins 
in closer proximity. Thus, the linker may be less accessible to proteolytic cleavage, 
potentially preventing degradation of the full-length amber protein. Consequently, these 
constructs are not only full-length expressed, but can also act as dominant suppressors for 
Rab1 function, causing Golgi fragmentation. However, it remains unclear whether aRab1b 
constructs containing C-terminal truncated mCitrine are full-length expressed and TMR-
labeled or whether the shortened linker indeed prevents degradation. 
 
The third strategy to determine the sensor’s ‘OFF’ state, the deletion of the C-terminal 
double cysteine motif of aRab1b, did also not yield a specifically labeled construct (Figure 
3.29). In fact, the observed differences in aRab1b localization pre- and post-labeling may 
indicate a change of protein fate due to the labeling step. Similar to coexpression of 
TBC1D20 and expression of inactive aRab1b mutants, the full-length amber construct may 
be degraded while the mCitrine-aRab1b fragment remained in the cell. If this process is due 
to the labeling reaction, the localization of aRab1b would differ before and after labeling as 
observed for the C2. This finding, together with the observations made for TBC1D20 
coexpression and expression of constitutively inactive aRab1b mutants, raises the possibility 
that the labeling of the inactive state of aRab1b may cause the construct’s degradation. 
However, further investigations, such as Western blot analysis of aRab1b C2 pre- and 
post-labeling may confirm whether inactivation of labeled aRab1b or labeling of inactive 
aRab1b proteins causes degradation. Another possibility might be monitoring the labeling 
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reaction of aRab1b C2 by confocal and fluorescence lifetime microscopy over time, as 
previously performed for aRab1b and aRheb labeling. 
 
As an alternative strategy to dissect different Rab1b sensor signals without interfering 
with its function, Rab1b trafficking was investigated by reversible cryo-arrest approach. 
Despite the lower temperature and the elevated DMSO concentration during the freezing 
process, specific labeling of vesicles-bound aRab1b was detected against the background 
signals. Since Rab1b is known to participate in vesicular transport at the ER-Golgi 
interface 59-61, these vesicle structures may represent COPII-coated vesicles. However, the 
vesicle identity was not further determined, but will be targeted by future work, e.g. by 
immunostaining of COPII coat subunits. 
Analysis of the sensor lifetime pre- and post-freezing revealed similar signals for Golgi 
and cytosolic fraction at 37 °C and -45 °C. Although the fluorescence lifetime of 
mCitrine-Rab1b WT differed marginally between the two conditions, both signals were 
comparable for the Rab1b sensor. Interestingly, the Rab1b sensor fraction on vesicles varied 
in mean vesicle lifetimes between cells, but the vesicle fraction of a single cell correlated 
with the lifetimes of Golgi region and independent within the same cell. It is thus possible, 
that the variations of mean vesicle lifetimes between cells are due to differences in sensor 
expression levels or labeling efficiency. Nevertheless, the mean vesicle lifetimes extracted 
from Rab1b sensor expressing cells were significantly different to lifetimes of Rab1b WT 
vesicles. The observed range of mean vesicle lifetimes (vesicles = 2.2 – 2.9 ns) is almost three 
fold broader than the dynamic range observed for effector binding reported by aRab1b S36 
( = ~170 ps). It may thus be possible, that other, so far unknown factors, affect the 
sensor’s read-out. Moreover, the dramatic changes in temperature and environment may 
affect the sensor’s dynamic range. Further investigations are required to dissect the sensor 
read-out and to identify e.g. effector bound sensor fractions. Future experiments will 
include coexpression of the Rab1b effector p115 as well as specific markers for ER exit sites 
(ERES). p115, the mammalian homologue of the yeast protein Uso1, is a Rab1 effector 
protein and is thought to mediate COPII vesicle tethering and fusion at the ER-Golgi 
interface 62. Cryo-arrest of cell expressing p115 and the Rab1b sensor will allow for 
identification of the effector bound sensor fraction on vesicles. To confirm versatility of the 
sensor signal between live cell and cryo-arrest conditions, the OCRL RBD coexpressed with 
the sensor during cryo-arrest will serve as a control. In addition, identification of ERES, 
highly specialized ER areas that are responsible for cargo sorting and formation of COPII 
vesicles, will enable to determine the nucleotide state of Rab1b sensor on budding vesicles. 
This approach will allow dissecting the role of Rab1b activity during ER-to-Golgi vesicular 
transport.  
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4.4 Characterization of the genetically encoded Rheb sensor 
In parallel to the characterization of the genetically encoded Rab1b conformational 
sensor, preliminary experiments were performed to demonstrate whether the labeled 
aRheb N50 amber protein indeed reports Rheb activity. To this end, cells were serum 
starvation overnight, labeled and analyzed pre- and post-treatment with insulin. Insulin 
stimulation activates the PI3K-AKT signaling pathway, resulting in phosphorylation of the 
TSC complex 113,124,282. The phosphorylated TSC complex dissociates from the lysosomal 
surface, allowing Rheb to adopt GTP-bound state and thus to become active by a yet 
unknown mechanism 113,282. In fact, insulin stimulation of serum-starved aRheb N50 
expressing cells caused a rapid decrease in fluorescence lifetime of specifically labeled cells. 
The observed lifetime reduction is in agreement with previous results on COSGA sensors 
that have the acceptor fluorophore introduced in the interswitch region, reporting GTPase 
activation by a decrease in sensor lifetime. However, it has to be noted that introduction of 
the FRET acceptor at position D53 in recombinant Rab1b protein, the structural equivalent 
to aRheb N50, yielded a probe reporting effector binding both in vitro and in vivo by a 
significant increase in sensor lifetime ( =~ +10 %) 160,161. In contrast, GEF-mediated 
protein activation of Rab1b D53C in vitro was reported by a non significant reduction in 
sensor lifetime ( =~ -3 %). Interestingly, the here observed lifetime decrease of 
aRheb N50 equals a 3 % change in sensor lifetime and is thus similar to the previously 
reported sensor signal reporting GEF-mediated activation of the recombinant Rab1b D53C 
probe. Nevertheless, the Rheb sensor signal was analyzed for the whole cell and not on 
higher spatial resolution, e.g. only for the perinuclear fraction. Extraction of the lysosomal 
Rheb fraction may allow for a more precise read-out of Rheb activity in response to growth 
factor stimulation. Moreover, additional removal of essential amino acids may increase the 
fraction of inactivated lysosomal Rheb via Rag GTPase signaling and may thereby lead to a 
larger signal change upon stimulation 113,124,287-289.  
Future work will further investigate whether the Rheb conformational probe in fact 
specifically reports Rheb activation and to which extend effector binding may contribute to 
the signal. Determining whether the sensor reports binding of effector proteins is quite 
challenging, due to the lack of known effector proteins for Rheb. Further investigations may 
involve coexpression of Phospholipase D1 (PLD1), which was proposed as a Rheb effector 
protein 229. If PLD1 is indeed a Rheb effector, the Rheb N50 probe should report the binding 
event by a significant signal change. Furthermore, the sensor signal will be integrated with 
traditional methods to monitor Rheb-mTORC1 activity such as S6K1 activity and 
phosphorylation of 4E-BP1. Although the amber mutation site was not reported to affect 
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Rheb function 98, this approach may also reveal whether the incorporated UAA or the 
subsequent labeling impairs Rheb function. Moreover, nucleotide mutants, such as the 
active Rheb Q64L mutant, may enable eliminating the sensor signal’s origin 174. Using 
mutants which exhibit e.g. an altered nucleotide state or lower sensitivity for GAP activity 
will influence the sensor read-out and thus, allow eliminating different events which may 
contribute to the sensor signal. Moreover, engineering of the sensor’s CAAX box to 
generate an exclusively cytosolic sensor, or to redirect the sensor to another compartment, 
could give further insights into the signal’s dependency on the endogenous regulation 
factors. In addition, transfection and cultivation conditions of aRheb samples may increase 
BcnK incorporation efficiency. Higher stop codon suppression efficiency in turn elevates 
intracellular labeling intensity, enlarging the donor-acceptor fraction which may increase 
the dynamic range of the sensor.  
 
4.5 Conclusion and Perspectives 
In conclusion, this study demonstrates the development of a new type of genetically 
encoded conformational probe for small GTPase activity by amber suppression and 
intracellular labeling approach. First, the sensors were genetically encoded by amber 
suppression and intracellular labeling, allowing monitoring of Rab1b effector binding in live 
cells. In the second part of this work, the sensor principle was applied to the small GTPase 
Rheb, demonstrating the versatility of this approach. To date this is the first sensor 
spatiotemporally reporting Rheb activity in live cells.  
Comparison of the two genetically encoded conformational sensors presented in this 
work revealed the impact of a cognate stimulus enabling to directly address the GTPase 
activity state. Growth factor deprivation and subsequent insulin treatment, a signal leading 
to activation of the lysosomal Rheb fraction, served as a simple and rapid method to 
confirm functionality of the Rheb sensor in live cells. In contrast, determining the dynamic 
range of the conformational Rab1b sensor suffered from a number of pitfalls. Due to its 
function during vesicular transport, Rab1b activity is hardly addressable by external stimuli. 
Thus, three different strategies were applied to determine an ‘OFF’ state signal for the 
Rab1b sensor, including coexpression of the respective GAP, nucleotide state mutants and 
deletion of the C-terminal double cysteine motif. Unfortunately, none of these strategies 
yielded success. Further investigations are required to determine the conformational Rab1b 
sensor’s ‘OFF’ state. However, interfering with Rab1b function affects Golgi biogenesis 
massively, causing a dramatic change in cellular physiology. In contrast, identification of the 
Rab1b sensor’s “ON” state using the active QL mutant was successful. In fact, the observed 
increase in sensor lifetime was predominantly in the Golgi region and was similar to the 
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sensor read-out obtained for effector coexpression. It is thus possible, that the sensor 
reports predominantly effector binding events, which would be in agreement with the 
previous in vitro characterization of the respective recombinant probe 160,161.  
Although the findings of this study are restricted to the development of the genetically 
encoded conformational sensor and did not asses Rab1b biology further, the combination 
of the conformational probe and the novel reversible cryo arrest of living cells allows for 
precise tracking of Rab1b activity during vesicular transport. The here obtained results will 
pave the way for elaborate studies allowing dissection of Rab1b activity during ER-to-Golgi 
transport using the genetically conformational Rab1b sensor.  
 
Unless specifically determined, the activity state of small GTPases is traditionally 
assumed by colocalization with their cognate GEF and GAP proteins. Although no GEF is 
known for Rheb yet, this strategy is frequently applied to the lysosomal Rheb fraction, 
which is supposed to be inactivated if its GAP, the TSC complex, localizes to the lysosomal 
surface 113,124. Another indicator for the nucleotide state of the small GTPase could be their 
cellular localization, being active in membrane-bound state and inactive in cytosolic, GDI-
bound state. However, whether these paradigms are ubiquitously applicable to any small 
GTPase remains elusive. Specific biosensors for small GTPase activity, including the probes 
developed in this work, enable direct and spatiotemporal detection of the protein’s activity 
state in live cells.  
Future experiments will explore the role of Rab1b activity at the ER-Golgi interface 
using the conformational sensor. Rab1b localizes to different cellular compartments, 
including the Golgi and COP-coated vesicles at the ER-Golgi interface. Moreover, Rab1b was 
also found to colocalize with specific ERES markers and seems to play a role in cargo sorting 
during COPII budding 69,91,290. In contrast, the known Rab1 GEF and GAP were found to 
localize to the Golgi complex and the ER, respectively 80,90. The ER-localized 
Tre2/Bub2/Cdc16 domain containing protein TBC1D20 has been shown to promote GTP 
hydrolysis of Rab1b and Rab2a 89,90,93. While overexpression of TBC1D20 maintained Rab1b 
in its inactive state, causing a block of ER-to-Golgi transport and Golgi fragmentation 89,91, 
depletion of TBC1D20 did not affect anterograde transport 90. It was thus proposed, that an 
alternative, yet unknown GAP may be responsible for negative Rab1 regulation at the Golgi 
complex 90. Moreover, little is known about the Rab1 GEF, the mammalian multi-subunit 
protein complex Transport Protein Particle (mTRAPP). Three distinct multi-domain TRAPP 
complexes possessing GEF activity for Ypt1 were found in yeast. Each complex functions in a 
different trafficking pathway, including anterograde transport and trafficking from the ER to 
pre autophagosomal structures (PAS) 79,81,82. In contrast, composition and function of the 
mammalian TRAPP complex (mTRAPP) remain largely elusive (reviewed in 76). Based on 
genetic interaction maps, two mammalian TRAPP complexes, mTRAPP II and III, were 
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proposed, but no evidence was found for a potential mTRAPP I complex 78. Localization and 
knock down studies of specific subunits suggested a role of mTRAPP II in ER-to-Golgi 
transport, whereas trafficking at the late Golgi is independent of mTRAPP II 80,85. Moreover, 
due to the interaction of mTRAPP II and III subunits with COPI and COPII coat components, a 
role for TRAPP complexes as tethers for vesicle tethering and fusion has been proposed 
78,80,84. Whether the function of mTRAPP complexes in ER-to-Golgi transport is restricted on 
its function as a Rab1 GEF, or if the complex alone could act as a tether, remains 
controversial. Thus, both regulatory enzymes of Rab1 are involved in ER-to-Golgi 
anterograde transport, but their colocalization with Rab1 is not sufficient to explain Rab1 
activity in membrane trafficking.  
 
The lysosomal fraction of the small GTPase Rheb has been shown to play a key role in 
nutrient sensing and mTORC1 activation upon growth factor stimulation. Although in this 
study insulin treatment was used as a proof of principle to confirm Rheb sensor 
functionality, it is the first direct evidence of Rheb activation during the growth factor 
sensing process. Rheb activity was traditionally monitored by indirect read-out of 
phosphorylation of mTORC1 substrates such as S6K1 or 4E-BP1, because Rheb-mediated 
mTORC1 activation is nucleotide-state dependent 126-129,173. Another study utilized 
fluorescent protein tagged mTORC1 and Rheb to monitor their interaction by fluorescence 
lifetime analysis 291. However, in both cases the exact activity state of Rheb remained 
elusive. Different signaling pathways were proposed for signal integration at the lysosomal 
surface. Two main signaling axes have evolved, the PI3K-AKT-pathway which acts through 
TSC complex localization and activity to activate mTORC1 via Rheb, and the RagGTPase 
mediated TSC recruitment to sense amino acids. However, a plethora of other signals 
collectively restrict mTORC1 mediated cell growth, such as hypoxia 130,132,292, low energy 
137,175 and genotoxic stress 131. Several stimuli regulate mTORC1 in a TSC-dependent fashion, 
while other signals, such as energy depletion, have been shown to act directly on Rheb by 
phosphorylation of Rheb S130 137. Thus, Rheb is indispensible for mTORC1 activation by 
virtually all stimuli, although the exact mechanism remains unclear.  
In addition to mTORC1-dependent function, Rheb was reported to play regulatory roles 
in mTORC1-independent fashion. Rheb were found to bind GAPDH and that interaction is 
depending on the enzyme’s substrate abundance 139,140. Interestingly, the interaction of 
Rheb and GAPDH was not altered by the nucleotide state and did not depend on TSC 
activity. This study suggested a mechanism by which GAPDH sequesters Rheb away from 
mTORC1 under low glucose conditions, whereas glucose-rich conditions disrupted Rheb-
GAPDH interaction, allowing for Rheb-mediated mTORC1 activation and eventually cell 
growth. A similar substrate-dependent binding mechanism was reported for PDE4D and 
Rheb, but whether this interaction alters mTORC1 activity was not determined 138. Hence, 
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the small GTPase Rheb possesses a variety of cellular signaling functions. While Rheb-
mediated mTORC1-activation seems to depend on the Rheb nucleotide-state 126,128,129, 
other stimuli may not alter Rheb nucleotide binding. The newly developed conformational 
sensor for Rheb activity will enable to directly monitor spatiotemporally Rheb signaling 
allowing for precise detection of the Rheb nucleotide state in response to specific stimuli. In 
combination with traditional methods to monitor mTORC1 activity, the Rheb sensor will 
provide insights into the signal integration at the Rheb-mTORC1 hub.  
In the past, development of a Rheb sensor was impaired by the lack of known Rheb 
effectors. Specific binding domains of small GTPase effector proteins are traditionally used 
as affinity tags to generate intramolecular FRET probes, allowing for spatiotemporal 
tracking of protein activity in cells. However, the FRET signal of such probes depends on the 
interaction of the affinity tag with the active small GTPase. Thus, protein activation is 
reported indirectly by the binding of the effector domain. Another disadvantage of these 
probes is the incorporated specific effector binding, which competes in binding to the small 
GTPase with endogenous proteins. In contrast, the sensors for small GTPase activity 
presented here directly report conformational changes instead of a subsequent binding 
event. Moreover, the conformational probes are independent of an affinity tag and can 
hence also be applied on small GTPases without known effectors. Furthermore, these 
sensors underlie native regulation by endogenous proteins, e.g. GEF or GAP, and, due to the 
lack of an intramolecular affinity tag, interaction with endogenous proteins is not affected. 
However, although the labor-intensive preparation process of the first generation of 
conformational sensors for small GTPase activity was circumvented by the use of amber 
suppression technique and intracellular labeling approach, the sensor establishment 
remains challenging. UAA methodology has been massively enhanced in the past few years 
and became more wide-spread, allowing for broad applications. In contrast, intracellular 
labeling remained largely challenging, which limits its application. Nevertheless, the rapid 
progress in the UAA field may also promote intracellular fluorescence labeling approaches, 
e.g. by development of new UAA and tetrazine-functionalized dyes for intracellular labeling 
219,293. The growing number of applications and studies using this sophisticated 
methodology, such as the here presented work, will enhance general user knowledge, 
facilitating development of new methods. Ultimately, this process may also promote the 
use of the genetically encoded conformational probes for small GTPase activity developed 
in this study. 
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